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An ageing population has raised the priority of reducing the risk for age-related eye 
diseases that impair sight and quality of life. Chief among these diseases is age- 
related macular degeneration (AMD), the leading cause of visual impairment among 
older adults in the developed world. The dietary xanthophylls lutein and zeaxanthin 
may be effective at attenuating the risk and/or progression of AMD due to their 
antioxidant and photo-protective properties in the macula, where they are known as 
the macular pigment. The macular pigment is entirely of dietary origin therefore it is 
important that AMD patients adopt appropriate dietary modification. 
Currently, there is a lack of information regarding the lutein values of specific 
xanthophyll containing food sources. A lab based investigation was undertaken to 
determine the lutein concentrations in kale by high-performance liquid 
chromatography (HPLC); information was established that may improve knowledge 
on the climate and post-harvest handling, processing and storage effects. Lutein 
concentrations in minimally processed kale were significantly lower (p<0.001) than 
that of kale freshly harvested. Domestic cooking and storage also had substantial 
negative effects on kale lutein levels. 
A dietary analysis study and a qualitative based study were conducted to determine 
dietary habits in AMD patients. In align with previous work, AMD patients were found 
to be under consuming nutrients regarded as important for their condition. Subjects 
consumed an average of 1.7 mg of L and Z per day, and calorie intakes were 
significantly below government DRVs (p<0.05). Further investigations suggested that 
this may be attributed to certain physical and psychosocial barriers. Using the results 
of the laboratory based study, ready meals were created as a novel intervention to 
improve diet in this population. 
This body of research adds insights into dietary interventions within visually impaired 
groups, studies embedded may enrich dietary advice in the context of AMD. 
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Chapter 1: Introduction 
Age-related macular degeneration (AMD) is a multifactorial progressive condition 
affecting the macula, the central area of the retina in the posterior eye. It is the leading 
cause of visual impairment and blindness registration in the UK [1] [2]. In 2008 the 
direct and indirect healthcare costs associated with sight loss were around £6.5 billion 
in the UK which is likely to increase as the number of people with sight loss increases 
[3]. Along with the burgeoning population of elderly, the number of people suffering 
with AMD in the UK is predicted to rise, potentially totalling nearly 700,000 cases by 
2020 [2]. In the last decade, tremendous research progress has helped with the 
understanding of the pathogenesis of the disease and in the development of 
treatment and preventive strategies. While treatments for neovascular (wet) AMD 
have been used to limit the progression of the condition and reduce the risk of vision 
loss, proven treatments for the atrophic (dry) form of AMD are yet to be established. 
Preventive interventions through dietary modification and supplementation have been 
the focus of a number of observational and interventional trials, [4-10]. This is in part 
due to the fact they are more affordable than clinical therapies, do not require 
specialists for administration and many studies suggest that specific nutritional 
compounds, such as antioxidants and lipids, may influence the 
development/progression of AMD with few, if any, adverse effects. 
1.1 Pathogenesis of AMD 
AMD is the degradation of the macula, a pigmented area at the central part of the 
retina. Near the centre of the macula is the fovea, a small pit that contains a high 
density of photoreceptors that are responsible for sharp, high-resolution central 
vision. This part of the retina is able to receive light signals and rapidly transform such 
signals into chemical and then electrical signals that are sent to the brain via the optic 
nerve. The brain then converts these electrical signals into visual images. The 
characteristics of AMD include the loss of central visual function occurring within days 
or over many years, depending on the type and severity of AMD. 
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Figure 1.1: Fundus photograph of the back of the eye (source: Aston University staff 
member, consent obtained). 
The following is a fundus photograph of the retina on the interior surface of a healthy 
eye, showing the macula region and fovea within the shaded area. The retina is the 
light-sensitive layer lining the inner surface of the eye that contains the photoreceptor 
rod and cone cells. The fovea is the central area of the macula that contains the 
highest density of these cells. 
If the photoreceptors in the macular region are damaged, as in AMD, the central field 
of vision is distorted or lost [5]. These photoreceptors are damaged by exposure to 
extensive oxidative stress in the form of light and oxygen [6] and as a result are 
persistently shed and turned over. The retinal pigment epithelium (RPE) is 
responsible for the degradation of the photoreceptor debris and for maintaining the 
nourishment of the photoreceptors by adequate nutritional support. In the early stages 
of AMD the combination of inadequate nutritional support and the inability to properly 
degrade and dispose of cellular debris by the RPE may contribute to the deposition 
of metabolic debris between the RPE and Bruch’s membrane [11]. These lipid 
deposits are clinically visual as pale yellow spots known as ‘drusen’ and are the first 
indicators of early AMD [12], as shown in figure 2.1. In the later stages of the disease, 
the RPE may atrophy completely. Atrophy can occur in small areas or can be 
widespread. This form of the disease is known as ‘dry AMD’ or ‘geographic atrophy’. 
In some cases, new blood vessels (neovascular capillaries) grow under the RPE and 
occasionally into the sub retinal space. This is known as ‘wet’ or ‘neovascular’ AMD 
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[13]. Haemorrhage can also occur which often results in increased scarring of the 
retina. The early stages of the disease are in general asymptomatic. In the later 
stages, there may be considerable distortion within the central visual field leading to 
a complete loss of central visual function. 
Figure 2.1: Retinal changes of AMD with age. 
The figure displays the graphical breakdown of the photoreceptor cells in the macula 
responsible for the production of high resolution central vision. 
Geographic atrophy or dry AMD is the most common form, and is estimated to be 
present in 15% of eyes by 80 years of age [14], [15], [16]. Progression is slow and 
legal blindness has been estimated to occur between 5 and 10 years [17]. 
Neovascular AMD is less common, occurring in 5.2% of the population over 75 years 
[18], but accounts for  90% of blind registrations [19]. In terms of the demographics 
of AMD, women have a slightly higher risk for AMD than men. Non-Hispanic blacks 
have less risk for non-exudative AMD at age 80 than Caucasians, and Asians have a 
higher rate of non-exudative AMD at age 60 than Caucasians [20, 21]. The three main 
risk factors for AMD are increasing age [22], [23], [24], [25], smoking [26], [27], and 
genetic predisposition [28], [29], [30] although other proposed factors include gender 
[18], race [31], [20], socioeconomic factors [23], cardiovascular disease [23], [28], 
[32], [33], and as mentioned an area of increasing significance, poor nutrition [34], 
[35]. These risk factors for AMD have been comprehensively studied in the following 
reviews [36], [37]. Currently, there are no therapies to treat dry AMD [38] [24]. There 
are  available  treatments  for  some  neovascular  AMD  patients  in  the  form  of 
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photocoagulation, photodynamic therapies or pharmacological approaches by 
inhibition of the angiogenesis [39]. However, the difficulty in the active management 
of these therapies has instigated a critical need for the prevention of the onset or 
progression of AMD through use of dietary antioxidants. 
 
It is thought that people with low systemic antioxidant levels may be more prone to 
oxidative damage of the retina and therefore, AMD [46]. Oxidation is a natural process 
of the body and may be defined as the loss of at least one electron when two or more 
substances interact and produce Reactive Oxygen Species (ROS). Oxidative stress 
may refer to cellular damage by ROS, which include free radicals, hydrogen peroxide, 
and singlet oxygen [47]. In a biological context, most ROS are generated as natural 
by-products of normal cellular metabolism and play vital roles in stimulation of 
signalling pathways in plant and animal cells in response to changes of intra- and 
extracellular environmental conditions [40]. ROS are also generated by exogenous 
sources such as pollutants, tobacco, smoke and radiation. When ROS overwhelm the 
cellular antioxidant defence system, whether through an increase in ROS levels or a 
decrease in the cellular antioxidant capacity, oxidative stress occurs [41]. This may 
result in significant damage to cell structures as these molecules contain one or more 
unpaired electrons and are rendered unstable and a cytotoxic chain reaction results. 
Proteins and lipids are significant targets for oxidative attack, and modification of 
these molecules can increase the risk of mutagenesis [42]. Lipid peroxidation is 
defined as the process where reactive oxygen species readily attack the 
polyunsaturated fatty acids of the fatty acid membrane, initiating a self-propagating 
chain reaction. The destruction of membrane lipids and the end-products of lipid 
peroxidation reactions are especially dangerous for the viability of cells and tissues 
[43]. The retina is particularly susceptible to oxidative stress because of its high 
consumption of oxygen, high tissue content of polyunsaturated fatty acids and its 
frequent exposure to visible light [44]. 
 
Ocular tissues encompass both low molecular weight antioxidants (ascorbic acid, 
glutathione and alpha-tocopherol) and high molecular weight antioxidants (catalase, 
superoxide dismutase, glutathione peroxidase and reductase) which are essential 
components in the protection against oxidative damage [45]. The eye has a 
particularly high metabolic rate, and thus an added need for antioxidant protection. 
Moreover, the natural ageing process decreases the normal production of 
antioxidants in the ocular media [46], [47, 48]. The macular in particular has a high 
density of photoreceptor cells which are susceptible to light induced damage. A 
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photosensitizer is a light-absorbing substance that initiates a photochemical or 
photophysical reaction. The retina contains a large number of chromophores many of 
which become photosensitizers when excited by the appropriate wavelength of light 
[49]. After initial photon absorption, a change in distribution of electrons in the 
chromophores/photosensitizer molecule occurs and generates an excited singlet 
state. In this long-lived state, interactions with other intracellular molecules occur 
generating ROS either via electron transfer (type I photosensitization), or singlet 
oxygen (type II photosensitization) [50]. These factors have led to an increased 
interest in the use of dietary antioxidants as a form of added protection against 
oxidative stress in the retina and subsequent ocular disease [51], [52]. Free radical 
scavengers such α-tocopherol (vitamin E), ascorbic acid (vitamin C) and lutein (L) 
and zeaxanthin (Z) are thought to serve as exogenous components of an endogenous 
defence system that may help to limit light-induced retinal damage [53], [54]. 
 
1.2 The role of nutrition in AMD 
 
 
Evidence supporting an oxidative pathogenesis of AMD and the lack of effective 
treatment options has increased interest in the potential preventative role of nutritional 
supplementation or dietary modification. There have been many large and small scale 
trials which have investigated the link between nutrition and AMD which have yielded 
positive results. The nutrients associated with the prevention of onset of progression 
of AMD include the antioxidant vitamins C, E and the vitamin A precursor beta- 
carotene, the xanthophylls L and Z, omega-3 fatty acids DHA and EPA, zinc, and 
some B vitamins (folic acid, B2, B3, B6, and B12) [55], [56]. 
 
Antioxidant vitamins 
 
 
With the possibility that long-term exposure to free radicals damages the internal 
ocular media, diets rich in antioxidants have become of interest with regard to AMD. 
The antioxidant vitamins which are of particular interest include vitamins A (in the 
form of beta-carotene), E (in the form of alpha-tocopherol), and C. Beta carotene is a 
pro-vitamin A carotenoid and the major precursor of vitamin A.  Beta-carotene is 
predominantly found in fruits and vegetables. It is regarded as a powerful antioxidant 
and has a well-documented role as a quencher of singlet oxygen radicals [57]. Vitamin 
E, in the form of alpha-tocopherol [58], [59] is predominant in the retina where it is the 
major lipid-soluble antioxidant of all cellular membranes and lipoproteins [57] [60]. It 
is highly important in the protection against lipid peroxidation which the eye is 
particularly susceptible to due to the high concentration of fatty acids [61]. Other roles 
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of α-tocopherol that are of benefit to ocular health include the maintenance of 
membrane integrity, lipid metabolism and effective scavenging of ROS [62], [63]. 
Vitamin C is water-soluble and is involved with several biological processes. It has 
been shown to have antioxidant properties which enable it to react directly with 
hydroxyl radicals [64], superoxide [65] and singlet oxygen molecules [66]. 
 
The largest trials to investigate the impact of these vitamins combined with other 
antioxidants, on AMD were the Age-Related Eye Disease Studies (AREDS 1 and 2). 
This first AREDS trial in 1992 was a long-term multi-centre, prospective study of the 
clinical course of AMD and age-related cataract. The AREDS trial included a clinical, 
randomised placebo controlled study to evaluate the effects of high-doses of 
antioxidant vitamins and zinc on the progression of AMD and vision loss. AREDS 
participants were 55 to 80 years of age at enrolment and had to be free of any illness 
or condition that would make long-term follow-up or compliance with study 
medications unlikely or difficult. On the basis of fundus photographs graded by a 
central reading centre, best-corrected visual acuity and ophthalmologic evaluations, 
4,757 participants were enrolled in one of several AMD categories (table 1.1). The 
participants' stages of disease ranged from early signs of AMD in one or both eyes 
such as the presence of small of medium size drusen, to advanced AMD with vision 
loss in one eye but good vision (at least 20/30) in the other eye. 
 
 
Category 1 Category 2 Category 3 Category 4 
No AMD Early AMD Intermediate AMD Advanced AMD 
A few small or no 
drusen in either 
eye 
Several small 
drusen or a few 
medium sized 
drusen in both eyes 
Many medium-sized 
drusen or one or more 
large drusen in one or 
both eyes 
In one eye only, either a 
break-down of 
photoreceptor cells and 
supporting tissue in the 
central retinal area 
(advanced dry form), or 
abnormal and fragile blood 
vessels under the retina 
(wet form) 
 
Table 1.1 AREDS 1 study categories 
 
This first AREDS trial found that people with the intermediate stage of dry AMD or 
advanced AMD in one eye had a 25% relative risk reduction of developing advanced 
AMD over 5 years after taking a supplement which contained beta-carotene (15mg), 
vitamin C (500mg), vitamin E (400IU), zinc (80mg) and copper (2mg). However, the 
absolute risk reduction in progression to advanced AMD was 8%, from 28% in the 
placebo group compared to 20% in the group taking the AREDS formula. The small 
amount of copper was added to the supplement as high doses of zinc can reduce the 
levels of copper in the body [8]. The relative risk of losing vision of three or more lines 
16  
was reduced by 19% with this combination treatment and the absolute risk reduction 
for visual acuity loss was 6%. For those study participants who either had no AMD or 
early AMD, the nutritional combination did not provide an apparent benefit. It was 
concluded from the study that those with extensive intermediate drusen, large drusen, 
or non-central geographic atrophy (GA) in one or both eyes, or visual acuity <20/32 
attributable to AMD in one eye and without contraindications such as smoking, should 
consider taking a supplement of antioxidants plus zinc at the dosages used in the trial 
[8]. Although the AREDS 1 trial gave some promise to nutritional therapy combatting 
the progression of AMD, the safety of the formula was questioned due to the high 
doses of nutrients. The UK government recommends that the daily values of these 
nutrients for those over the age of 50 years should be 40 mg per day for vitamin C, 
10 mg per day for vitamin E, 15 mg per day for beta-carotene and 9.5 mg per day for 
zinc. Table 1.2 displays the combination amounts of nutrients in the AREDS formula 
in comparison with the UK Reference Nutrient Intakes (RNI’s). The RNI values for 
protein, vitamins and minerals are set for each age/sex group at a level of intake 
considered likely to be sufficient to meet the requirements of 97.5% of the population. 
 
These UK dietary guidelines are based on the 1991 Report on Dietary Reference 
Values (DRVs) and set up by the Committee on Medical Aspects of Food Policy 
(COMA). They include DRVs for energy, protein, fats, sugars, starches, non- 
polysaccharides (NPS) and 13 vitamins and 18 minerals [67]. The panel found no 
single criterion to define requirements for all nutrients, so the recommendations are 
based upon reliable experimental, associations and epidemiological data. For most 
nutrients, the panel found insufficient data to establish any of these DRVs with great 
confidence. Thus hypothetical judgements had to be made due to the uncertainties 
relating to the appropriate parameter by which to assess the requirement and the 
questionable accuracy of dietary intake data. These references are the current 
measure until superseded by more rigorous validity studies. The Scientific Advisory 
Committee on Nutrition (SACN) is currently reviewing some of these nutrient 
recommendations. The DRV’s are deployed in a variety of ways in practice, such as 
indexes for surveys (EAR), guidance of dietary composition (RNI), for food labels 
(EAR) and for provision of a general guide in assessing the adequacy of an 
individual’s diet (LRNI/RNI). 
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AREDS 1 
 
Reference Nutrient Intake 
(RNI) 
 
 
Nutrient 
 
Amount 
 
(mg) 
 
 
Men 
 
 
Women 
 
 
Vitamin C 
 
 
500 
 
 
40 
 
 
40 
 
 
Vitamin E 
 
 
273 
 
 
10 
 
 
10 
 
 
Beta- 
carotene 
 
 
15 
 
 
15 
 
 
15 
 
 
Zinc 
 
 
80 
 
 
9.5 
 
 
7 
 
Table 2.1: AREDS 1 formulation and the corresponding reference nutrient intakes 
 
(RNIs) for men and women. 
 
 
The investigators of the AREDS 1 trial found marginal evidence to suggest there was 
an increased risk of genitourinary complications in subjects due to the high doses of 
zinc, (7.5% of subjects) [8]. Similarly, the safety of beta-carotene has been questioned 
in other studies. Two large randomised controlled trials indicated that smokers who 
take beta-carotene may be at an increased risk of developing lung cancer [68], [69]. 
In people with heart disease or diabetes taking high dose vitamin E supplements may 
also increase their risk of heart failure [70]. The follow up AREDS 2 trial published in 
2013 was designed to evaluate the effects of lutein, zeaxanthin and omega 3 as 
additional ingredients to the original AREDS formula. It also had the additional goal 
of assessing whether the safety of the formula could be improved by removing beta- 
carotene and reducing the amount of zinc to 25mg [71]. Results of the AREDS 2 trial 
will be discussed later with respect to the xanthophylls. 
 
Studies assessing supplementation with antioxidant vitamins individually in AMD and 
without the use of other antioxidants have been less consistent. Low levels of vitamin 
C in the serum have been associated with an increased risk of AMD, however high 
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levels were not found to be protective [72]. Vitamin C is also a water soluble nutrient 
meaning reliable estimates of its status within the body are difficult to assess. Other 
studies have found no evidence for a beneficial role of vitamin C supplementation 
within AMD [73], [74], [75]. A recent randomised, double-masked, placebo-controlled 
trial which investigated 8 years of treatment and follow-up with 400IU/day of vitamin 
E (synthetic α-tocopherol) and 500mg/day of vitamin C (synthetic ascorbic acid) in 
14,236 healthy male physicians, found a total of 193 incident cases of visually 
significant AMD. There were 96 cases in the vitamin E group and 97 in the placebo 
group (hazard ratio [HR], 1.03; 95% confidence interval [CI], 0.78-1.37). For vitamin 
C, there were 97 cases in the active group and 96 in the placebo group (HR, 0.99; 
95% CI, 0.75-1.31), concluding that neither supplement had a beneficial effect on risk 
of incident diagnosis of AMD [73]. However, it is possible that the findings reflect the 
nutritional status of the study population as subjects were generally well-nourished 
and thus results may not apply to less well-nourished populations. 
 
Similarly, supplementation of over 29,000 male smokers in Finland with 20 mg/day of 
beta-carotene and 50 mg/day of alpha-tocopherol  for six years did not decrease the 
risk of AMD compared to placebo [76]. In the vitamin E cataract and ARM trial, 
(randomised controlled trial) 1204 men and women aged 55–80 years were randomly 
allocated vitamin E (335 mg of natural d-α tocopherol) or placebo and followed up for 
4 years. 82% of the subjects had no incidence of AMD. It was found that the incidence 
of early AMD was 8.6% in those receiving vitamin E versus 8.1% in those on placebo. 
For late disease, the incidence was 0.8% versus 0.6%. This study indicated that daily 
supplement with vitamin E supplement did not prevent the development or 
progression of early or later stages of AMD [77]. A placebo-controlled trial in a cohort 
of 22,071 healthy US men found that beta-carotene supplementation (50 mg every 
other day) had no effect on the incidence of ARM- an early stage of AMD [78]. 
Moreover, two large systematic reviews of randomised controlled trials have 
concluded that there is no evidence that beta-carotene supplementation prevents or 
delays the onset of AMD [79], [80]. 
 
Xanthophylls 
 
 
While the first AREDS study was in progress, evidence was emerging to suggest that 
the dietary xanthophylls L and Z may be more effective than other antioxidants 
nutrients in reducing AMD risk or progression due to their antioxidant and photo- 
protective properties [41]. Lutein and Z are part of the xanthophyll family of pigments, 
more specifically known as xanthophyll hydroxycarotenoids [81]. Within the eye, 
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these carotenoids are present in higher concentrations than other human tissues 
being particularly prominent in the peripheral retina, the iris and lens [82]. Lutein, Z 
and a related compound meso-zeaxanthin (MZ) are at their highest concentrations in 
the macula, were they are known as macular pigment (MP) [83]. The protective 
properties of the MP are now well established and include the ability to interact with 
free radicals, prevent lipid peroxidation and filter out high energy, damaging, blue light 
[84], [85], [86]. The macular pigment has biochemical significance to ocular health by 
possibly preventing disease onset and sustaining visual functionality through its 
antioxidant capabilities. Reactive oxygen species may be formed in the retina due to 
its high demand for oxygen. These highly oxidised radicals have shown to induce 
apoptosis of the macular photoreceptors; however L has been shown to scavenge 
the oxygen intermediate by quenching them via the numerous unconjugated double 
bonds in the L molecule [87]. Lutein has also been shown to inhibit lipid peroxidation 
by decreasing lipofuscin (lipid residue from liposomal digestion), which may 
contribute to drusen formation [88] [89] in cultured RPE cells [90]. By acting as a blue 
light filter, the lens and macular pigments can also protect the photoreceptor cells 
responsible for vision, from light induced damage. Lutein in particular has been shown 
to have the highest blue light filtering properties [84]. 
 
Lutein and Z are obtained by the human body exclusively from dietary sources [91], 
[81], and MZ is thought to be converted from L in the macula [92], [82]. Therefore, an 
individual’s ocular tissue concentrations of these nutrients can vary depending on diet 
and lifestyle habits. It has been reported that around 78% of dietary L and Z is 
obtained from vegetables, with the highest concentrations found in dark green leafy 
vegetables, such as kale and spinach [93], [94]. Corn and corn products are 
confirmed as being a major source of Z [95]. Eggs also contain high levels of L and Z 
and have enhanced bioavailability of carotenoids in this form due to the fat which they 
contain [96]. Similarly, cooking, or ingesting other carotenoid-containing foods with 
dietary fat, or choosing a nutritional supplement that contains L and Z bound in oil, 
can also increase the bioavailability of L and Z [97].  It appears that humans intake 
low levels of MZ from the diet, however research is still on going in this area. Some 
food items have been reported as being rich sources of MZ such as eggs from hens 
fed MZ [114], and specific species of edible sea food such as shrimp. 
 
Macular pigment optical density (MPOD – the amount of MP measured in the retina) 
can be increased with appropriate dietary modification: either by supplementation 
with L and Z or by consuming L and Z rich foods, as demonstrated in human and 
animal epidemiological and intervention trials [98-106]. A large body of this evidence 
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suggests that doses of 10mg/day or higher of L are associated with the most positive 
effects on MPOD [99-101,103,104]. One research group has investigated the 
relationship between supplemental MZ and MPOD. Their findings suggest that MPOD 
may also be increased with supplements which contain all three macular carotenoids, 
potentially offering advantages over preparations lacking in MZ. A study involving high 
MZ (20mg per day), and low L and Z supplementation reported that MPOD increased 
significantly over a period of 120 days. The average rate of increase for MP in both 
eyes of all 10 subjects was 0.56 mAU/day (range 0 to 2.2 mAU/day). The average 
rate of increase in MPOD was very similar to the value of 0.53 mAU/day observed in 
an earlier supplementation study where subjects took 20 mg/day of lutein. A milli 
absorbance unit (mAU) refers to the amount of light absorbed by a material, in this 
case the macula. At 20 mg/day, over a 120-day period, the predominantly MZ 
supplement was capable of increasing MPOD by an average of 18% [26]. 
 
Other factors which may influence MP levels include smoking habits (lower levels in 
smokers) [107], iris colour (lower levels with lighter iris colour) [108], gender (higher 
levels reported in men in some studies) [109], [110], and body fat (lower levels in 
those with a high percentage of adipose tissue) [111], [112]. The possible 
explanations for a relative lack of MP among cigarette smokers include a poor diet 
(with consequentially reduced levels of antioxidants) and/or increased overall oxidant 
load associated with tobacco.   Smokers also frequently display evidence of 
inflammation, due to increases in the systemic inflammatory marker C-reactive 
protein [113] [114]. Inflammation in both smokers and non-smokers is inversely 
related to serum carotenoid concentrations [115]. Studies have also reported that 
elevated concentrations of C-reactive protein are an independent risk factor for AMD 
[116]. The inverse relationship between increased adipose tissue and MPOD may be 
explained by the competition between the retina and adipose tissue for the absorption 
and uptake of carotenoids, with the idea that adipose tissue acts as a sink and a 
reservoir for these nutrients [111], [117], [118]. This is because among all the tissues 
that store carotenoid pigments [119, 120] adipose tissue contains more than 80% of 
the body carotenoids [121]. Furthermore, increased body max index has been 
reported to result in increased oxidative stress [122], [123], [124], and reduced 
antioxidant defence mechanisms [125] which have been linked to the pathogenesis 
of AMD [126]. However, it is also possible that a relative lack of MP in obese subjects 
simply reflects a poor diet among those persons, as it has been demonstrated that 
obesity is correlated with reduced dietary intake of the carotenoids which comprise 
the macular pigment [119], [118]. 
21  
Supplementation with L and Z has been correlated with a delay in progression or 
onset of AMD in some epidemiological and intervention studies, therefore on-going 
research into its role is important. The AREDS 2 is the largest trial to date that has 
investigated the effect of omega-3 fatty acids and/or L and Z within AMD. It was a 
multi-centre, randomised trial designed to assess the effects of oral supplementation 
of the macular xanthophylls (L and Z) and/or long-chain omega-3 fatty acids (DHA 
and EPA) on the progression to advanced AMD.  Due to the possible side effects 
associated with high dose zinc and beta-carotene supplementation the trial also 
investigated whether a modified supplement with reduced zinc and/or no beta- 
carotene provided benefits similar to the original AREDS supplement. Inclusion 
criteria were males and females aged 50 to 85 years who were present with bilateral 
large drusen (≥ 125 microns) or large drusen in one eye and advanced AMD in the 
fellow eye. A study eye (eye without advanced AMD) may have been present with 
definite geographic atrophy not involving the centre of the macula without evidence 
of drusen, i.e. anybody with dry AMD in both eyes and dry AMD in one eye and wet 
AMD in the other eye [10].  In the primary analysis, participants were given one of 
four supplements to take on a daily basis, which included a placebo, L/Z, omega 3 
fatty acids, or L/Z plus omega 3 fatty acids.  Participants were also given one of four 
versions of the original AREDS formula to take simultaneously. The following figure 
shows a summarised study design key of the AREDS 2 trial. 
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Figure 2.2: AREDS 2 study design key. L/Z – Lutein/zeaxanthin, DHA/EPA – 
docosahexaenoic acid/eicosapentaenoic acid (omega-3 long-chain polyunsaturated 
fatty acids), AREDS 2 – Age-related eye disease study 2. 
 
 
The study found that overall there was no additional benefit of adding omega 3 fatty 
acids (DHA 350mg EPA 650mg), 10 mg of L and 2 mg of Z to the original AREDS 
formula of antioxidants. However, participants who took the AREDS formulation with 
no beta-carotene but with L and Z at these doses, had their risk of progression to 
advanced AMD reduced by 18% compared to those participants who took the AREDS 
formulation that contained beta-carotene without L and Z. In addition, participants 
who had a low dietary intake of L and Z at the start of the study (≤ 0.823 mg per day), 
but who took the AREDS formulation with L and Z during the study, were 25% less 
likely to develop advanced AMD compared with participants with similar dietary intake 
who did not take L and Z. There was no benefit from L and Z supplementation to 
those who consumed ≥ 1.030 mg of L and Z per day in their diet [71]. 
 
Investigators have suggested that beta-carotene may have masked the effects of L 
and Z in the overall analysis because it competes for absorption in the body. 
Participants who took beta-carotene and L and Z, had lower blood levels of both 
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compared with those who only took L and Z. The investigators also found that former 
smokers, who made up approximately half of the study population, were at greater 
risk of developing lung cancer if they took the formula which contained beta-carotene. 
This means it is likely to be safer for anybody who has ever smoked not to take 
supplements that contain beta-carotene. The results suggest that taking a 
combination of 500 mg vitamin C, 400 IU vitamin E, 25 mg zinc, 2 mg copper, 10 mg 
L and 2 mg Z may reduce the risk of progression to advanced AMD in people who 
already have signs of the disease. Including L and Z in the original AREDS 
formulation rather than beta-carotene appears to be safer and more effective. 
Reducing the amount of zinc from 80 mg to 25 mg does not appear to impact on the 
effectiveness of the formulation, and a formulation with a reduced zinc content is very 
likely to result in fewer gastrointestinal side effects [71]. 
 
Other large scale epidemiological studies such as the NHANES and the EDCC trials 
provide evidence that antioxidant status, particularly dietary xanthophyll intake may 
protect against the onset of AMD [127], [72].  In 2006, the CAREDS trial concluded 
that L-rich and Z-rich diets may protect against intermediate AMD in female patients 
less than 75 years of age [128]. The Blue Mountain Eye study reported that higher 
dietary L and Z intake reduced the risk of incident early or neovascular AMD over 5 
and 10 years [129]. Moreover, a number of small randomised controlled trials have 
reported positive effects of lutein supplementation on visual performance in AMD 
patients, in terms of visual acuity, contrast sensitivity, glare recovery and visual 
distortion. Similarly, the majority of these trials have found improved measures of 
visual function in patients given 10 mg or higher per day with L alone or combined 
with Z and other antioxidants [130-133]. Supplementation with lower doses has not 
been found to show these results in some studies [134], [135].  Further studies are 
needed with more patients, of both genders, and for longer periods of time to assess 
long-term effects of L alone or L together with a broad spectrum of antioxidants on 
visual function. The AREDS 2 trial found no effect of L and Z together on visual acuity 
[71]. The trial analysed the progression to moderate or worse vision loss, defined as 
a reduction of 15 or more letters, as a secondary outcome. These results suggest that 
findings from smaller trials which suggest an inverse association between L and Z 
supplementation and visual performance should be treated with caution [130-133]. 
 
Omega-3 fatty acids 
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Omega-3 fatty acids are essential nutrients meaning humans have to obtain them 
exclusively from dietary sources. They include alpha-linolenic acid (a short-chain 
omega-3 fatty acid), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), 
(both long chain omega 3 fatty acids). Alpha-linolenic acid is the dietary precursor to 
both DHA and EPA and is converted to a long-chain omega-3 fatty acid [136]. Omega- 
3 fatty acids are well known to exhibit anti-inflammatory, anti-atherosclerotic and anti- 
thrombotic effects on vascular tissue [137], [138] which have been largely correlated 
with a reduced risk of cardiovascular health problems in several epidemiological 
studies [139], [140]. It is hypothesized that cardiovascular disease and AMD share 
similar mechanisms and risk factors, as omega-3 fatty acids such as DHA have been 
found in high concentrations in the retina, where they are important structural 
components of vascular tissue and retinal photoreceptor- rod and cone outer 
segments, which are systematically shed and turned over during the visual cycle 
[141], [142]. 
 
Long-chain omega-3 fatty acids predominantly found in oily fish, may also protect 
against oxidative damage and help modulate retinal cell gene expression, cellular 
differentiation and cellular survival [143]. The critical role of DHA in normal retinal 
function is well documented in animals [144], [145], and humans [9], [146], [147]. It 
has an influence on cell membrane integrity and permeability, modulates the activity 
of enzymes and receptors on the membrane and acts as a precursor for the synthesis 
of other important biological molecules [9]. Observational studies suggest that 
omega-3 poly-unsaturated fatty acids (PUFA) are protective in the eye. A 2008 meta- 
analysis of epidemiological studies reported that a high intake of omega-3 fatty acids 
and fish intake at least twice a week may reduce the primary risk of both early and 
late AMD by up to 38% [148]. In a 5-year follow-up study of the Blue Mountains Eye 
Study cohort, fish consumption at least once a week was associated with a 40% 
reduction in incident early AMD and more frequent consumption of fish (3 times a 
week) was found to be protective against late age-related maculopathy (ARM) [149]. 
Other studies have found similar findings [150-153]. Some prospective studies also 
reveal a decreased likeliness of AMD progression in those with early AMD [154-156]. 
It is important to note that in these studies, positive correlations involving the risk or 
progression of AMD were only seen in subjects who had a low dietary intake of 
omega-6 fatty acids. These findings support similar evidence found in other cohort 
studies [157], [154] highlighting the importance of maintaining a healthy ratio between 
these two essential fatty acids in the diet [158, 159]. Increased dietary intake of 
omega-6 fatty acids can lead to oxidation of LDL cholesterol, platelet aggregation and 
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interference with the incorporation of EPA and DHA in cell membrane phospholipids 
[158]. Western diets are characterized by high omega-6 and low omega-3 fatty acid 
intake, with a ratio of omega-6 to omega-3 of 10–20:1 [17] [18], which is due to the 
increased consumption of omega 6-rich vegetable oils, and the low consumption of 
fish [19]. Optimal dietary intakes of the n-6 : n-3 ratio are however estimated to be 
around 1–4 : 1 [160]. 
 
There is a small amount of conflicting evidence which suggests no effect on the risk 
or progression of AMD [161], [71] or an increased risk of progression of AMD with 
omega-3 fatty acids [162], [163].  Primary, secondary and subgroup analyses from 
the AREDS 2 trial demonstrated no additional benefit on the reduced risk of 
progression to advanced AMD by adding the omega-3 fatty acids EPA and DHA to 
the original formulation. The doses used (DHA 650mg and EPA 350mg) were also 
found to exhibit no adverse effects after 5 years of follow up. These null results may 
mean that omega- 3 is simply an ineffective treatment option for AMD or it could be 
related to an inadequate dose, inadequate duration of treatment, or both [71]. 
 
Omega-3 supplements containing the doses used in the AREDS 2 trial may not be 
recommended for AMD patients; however, it is still essential that adequate amounts 
are met through diet alone as they have important cardiovascular health benefits. The 
UK Department of Health recommends consuming at least 1-2 portions of oily fish per 
week [164]. 
 
Zinc 
 
 
Zinc is the second most abundant trace mineral in the body as it is an essential 
component of over two hundred enzymes. It plays an important role in a number of 
physiological processes including immunity, reproduction, and neuronal development 
[165]. In the eye it acts as a cofactor for the antioxidant enzymes retinal 
dehydrogenase and catalase and is also involved in retinal metabolism [166]. Low 
levels of zinc are thought to play a role in the development of AMD for several 
reasons. Firstly, zinc is highly concentrated in the RPE [166], [167], [168] and retinal 
zinc levels have been shown to decline with age [169], [170], [171]. Thus, it is 
hypothesized that zinc supplementation may aid retinal health. 
 
The elderly are at particular risk from zinc deficiency [169], [170], [171], [172], which 
can lead to a reduction in T lymphocytes and B lymphocytes and the macrophage 
through increased apoptosis. Zinc deficiency can also alter the function of alcohol 
dehydrogenase in the retina [173], which can result in increased overall vitamin A 
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uptake. The possible accumulation of retinyl esters in the RPE may interfere with 
normal biosynthesis and could also produce a toxic effect. Furthermore, zinc 
deficiency promotes lipid peroxidation and damage to lipid membranes. [174] 
 
The evidence which suggests a link between dietary zinc and AMD comes mostly 
from the AREDS 1 and 2 trials. There have been no randomised or case controlled 
investigations involving zinc and the risk of AMD; however other prospective data has 
demonstrated some positive results. A small number of cohort studies assessing 
dietary intakes of zinc in elderly subjects have found an inverse relationship between 
high zinc intake and the incidence of early AMD [175], [150]  and any stage of AMD 
[176]. One study also reported a decrease in pigment abnormalities in those with a 
high consumption of zinc intake from food or supplements [75]. 
 
In terms of zinc intake and the progression of AMD, a large proportion of the perceived 
benefit comes from the AREDS 1 trial which found a 25% reduction in AMD 
progression in patients with early AMD using 80mg of zinc plus other antioxidants 
daily. Two smaller sized randomised clinical trials have also found that 
supplementation with zinc alone improves visual function in patients with AMD. The 
doses used in the studies were 25mg [177] and 100mg daily [178]. There were little 
adverse associations in the subject group who received 25mg of zinc. Other large 
cross sectional studies involving zinc and the progression of AMD have yielded 
conflicting results [7], [179], [180]. 
 
The negative effects of high zinc supplementation are not fully understood. It is 
suggested that intakes above the daily recommended values are associated with 
copper deficiency, [180], [181]. It was also found in the AREDS 1 trial that a small 
number of subjects (7.5%) receiving 80mg per day of zinc suffered with genitourinary 
infections [8]. The AREDS 2 trial found that reducing the amount of zinc from 80 mg 
to 25 mg does not appear to impact on the effectiveness of the formulation. Rates of 
reported gastrointestinal disorders and hospitalisations for genitourinary diseases 
were similar in the 2 randomly assigned groups (high-dose zinc, low-dose zinc) in the 
trial, however recommending an AREDS 2 formulation with a reduced zinc content 
(25mg) is considered safer  [71]. 
 
B vitamins 
 
 
The B vitamins are a group of water soluble nutrients. These vitamins, often referred 
to as B complex vitamins, play a role in energy conversion which help the body 
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metabolise fats and protein. B complex vitamins are needed for a healthy liver, skin, 
hair, and eyes. They also help with the function of the nervous system. Vitamin B2 
(riboflavin) acts as an antioxidant, has a role in the synthesis of steroids and 
erythrocytes (red blood cells), and in maintaining the integrity of mucous membranes. 
Vitamin B6 (pyroxidine) refers to a group of nitrogen-containing compounds with three 
primary forms: pyridoxine, pyridoxal and pyridoxamine. Vitamin B6 participates in 
over 100 enzymatic reactions and has a reported role in gluconeogenesis (the 
synthesis of glucose from non-carbohydrate sources) [182], lipid metabolism [183], 
erythrocyte metabolism [184], and immune function [185], [186]. Vitamin B12 is an 
essential cofactor for two enzymes: methylmalonyl-CoA mutase, is needed for fatty 
acid metabolism, and methionine synthase [187], which controls nucleic acid 
synthesis and methylation reactions within the body. Deficiency leads to 
megaloblastic anaemia via a reduced production of red blood cells. 
 
Vitamins B6, B12 and folic acid regulate levels of a protein known as homocysteine 
in the blood. High levels of homocysteine are a significant risk factor for 
cardiovascular disease and research suggests that cardiovascular disease and AMD 
share a similar risk profile. Furthermore, high levels of homocysteine have been found 
in AMD patients, suggesting an association between elevated serum homocysteine 
levels and the risk of AMD [188-191]. Treatment with folic acid, vitamin B6 and vitamin 
B12 has been shown to reduce homocysteine levels. In a meta-analysis of 
randomised controlled trials, folic acid lowered plasma homocysteine levels by 25%, 
and an addition of B12 lowered levels by a further 7% [192]. Further evidence from 
controlled trials since this review which examine the effect of therapy to lower 
homocysteine levels within AMD risk or progression are limited. There is one relatively 
large scale randomised controlled trial which suggests that a combination of folic acid, 
vitamin B12 and B6 may reduce the risk of AMD in those with pre-existing 
cardiovascular disease. [193] 
 
Although there are a significant proportion of studies suggesting an association 
between elevated plasma homocysteine and AMD regardless of the subtype, further 
evidence from controlled trials which examine the effect of these nutrients on 
homocysteine levels in relation to AMD risk or progression is limited and therefore 
they cannot be recommended as supplements. AMD patients can however try to 
include more foods in the diet which contain these nutrients such as whole grains, 
dairy products, leafy green vegetables, nuts, fish, beef, liver, poultry, potatoes and 
non-citrus fruits [194, 195]. 
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1.3 Bioavailability of lutein and zeaxanthin within food sources 
 
 
Lutein and Z are the only carotenoids found at appreciable levels in the macula [49, 
 
62–66], where they are implicated in the maintenance of retinal health and possible 
prevention of the onset or progression of AMD. Lutein and Z have been shown to 
protect against reactive oxygen species [87], and to inhibit lipid peroxidation by 
decreasing lipofuscin (lipid residue from liposomal digestion), which may contribute 
to drusen formation [88] [89] in cultured RPE cells [90]. Lutein has also been shown 
to have the highest blue light filtering properties. The concentration of L and Z in the 
macula and their potential biologic function may be modified by diet or supplement 
use and they are therefore the central focus of AMD research regarding nutrition [98, 
99]. 
 
 
Kale (Brassica oleracea var. sabellica), which is commonly cultivated in central and 
northern Europe and North America, belongs to the Brassicaceae family of 
vegetables.   It is an excellent source of dietary carotenoids and typically has the 
highest concentrations of L and Z amongst other green leafy vegetables [196], [94, 
95]. However, the qualitative and quantitative composition of carotenoids in fruits and 
vegetables is known to vary with multiple factors such as, cultivar or variety, maturity 
at harvest, climate, farming practice and post-harvest processing and storage [197- 
200]. Due to the high concentration of L and Z in dark green leafy vegetables their 
consumption is recommended in order to increase MP as prevention of onset or 
progression of AMD [55, 201]. It is therefore important to establish the most effective 
way to use these important food sources such as kale, in order to preserve the levels 
of L and Z. Results from such a study will provide patients and clinicians with a clearer 
understanding of the effects of pre-and post-harvest conditions on the carotenoid 
content of vegetables which will enable precise suggestions for increasing retinal 
levels of these nutrients.  Firstly, it is important to identify the specific effects of pre- 
and post-harvest conditions on L and Z concentrations in kale from the current 
literature, and thus to identify where further research is needed. 
 
A literature review was carried out to determine the compositional carotenoid 
variations in dark green leafy vegetables due to variety/cultivar, stage of maturity, 
climate or season, farming practice, storage, and processing effects. The review can 
be found published here: Walsh, R. Bartlett, H. Eperjesi, F. Variation in Carotenoid 
Content of Kale and Other Vegetables: A Review of Pre- and Post-Harvest 
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Effects, J. Agric. Food Chem., 2015, 63 (44), pp 9677–9682. The abstract is 
presented below and the full paper is attached in the appendix (appendix 1). 
 
 
Abstract 
 
 
Lutein and zeaxanthin are carotenoids that are selectively taken up into the macula 
of the eye, where they are thought to protect against the development of age-related 
macular degeneration. They are obtained from dietary sources, with the highest 
concentrations found in dark green leafy vegetables, such as kale and spinach. In 
this review, compositional variations due to variety/cultivar, stage of maturity, climate 
or season, farming practice, storage, and processing effects are highlighted. Only 
data from studies which report on lutein and zeaxanthin content in foods are reported. 
The main focus is kale; however, other predominantly xanthophyll containing 
vegetables such as spinach and broccoli are included. A small amount of data about 
exotic fruits is also referenced for comparison. The qualitative and quantitative 
composition of carotenoids in fruits and vegetables is known to vary with multiple 
factors. In kale, lutein and zeaxanthin levels are affected by pre-harvest effects such 
as maturity, climate, and farming practice. Further research is needed to determine 
the post-harvest processing and storage effects of lutein and zeaxanthin in kale; this 
will enable precise suggestions for increasing retinal levels of these nutrients. 
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Author Cultivar Maturity Climate Farming Practise 
Mercadante et al 
1991 [202] 
L concentrations in two field 
grown cultivars in Brazil 
ranged between 
11.4mg/100mg of fresh weight 
(‘tronchuda’) and 7.1 
mg/100mg of fresh weight 
(‘manteiga’). 
 Carotenoid concentrations were 
found to be higher in the winter 
than the summer for kale 
harvested in open fields, 
suggesting that sunlight and high 
temperature may promote photo 
degradation when vegetables are 
not protected by roofing or 
packaging 
The study compared kale of the 
same cultivar at the same stage 
of maturity produced on these 
opposing farms, and found 
significantly higher 
concentrations of all carotenoids 
in samples collected from the 
natural farm 
Kopsell et al 2004 
[198] 
L concentrations ranged from 
13.43 mg/100g fresh weight to 
a low of 4.84 mg/100g in 
cultivars. 
   
De-Azevedo, et al. 
2005 [199] 
 L and beta-carotene 
concentrations were much 
higher in fully expanded mature 
kale than younger leaves 
‘Manteiga’ kale purchased from a 
Brazillian supermarket and 
cultivated under polythene roofing, 
had a higher concentration of all 
four principal carotenoids in the 
summer as opposed to winter 
 
Lefrsrud, et al 2007 
[203] 
 Mature fully expanded kale 
leaves, harvested between 1-3 
weeks accumulated higher 
carotenoid concentrations than 
young leaves 
  
 
 
 
Table 2.2: Summary of studies which have investigated the pre-harvest effects on carotenoid concentrations (those which include L) in 
kale. 
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Author Storage Boiling/Blanching Steaming Frying Microwaving 
De-Azevedo, 
et al. 2005 
[199] 
In minimally processed 
kale monitored during 5 
days of storage at 7–9 
◦C, β-carotene, L, 
violaxanthin and 
neoxanthin were 
reduced by 14, 27, 20 
and 31% respectively. 
    
Murador et 
al. 2016 
[204] 
 Boiling after 4 min 
showed a higher 
degradation of total 
carotenoids in kale 
relative to the raw sample 
(77%; p < 0.0001). Raw 
kale contained 56.18 ± 
2.9 μg/g of lutein, after 
boiling this was 6.9 ± 
0.54 μg/g. 
Steaming kale for 5 min 
showed a degradation 
of 72% (p < 0.0001) of total 
carotenoids relative to the 
raw sample, however lutein 
levels decreased further than 
boiling to 5.81 ± 1.14 μg/g. 
Stir-fried kale (4 min with 
soybean oil) showed the best 
conservation of total 
carotenoids with a reduction 
of 55% (p < 0.0001) of the 
total carotenoids. For lutein, 
however, levels decreased 
further than all other cooking 
methods to 4.66 ± 1.81 μg/g. 
 
 
Table 2.3: Summary of studies which have investigated the post-harvest effects on carotenoid concentrations (those which include L) of 
kale. 
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The above tables summarise the findings of a small number of studies which have 
investigated the pre-and post-harvest effects on the carotenoid concentrations in 
kale. These include studies which have investigated the variation in L concentrations 
for different kale cultigens and the effects of maturity, climate, farming practice, 
storage and processing on kale carotenoid concentrations. One study to date has 
investigated the post-harvest storage effects on the carotenoid concentrations, 
including L, in kale. Since publication of the literature review, only one study to date 
has investigated the post-harvest domestic cooking effects on the L concentrations in 
kale. 
 
 
1.4 Summary 
 
 
Overall, there is a great deal of potential for the benefits of including nutrients such 
as antioxidant vitamins, L and Z, omega 3, and B vitamins in the diet of AMD patients 
and it is therefore important that people aged between 50 and 85 years who present 
with early signs of the disease are counselled about appropriate dietary modification 
or supplementation. The AREDS 1 and AREDS 2 are the largest clinical trials that 
have taken place in the field of nutrition and ocular disease and it is likely that eye 
care practitioners would feel more comfortable about recommending this specific 
combination of nutrients if dietary supplementation is chosen based on an individual’s 
suitability to the study criteria.  Results from the AREDS 2 trial suggest that taking a 
combination of 500 mg vitamin C, 400 IU vitamin E, 25 mg zinc, 2 mg copper, 10 mg 
L and 2 mg Z may reduce the risk of progression to advanced AMD in people who 
already present with signs of the disease. In this new AREDS formula beta-carotene 
has been replaced with L and Z, and the high levels of zinc have been reduced. In 
terms of dietary modification, patients should be encouraged to consume more dark 
green leafy vegetables such as kale and spinach to increase L levels in the diet. Oily 
fish should also be recommended in moderation to increase essential fatty acids in 
the diet as well as other food sources containing antioxidant vitamins and minerals 
such as nuts, seeds, and other fruits and vegetables. To provide patients with 
unsurpassed advice on enhancing MP levels through increased consumption of dark 
green leafy vegetables such as kale, it is essential that we gain further knowledge on 
how these food sources should be cooked and stored in order to best preserve the 
levels of L and Z. 
 
This chapter has reviewed the information regarding nutrition and AMD. In chapter 
two, an investigation of dietary intake amongst people with AMD will be described. 
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Chapter 2: Dietary analysis in AMD patients by repeat 24 hour recalls 
 
 
2.1 Background and rationale 
 
 
Age-related macular disease (ARMD) is a multifactorial degenerative condition 
affecting the central area of the retina. While treatments for neovascular AMD (wet 
AMD) have been used to limit the progression of the condition and reduce the risk of 
vision loss, proven treatments for the atrophic (dry) form of AMD are yet to be 
established. Preventive interventions through dietary modification and 
supplementation have therefore been the focus of a number of observational and 
randomised clinical trials, [4, 6-10]. This is in part due to the fact that they are more 
affordable than clinical therapies and do not require specialists for administration. In 
addition, many studies suggest that different nutritional factors, such as antioxidants 
and lipids, are believed to influence the development/progression of AMD with few, if 
any, adverse effects. The nutrients that have been associated with the prevention of 
onset or progression of such condition include the antioxidant vitamins C, E and the 
vitamin A precursor beta-carotene, the xanthophylls lutein (L) and zeaxanthin (Z), 
omega-3 fatty acids DHA and EPA, zinc, and some B vitamins (folic acid, B2, B3, B6, 
and B12) [8, 10, 55, 189, 193, 205]. 
 
This has been broadly supported by the AREDS 1 [8] and AREDS 2 [10], the two 
largest randomised clinical controlled trials in the field of nutrition and AMD. The first 
AREDS study documented that taking a supplement containing vitamins E and C, 
beta-carotene and zinc reduced the risk of progression of the disease by 25% in those 
with intermediate or advanced stages of the disease in one eye. Since then, the 
carotenoids L and Z have been identified as nutrients that can provide a protective 
role in the progression of AMD due to their antioxidant and photo-protective properties 
[50]. Collectively, L and Z form the macular pigment [206] which interacts with reactive 
oxygen species, prevents lipid peroxidation and filters out high energy blue light. The 
follow up AREDS 2 trial was the largest trial to date which has investigated the effect 
of omega-3 fatty acids and/or L and Z within AMD. The study found that overall there 
was no additional benefit of adding omega 3 fatty acids (DHA 350mg EPA 650mg), 
10 mg of L and 2 mg of Z to the original AREDS formula of antioxidants. However, 
participants who took the AREDS formulation with no beta-carotene but with L and Z 
at these doses, had their risk of progression to advanced AMD reduced by 18% 
compared to those participants who took the AREDS formulation that contained beta- 
carotene without L and Z [10]. 
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Not all AMD patients will benefit from an AREDS supplement. Those with very early 
stages of the disease may wish to consider dietary modification, as increasing intake 
of L and Z has been shown to increase macular pigment levels [207]. Macular 
pigments such as L and Z have biochemical significance to ocular health by possibly 
averting AMD onset and sustaining visual functionality through their potent 
antioxidant capabilities [208], [103]. Nutrients such as L and Z are not formed within 
the body and so can only be obtained from our diet. Patients are presented with a 
wealth of nutritional information available from a variety of sources such as 
magazines, newspapers and the internet. Conflicting information, a lack of evidential 
research and aggressive marketing campaigns have led to confusion among patients 
and practitioners in what supplements to take, and  what foods should be consumed 
in order to maximise absorption of L and Z [209]. Previous work from the author that 
characterised  AMD patients seeking the services of the Macular Society (A UK 
charity devoted to helping those with diseases of the macula) and determined their 
awareness of the relationship between nutrition and AMD, found that over half (63%) 
of the participants felt that they did not have enough information on lifestyle factors 
and their relationship to AMD [210].  Following the results of the AREDS2 trial, the 
Macular Society (MS) have advocated the use of the AREDS2 formulation, where 
appropriate, and eating vegetables that are L and Z rich. They also encourage the 
intake of a wide variety of fruits and vegetables in the diet to ensure an adequate 
supply of antioxidants such as vitamins A, C, E and zinc. Patients have access to a 
variety of nutritional information resources including leaflets, magazines and a patient 
portal displayed on the main website. 
 
One recent study within MS members analysed whether this ‘informed’ population 
were following the nutritional guidelines for AMD by analysing the individual dietary 
intake of nutrients and comparing the results with people not affected by AMD [211]. 
Interestingly, after assessment via a single 24 hour recall, it was found that many 
AMD participants were under-consuming nutrients considered to be useful for their 
condition, despite the wealth of nutritional information contained on the MS website. 
On average AMD patients consumed only 1.6 mg of lutein per day. These findings 
correspond with another study which estimated the intake of antioxidant nutrients in 
wet AMD patients living in the Balearic Islands, Spain using 24 hour recalls and food 
frequency questionnaires [212]. This study reported that the majority of patients 
showed inadequate antioxidant nutrient intake (<2/3 of Recommended Dietary Intake, 
(RDI)), and more than 60% of patients showed a deficient intake (< 1/3 recommended 
10mg) of L and Z. The fat and saturated fatty acids (SFA) intake of study participants 
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were also higher than recommendations; 61.9% of men and 58.1% of women were 
overweight; and 83% of patients (90.5% men and 77.4% women) showed body fat 
mass over the cut-off limits. It was concluded that the food pattern of wet AMD 
patients should be improved by means of an increase in the consumption of 
antioxidant rich foods, and a decrease in SFA rich foods [212]. 
 
In these previous studies, dietary intake data was collected via a single 24-hour recall. 
The 24-hour recall method is a popular tool for investigating the relationship between 
diet and disease. This is mainly due to its high response rate and its ability to obtain 
detailed information, and also because recall of intake over a longer time period is 
problematic particularly in the older generation due to the limitations of memory [213]. 
However, a single 24-hour recall is not considered to be representative of habitual 
diet at an individual level but more suited to analysing group variations as just a snap 
shot of dietary intake [214]. If the distribution of usual individual food intakes within 
the groups is also needed, at least two non-consecutive days of intake per individual 
are required to evaluate day-to-day variability. Therefore repeat 24 hour recalls are 
becoming more popular to asses a typical diet at an individual level [215, 216]. 
 
The aim of this study was to follow up a previous dietary assessment study and 
investigate dietary intake in AMD patients with the more robust method of a repeat 
24-hour recall.  The nutrient intake of a smaller group of AMD subjects from the MS 
 
was analysed using this method over three non-consecutive days. 
 
 
2.2 Methods 
 
 
Ethics 
 
This study was approved by the Aston University Ethics Committee (Ethics 
application 728). Verbal informed consent was obtained from all subjects and formally 
recorded. 
 
Sample size 
 
 
To calculate an appropriate sample size, the author referred to the research group’s 
previous work on single food recall dietary analysis [211], in which participants without 
AMD consumed an average of 647 kilocalories more than those with AMD, and in 
which AMD patients consumed on average 485 kilocalories fewer than the DRV. In 
order to detect a difference between groups of 300 kilocalories, a sample size of 40 
was required. The sample size of 40 participants was calculated to observe a medium 
effect size (d=0.5), with 80% power and a type I error probability of 5%. 
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Recruitment of subjects 
 
 
People who called the MS helpline between February 2015 and July 2015 were 
invited by staff to take part in the dietary assessment study. A script was given to all 
helpline staff to help with the recruitment process. It explained the study procedure 
and protocol including the inclusion and exclusion criteria for those wishing to be 
involved. The only pre-requisites were that participants should be aged over 50 and 
have been diagnosed with a form of AMD; the exclusion criteria were the inability to 
hear and reply to questions in English over the telephone. 
 
Method of dietary assessment 
 
 
When a helpline caller agreed to take part in the study, their details (name and contact 
number) were passed to the investigator, who then called them back at a convenient 
time to conduct each dietary assessment. Three dietary assessments were 
completed for each participant by a 24-hour recall from two non-consecutive week 
days and one weekend day. Background information about the study and a consent 
statement were read out to each participant at the start of the follow-up call, before 
the first dietary recall was carried out. Participants were asked to confirm that they 
had been diagnosed with AMD. The participants were given the opportunity to ask 
questions about the study both at recruitment and when they were first called by the 
investigator. Each dietary recall included a description of everything that was eaten 
or drunk in the previous 24 hours. A questionnaire for data collection purposes before 
the recall was also asked of the participant and included questions such as: 
 
 Age/Gender 
 
 Do you take any vitamin or nutritional supplements for your eyes? 
 
 How long have you suffered with AMD? 
 
 Are you registered severely sight impaired or sight impaired? 
 
 How would you describe your vision now? 
 
 Do you take any nutritional supplements? 
 
 Do you smoke? 
 
 
The short questionnaire did not include any questions that might cause concern for 
the participant. Participants had the opportunity to ask questions about nutrition for 
eye health that may have been prompted by the dietary assessment at the end of the 
interview and delivered a standard set of nutritional information about diet and AMD 
to each. All participants were given a contact number to call if they thought of any 
questions after the interview had ended. 
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Summary of telephone interview protocol 
 
 
 Introduction and confirmation that the participant was willing to participate 
 
 Arrangement of an alternative interview time if required 
 
 Withdrawal from the study if required 
 
 Study information read out to the participant 
 
 Consent statements read out to the participant and consent confirmed 
 
 Questionnaire of data collection delivered and responses recorded 
 
 Dietary assessment interview and responses recorded 
 
 Participant given the opportunity to ask questions 
 
 Participant provided with contact numbers in case any questions arose later 
 
 Telephone interview ended 
 
 
 
Method of dietary analysis 
 
 
Dietary data was collected from a total of 45 participants. The conversion of food 
consumption data to nutrient intakes was completed via the food database software 
‘Al La Calc’ (Red Hot Rails LLP, Doncaster UK) where each participant’s daily food 
intake is analysed using the USDA (United States Department of Agriculture) SR25 
food database (http://ndb.nal.usda.gov/). Each participant was registered in to the 
software anonymously and 24-hour recall data was added in to separate one day 
‘recipes’. Averages for individual nutrients were accounted for over the three recalls, 
leaving one total figure for each nutrient. A table was created in excel displaying the 
participant number with subsequent columns containing information such as - Age, 
gender, AMD type, number of eyes affected by AMD, duration of AMD, perceived 
vision, visual registration, supplement status, smoking status, total energy, total fat, 
of which saturates, carbohydrates, of which sugars, fibre, protein, potassium, calcium, 
magnesium, iron, zinc, selenium, vitamin D, vitamin E, vitamin b6, vitamin b12, folate, 
vitamin C, vitamin A and L/Z combined. Averages and standard deviation for each 
nutrient were collected from the total number of participants. Data was then analysed 
in statistical software IBM SPSS version 20 (IBM UK Ltd, Portsmouth, Hampshire) to 
draw comparisons between results using parametric (independent t-test, one-way 
ANOVA, Pearson product-moment correlation) and non-parametric tests (Mann 
Whitney U, Kruskal-Wallis, Spearmans rank-order) as not all the data was normally 
distributed. Normality of data was evaluated using a Shapiro-Wilk Test. 
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2.3 Results 
 
Table 2.4 displays the demographic differences of the whole group of AMD subjects. 
In total, there were forty-five AMD participants aged 55-88 (mean 77 ± sd 8 years). 
Of the cohort, 27% were male and 73% were female. Dry AMD was more 
predominant within the cohort with 73% of subjects diagnosed with this form, 
compared with only 15% of subjects diagnosed with wet AMD. A small number of 
patients had both wet and dry AMD. The mean duration of diagnosis with AMD was 
58 months. The majority of participants were not registered blind or partially sighted 
 
(81%), despite 30% of participants claiming that they felt their vision was ‘poor’ or 
 
‘very poor’ on the day of the survey and 65% of participants had AMD in both eyes. 
Only 8% of participants felt that their vision was ‘very good’ and 15% felt it was ‘good’ 
on the day of the survey. The majority of patients took some form of dietary 
supplement on a daily basis (72%). Finally, only 8% of the cohort smoked – one 
important risk factor for AMD. 
 
 
 
Characteristic Characteristic Percentage of AMD patients 
Gender Male 27% 
 Female 73% 
Perceived Vision Very poor 4% 
 Poor 26% 
 Average 47% 
 Good 15% 
 Very good 8% 
Visual Register Blind 4% 
 Partially sighted 15% 
 None 81% 
Supplements Yes 72% 
 No 28% 
Smoke Yes 8% 
 No 92% 
AMD type Wet 15% 
 Dry 73% 
 One wet one dry 12% 
Eyes affected One eye 35% 
 Both eyes 65% 
 
Table 2.4: Selected demographic differences of AMD patients. 
 
Tables 2.5 and 2.6 display results of the three-day dietary recall for subjects. 
Particularly important nutrients for AMD were included in the analysis and will be of 
focus such as L/Z. Table 2.5 shows the mean consumption and standard deviations 
of nutrients for the whole cohort as well as the range across the three days. Table 2.6 
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displays the mean consumption of various nutrients for males and females within the 
cohort together with the dietary reference values (DRV) for each constituent, as 
recommended by the UK government for those aged over 50 years [217]. The DRVs 
can be divided into three types: RNI - Reference Nutrient Intake (95% of the 
population's requirement is met), EAR - Estimated Average Requirement (50% of the 
population's requirement is met), LRNI - Lower Recommended Nutritional Intake (5% 
of the population's requirement is met). RNI’s are used for protein, vitamins and 
minerals and vary by age. The DRVs for food Energy are defined as EAR’s and have 
recently been updated by The Scientific Advisory Committee on Nutrition (SACN) for 
specific population groups. For those aged 50 years and above the new DRVs for 
daily calorie intake are as follows [218]: 
 
 
 Unit Mean whole Group SD whole group 
 
Energy 
 
kcal 
 
1594 
 
249 
Fat g 58.2 15.4 
of which saturates g 21.7 7.3 
Carbohydrate g 202.7 41.6 
of which sugars g 85.2 25.5 
Fibre g 15.9 4.5 
Protein g 71.5 19.4 
Sodium mg 2318.4 746.3 
Potassium mg 2942.5 858.9 
Calcium mg 740.7 193.7 
Magnesium mg 284.8 72.0 
Iron mg 12.7 4.3 
Zinc mg 8.2 1.8 
Selenium µg 50.3 22.1 
Beta Carotene µg 2800.5 1912.8 
Vitamin D IU 35.7 60.9 
Vitamin E mg 7.2 2.6 
Vitamin B6 mg 2.0 0.6 
Vitamin B12 µg 7.8 10.4 
Folate µg 287.2 88.5 
Vitamin C mg 121.3 64.9 
Vitamin A IU 2150.3 2033.1 
L/Z µg 1691.7 1726.3 
  L/Z  mg  1.7  1.7   
 
Table 2.5: Mean consumption, standard deviation and range across three days for 
the whole cohort of AMD patients. Please note: kcal refers to kilocalories, mg refers 
to milligrams, µg refers to micrograms, IU refers to international units and g refers to 
grams. 
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Unit 
 
Mean female (95% CI) 
 
Mean male (95% CI) 
DRV f 
>50 
DRV m 
>50 
 
Energy 
 
kcal 
 
1576 (1498-1654) 
 
1644 (1577-1709) 
1840- 
2079 
 
2294-2581 
Fat 
of which 
saturates 
g 
 
g 
56.7 (52.2-61.2) 
 
22.2 (19.9-24.5) 
62.5 (57.5-67.5) 
 
20.4 (18.5-22.3) 
70 
 
20 
95 
 
30 
Carbohydrate 
of which 
sugars 
g 
 
g 
205.4 (192.5-218.3) 
 
87.1 (79.7-94.5) 
195.4 (183.8- 207) 
 
80.3 (71.9- 88.7) 
230 
 
90 
300 
 
120 
Fibre g 16.4 (15.0-17.8) 14.4 (13.2-15.6) 24 24 
Protein g 70.7 (64.3-77.1) 73.6 (69.5-77.7) 53 53 
Sodium mg 2201.3 (1985-2417.6) 2640.4 (2414-2866.5) 1600 1600 
Potassium mg 2969.3 (2696.6-3242) 2868.8 (2647.1-3091) 3500 3500 
Calcium mg 765.0 (710.8-819.2) 673.7 (607.4-740) 700 700 
Magnesium mg 287.2 (264.6-309.8) 278.3 (258.7-297.9) 300 270 
Iron mg 12.1 (10.9-13.3) 14.3 (12.9-15.7) 8.7 8.7 
Zinc mg 7.9 (7.4-8.4) 9.0 (8.4-9.6) 7 9.5 
Selenium 
Beta 
Carotene 
µg 
 
µg 
48.2 (47.7-48.7) 
 
3086.3 (2494-3678.6) 
56.1 (48.1-64.1) 
 
2014.5 (1575.5-2507) 
60 
 
- 
75 
 
- 
Vitamin D IU 37.9 (18.8-57.0) 29.6 (13.2-46.0) 400 400 
Vitamin E mg 7.2 (6.5-8.0) 7.4 (6.6-8.4) 10 10 
Vitamin B6 mg 2.0 (1.8-2.2) 1.9 (1.7-2.1) 1.2 1.4 
Vitamin B12 µg 7.7 (4.6-9.2) 8.1 (6.3-9.9) 1.5 1.5 
Folate µg 286.4 (260.7-312.1) 289.5 (259.3-319.7) 200 200 
Vitamin C mg 124.3 (104.3-144.3) 113.2 (94.5-131.9) 40 40 
Vitamin A IU 2493.1 (1839.1-3147) 1207.7 (608.5-1807) 2000 2333 
L/Z µg 1958.3 (1398.6-2517) 958.5 (654.3-1263)   
  L/Z  mg  2.0 (1.4-2.5)  1.0 (0.7-1.3)  10  10   
 
Table 2.6: Mean consumption of various nutrients for males and females (with 95% 
CI’s), and the corresponding DRVs for those over 50 years old. Spaces indicate that 
there are no DRVs for that nutrient. 
 
Results demonstrate that both males and females of all age groups failed to meet the 
government DRV for energy requirements (kcal), carbohydrates, fibre, selenium, 
potassium, vitamin D, vitamin E, and L/Z. For males, there were dietary concerns 
regarding vitamin A intakes. Both men and women’s daily sodium intake was much 
higher than recommended. Of importance to AMD are the nutrients L/Z, beta- 
carotene, vitamin C, vitamin E and zinc. In comparison with the DRVs male and 
female subjects were under consuming L/Z and Vitamin E. Zinc was slightly below 
the DRV for male subjects. Dietary intakes of vitamin C in both males and females 
were substantially above the DRV. 
41  
 
 DRVs 
kcal 
Mean kcal 
intake 
% below 
DRV 
Statistical Test (Mann- Whitney U, 
independent t test) 
55-64 
years 
Male 2581 n=0 N/A N/A 
 Female 2079 1592 (n=3) 23% z = -2.087 p= 0.037 
65-74 
years 
Male 2342 1612 (n=4) 31% z = -2.460 p = 0.014 
 Female 1912 1678 (n=8) 12% z = -1.795 p = 0.073 
75+ 
years 
Male 2294 1660 (n=8) 28% z = -3.590 p < 0.001 
 Female 1840 1523 (n= 
22) 
17% t = -5.837 p < 0.001 
Table 2.7: DRVs for calories in males and females of different age groups, with the 
 
corresponding mean calorie intakes of this cohort: 
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Figure 2.3: DRVs for calories in males and females of different age groups compared 
with the mean calorie intakes for males and females of this cohort. 
 
Table 2.7 and figure 2.3 display the mean intake for calories of males and females in 
different age groups in comparison with the DRVs. Mean calorie intakes for both 
males and females of all age groups were consistently below the DRVs, with a 
substantial decrease ranging between 12-31% (Table 4). Results show that calorie 
intakes were significantly below the DRV for all males in the cohort (Man Whitney U 
test p < 0.005) and for females 55-64 years old (Man Whitney U test p = 0.037) and 
above 75 years old (independent t test p < 0.001). Females between the ages 65 and 
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74 years consumed an average of 1678 kcal per day, which was 12% below the DRV 
 
and not found to be a significant decrease (independent t test p > 0.005). 
 
 
Repeat 
 
24-hour recall 
24-hour recall Statistical Analysis 
 
(independent t test) 
 
L/Z (mg per day) 1.6 1.7 P=0.919 
 
 
Calories (kcal per day) 1511 1594 P=0.254 
 
 
 
 
Table 2.8: Comparison of L/Z and calorie intakes with data from a previous 24-hour 
recall study 
 
 
Average L/Z and calorie intakes from this cohort were statistically compared with 
intakes from AMD patients in the previous 24 hour recall study carried out by our 
research group [211]. Results demonstrated that mean L/Z and calorie intakes were 
similar in both studies and were therefore not significantly different. No significant 
differences were found between L/Z or calorie intakes and patient demographics. 
Carbohydrate intakes were found to be significantly lower (t (43) =2.164, p=0.036) in 
those with AMD in both eyes (M=193.1g, SD=41.64) compared to those in one eye 
(M=220.1g SD=36.76). 
 
2.4 Discussion 
Comparison of L/Z and Calorie Intakes between Single and Repeated Dietary Recall: 
Average L/Z and calorie intakes from this cohort of AMD patients were almost 
 
identical to the previous study from our research group which investigated a similar 
group of AMD patients using a 24 hour recall dietary assessment method [211]. 
Results demonstrated that there was no significant difference between L/Z intakes 
(independent t test F = 197 p = 0.919) and calorie intakes (independent t test F = 197 
p = 0.254) in the two studies. These nutrients were found to be considerably lower 
than the recommended amounts in both studies.  Although a smaller number of 
subjects were used for this cohort, it may be suggested that these intakes are 
representative of a daily dietary intake for AMD patients who seek the services of the 
macular society, as a three-day dietary recall provides a more accurate illustration of 
habitual diet. 
 
Lutein and Z: 
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This sample of subjects with AMD consumed an average of 1.7 mg of L and Z per 
day. This is considerably lower than the 10 mg daily amount considered to increase 
macular pigment optical density (MPOD) and delay the progression of AMD [219], 
[99], [103], [220], [71]. These findings correspond with a previous study carried out 
by our research group using a 24 hour recall to signify the diet of AMD patients who 
are members of the UK Macular Society. In this study reported average intakes of 
dietary L and Z were 1.6 mg per day [211]. L&Z consumption was compared with age, 
gender, AMD type (dry vs. wet), the number of eyes affected, perceived vision and 
visual registration status, but no trends were apparent. Despite 81% of subjects not 
being on a visual impairment register as sight impaired or severely sight impaired 
(blind), 74% of subjects claimed that their vision was average or below on the day of 
the survey and 65% of patients had AMD in both eyes. This may indicate that patients 
have not registered their visual impairment. The RNIB’s survey into certification and 
registration in 2011 [221], shows a steady decline in the number of registrations per 
year (a fall of 30% for new blind registrations, and a 28% decrease in new sight 
impaired registrations from 2003 to 2011), despite the fact that the prevalence of 
visual impairment is increasing. They attribute this decrease in registration not to a 
lack of interest in registration by the patient, but rather to the length of time it takes to 
complete the Certificate of Visual Impairment (CVI) by the professionals involved 
[222]. 
 
Calories and Carbohydrates: 
 
 
Results demonstrate that both males and females failed to meet the government 
DRVs for calorie intakes. The mean consumption of daily calorie intake was 1594 
kcal, much lower than the minimum DRV of 1840 kcal recommended for those over 
the age of 75 years (mean age of cohort). Similarly, mean intakes of calories 
specifically for those aged 75 or older were 1660 kcal for females, and 1523 kcal for 
males, both significantly lower than the DRV (p<0.001). In the previous 24 hour recall 
study average daily calorie intakes for AMD patients were 1511 kcal [211]. An 
average intake of 202.7 g per day of carbohydrate (80.3 g of sugars) was reported 
which was much lower than the government DRV of 230 g per day. Carbohydrate 
intakes were found to be significantly lower (independent t test =0.036, p <0.05) in 
those with AMD in both eyes compared with those with AMD in one eye. This decline 
in food intake presumably follows in part from a decrease in physical activity and the 
decline in muscle mass with age. This results in a lower requirement for energy 
(substantial reductions in energy intake may, in turn, result in lower physical activity, 
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a declining cycle) and thus a diminished appetite. This trend may be more apparent 
in those with more advanced stages of AMD as visually impaired patients are less 
physically active and more likely to have mobility limitations than individuals with 
normal visual capabilities [223], [224]. Other physical and psychosocial barriers which 
may exacerbate diminished appetite within this vulnerable population may also play 
a part, such as living alone [225], [226], poor cooking skills and the inability to cook 
and prepare foods [211]. Potential problems arise because, as total food intake 
declines, for most nutrients there is a simultaneous decline in nutrient intake. This 
was evident in the current study which indicated that subjects were also not attaining 
the DRV of other nutrients important for their condition such as L/Z, vitamin E, vitamin 
D and zinc, and nutrients important for general health such as fibre, potassium and 
vitamin A in males. 
 
 
It is important to note that other surveys of the UK population as a whole [227], [228] 
show that the mean Body Mass Index (BMI) and number of people classified as 
overweight or obese is increasing. The latter data indicate that average habitual 
energy intake may exceed energy needs. Reported intakes of food energy being 
lower than intakes actually consumed may be the reason behind this apparent 
paradox [229], [230]. In particular, under-reporting of foods during dietary assessment 
is significant in people who are overweight and obese [231], [232], [233]. Whether 
this may be the case in the present AMD cohort is unknown, data on body weight or 
body mass within this population may be required to support an accurate 
representation of calorific intakes. 
 
Other Nutrients with Clinical Significance to AMD 
 
 
Selenium and Vitamin E: 
 
 
Selenium and vitamin E were also below the DRV within this cohort despite foods rich 
in vitamin E being recommended by the MS in their patient resources. These nutrients 
have been implicated in the protection of biological membranes against lipid 
peroxidation, a process that may be induced either by production of metabolic by 
products such as reactive oxygen species (ROS) or by exposure to atmospheric 
oxidants [234], [235]. The eye is particularly susceptible to lipid peroxidation due to 
the high concentration of fatty acids [61].  Vitamin E, in the form of alpha-tocopherol 
[58], [59] is predominant in the retina where it is the major lipid-soluble antioxidant of 
all   membranes and the most effective scavenger of ROS [57] [60]. Evidence 
supporting an oxidative pathogenesis of AMD has increased interest in the potential 
45  
preventative role of nutritional supplementation with dietary antioxidants such as 
vitamin E. 
 
Vitamin D: 
 
 
Vitamin D levels for both males and females in the cohort were significantly below the 
DRV (independent t test p <0.001). Vitamin D deficiency is common in the elderly due 
to limited sun exposure because of changes in lifestyle factors such as clothing, 
outdoor activity and dietary habits. Vitamin D deficiency in this population may also 
be attributed to a reduced amount of vitamin D precursor in the skin and diminished 
renal function [236]. Exposure to sunlight, which enhances the production of vitamin 
D3 in the skin, is important as a limited number of foods contain vitamin D [237], [238]. 
Vitamin D deficiency is also common amongst ethnic minority groups in the UK such 
as Asians whose origins are from India, Pakistan, or Bangladesh as certain cultural 
habits such as covering the skin may restrict ultraviolet irradiation [239, 240]. 
Deficiency of vitamin D results in abnormalities in calcium, phosphorus, and bone 
metabolism, as absorption of dietary calcium and phosphorus is decreased. It is 
characterised by mild secondary hyperparathyroidism and an enhanced risk of 
osteoporotic fracture [241], [242], [243].  In the eye, vitamin D has anti-inflammatory 
properties which may suppress the cascade of destructive inflammation that occurs 
at the level of the retinal pigment epithelium-choroid interface in early stages of AMD. 
There are several epidemiological studies suggesting an association between vitamin 
D deficiency and AMD [244], [245], [246], although currently the MS do not include 
details of Vitamin D in their resources. This is because few have tested the effect of 
vitamin D supplementation on the prevention and treatment of AMD. Research does 
suggest that the recommended intakes for vitamin D are inadequate, and, in the 
absence of exposure to sunlight, a minimum of 1000 IU vitamin D is required to 
maintain a healthy serum concentration [247], [248]. 
 
Vitamin C: 
 
 
The mean intake of vitamin C was 121 mg/per day, which was significantly higher 
(one sample t test p <0.001) than the DRV of 40 mg per day for men and women over 
the age of 18 years. Vitamin C is water-soluble and is involved with several biological 
processes. It has been shown to have antioxidant properties which enable it to react 
directly with hydroxyl radicals [64], superoxide [65] and singlet oxygen molecules [66]. 
High dose supplementation with an antioxidant and zinc formulation, including vitamin 
C has been associated with a 25% reduced risk of progression of AMD in those 
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participants already suffering with the condition (AREDS 1) [49]. Low levels of vitamin 
C in the body have also been associated with an increased risk of AMD [72]. Some 
studies, however have found no evidence for a beneficial role of vitamin C 
supplementation alone within AMD [73], [74], [75].  It is therefore not known whether 
it can slow the progression of AMD when not in combination with other antioxidants. 
Despite this, the MS encourage inclusion of foods rich in Vitamin C in the diet which 
may explain the reason for an increased consumption within this cohort of subjects. 
 
Zinc: 
 
 
Zinc has been investigated regarding its potential preventative role in AMD. The 
AREDS group found a suggestive reduction in the risk of progression of AMD in 
participants supplementing with 25 mg zinc daily [71], which is a key research finding 
the MS discuss in their nutritional information for patients.  A small number of cohort 
studies assessing dietary intakes of zinc in elderly subjects have found an inverse 
relationship between high zinc intake and the incidence of early AMD. [175], [150]. 
However other large cross–sectional studies involving zinc and the progression of 
AMD have yielded conflicting results [7], [179]. Female subjects within this cohort 
consumed dietary zinc at levels above the government DRV of 7.0 mg per day [7.9 
(95% CI 7.4-8.4)] whereas male subjects were under consuming the DRV of 9.5 mg 
per day [9.0 (95% CI 8.4-9.6)]. This may be explained by an increased awareness of 
research into zinc supplementation and the condition within women subjects. 
 
Limitations 
 
 
The current study contains several methodological limitations. Firstly, dietary intake 
accuracy based on 24-hour recalls is influenced by memory errors and could result in 
over reporting or underreporting of food intake, particularly among elderly populations 
[214, 249]. To improve accuracy of data and give a more reliable estimation of 
habitual intakes, three non-consecutive days of 24 hour recalls were conducted. 
There was a lack of information regarding subjects BMI and activity levels, which 
would have given further insight in to the accuracy of calorific intake. Participants 
were not required to weigh their food during recording; therefore portion sizes were 
estimated from household measures and published food reports which may have 
resulted in some misreporting. Subjects were also told in advance of what day a recall 
was due to be conducted which may have led to bias as previous reports have found 
that individuals may over or under report “good/bad” food items [214, 250]. Finally, 
the sample used in this study may not be reflective of all AMD patients as only 
participants who were already part of the society and those who called the helpline 
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were invited to take part. Selection bias should therefore be considered as patients 
who have sought the help of the MS could be considered an ‘informed’ population as 
they have information available to them in the form of monthly magazines, written 
material, a helpline and the Society’s website. It is also important to highlight that a 
large proportion of the cohort were female and over the age of 75 years old and there 
was a lack of information regarding subject’s ethnicity. It would be beneficial to gain 
further dietary information from those with AMD from younger populations, of both 
sexes and varied ethnicities, who have not sought support from non-professional 
organisations. 
 
2.5 Summary 
 
 
This study supports the evidence that patients with AMD who seek the services of the 
MS are under consuming important nutrients for their condition. The reasons for this 
are likely to be multi-factorial. There may be several barriers to dietary change within 
this cohort of visually impaired patients in addition to the general individual variances 
of food choice and preferences. In a previous study, our research group looked further 
in to the barriers to why AMD patients who seek the services of the MS are under 
consuming important nutrients by determining their awareness of the relationship 
between nutrition and AMD [210]. It was documented that over half (56%) of AMD 
subjects could acquire food themselves, and used a supermarket as a primary source 
for acquiring food sources. However, the remaining 44% of patients were unable to 
shop for themselves. When considering patients’ food choices, the largest influencer 
appeared to be preference (44%), with the next largest (33%) being foods that the 
subjects believe would affect their health. The ability to prepare the foods was a factor 
for 6% of subjects, and 3% said that the ability to acquire the food was the 
predominant influencer. Further research from  a survey into independent living for 
the RNIB [251] indicated that ‘preparing a meal’ was one of the most commonly 
identified challenging task by visually impaired people (33%). When asked how they 
acquire their food, 56% of the participants said that they themselves were able to go 
food shopping; however, 28% relied on a family member, 3% had a friend and 2% 
had a caregiver who went food shopping for them and 12% had another method of 
acquiring food (this could be the internet, meals on wheels etc). Although subjects 
who seek the services of the MS may be considered an informed population as they 
receive dietary advice from the MS, altering long term dietary habits may be 
challenging in these older populated groups when there are underlying barriers to 
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change. Strategies to ensure that nutritional information and interventions consider 
possible multi-factorial barriers within this vulnerable group may be needed. 
 
This study investigated the dietary habits in a group of AMD patients to establish 
whether subjects were regularly consuming nutrients regarded as important for their 
condition such as L and Z. It was concluded that further research is needed to 
discover the potential barriers to dietary change within visually impaired populations. 
The following chapter will describe a study which aims to investigate the optimum pre- 
and post-harvest conditions for maximisation of L in kale. Findings from this study will 
enrich the current dietary advice given to AMD patients, and serve as a foundation to 
the development of novel intervention which aims to improve the overall diet of those 
suffering with AMD. 
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Chapter 3: Determination of the optimum pre and post-harvest conditions for 
the maximisation of lutein concentrations in kale 
 
 
3.1 Background and rationale 
 
 
The two major carotenoids in the human macula and retina are L and Z [252], which 
are often referred to as xanthophylls which form the MP. In the eye carotenoids such 
as L function as antioxidants and blue light filters to protect underlying tissues from 
phototoxic damage [50]. Fruits and vegetables are the most important source of 
carotenoids in the human diet and knowledge about this is important for preventive 
medicine. Dark green leafy vegetables such as kale and spinach are recognised as 
containing the highest amounts of dietary L [253].  Lutein and Z dietary intake is 
implicated in the maintenance of retinal health and possible prevention of the onset 
or progression AMD [254]. Currently AMD patients are advised to include more dark 
green vegetables such as kale in to the diet to increase their intake of L and Z. 
However, little is known about the pre-and post-harvest effects on the content and 
bioavailability of L and Z concentrations within fruits and vegetables. Combined L/Z 
levels in the leaves of kale are reported to range from 147 to 395 µg−1g of fresh tissue 
[94] as carotenoid accumulations in plants are often influenced by physiological and 
biochemical attributes such as processing and storage as well as environmental 
growth factors such as light, temperature and fertility [255] [196], [256]. Although 
some studies have looked in to the pre- and post-harvest effects on the carotenoid 
concentrations in spinach [257-260], there are very few studies to date which have 
investigated the post- harvest processing (cooking) and storage effects on kale L 
concentrations. Furthermore, no studies to date have investigated the L levels in kale 
grown and sourced within the UK. Therefore this study was designed to answer these 
questions. 
 
 
Kale is a vegetable of the plant species Brassica Oleracea. It has green or purple 
leaves, in which the central leaves do not form a head. It is considered to be closer 
to wild cabbage than most domesticated forms of vegetables. Kale is produced in the 
UK nearly all year round as it is a hardy, resilient plant which tolerates cold whether 
much better than other brassicas. According to industry source 
(www.discoverkale.com; January 2016) most of the kale in the UK which is supplied 
to supermarkets across the country is grown and produced on open fields in 
Lincolnshire farms between June and March, with the late autumn and early winter 
months when it is at its most plentiful. The first kale of the year is planted at the 
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beginning of April, and in order to provide a consistent supply of fresh young produce, 
sequential plantings are made through until August. Further information about the pre 
and post-harvest procedures of UK kale manufacturing was gathered from a day visit 
to one of the Lincolnshire farms (Emmet UK Ltd). It was noted that kale plants take 
two to three months to grow depending on the outside temperature and the early 
seeds are cultivated in greenhouses for the first few weeks to speed up their growing 
process. Once harvested, the kale is sliced and washed in water and citrox (fruit acid) 
for 90 seconds and dried and packaged ready for transportation to supermarkets 
around the UK. The packaging is done immediately after washing, in vacuum or in a 
gas mixture of 20% CO2  + 80% N2. The process from harvest to packaging takes 
around 24 hours. Kale is then in dispatch for up to 12 hours under refrigeration in dark 
at 4-5 °C. Once it reaches the supermarket it has a shelf life of 5 days at 8°C. This 
‘fresh-cut’ process (a term which refers to raw vegetables and fruits that have been 
cut, shredded, peeled, abraded, or otherwise prepared and packaged to produce 
convenient ready-to-eat or ready-to-cook portions) [261] is a current trend for 
marketing fruits and vegetables, stimulated by increasing consumer demand for high- 
quality, nutritive, fresh-like and convenient-to-use products. 
 
The aim of the present study was to determine the optimum conditions under which 
kale, the vegetable that contains the highest concentration of L and Z, can be 
acquired, stored and domestically processed for maximum retinal benefit. Due to cost 
implications, only L concentrations within kale were investigated. Zeaxanthin is 
required to support retinal function at much lower doses than lutein and therefore was 
not investigated within the study. Lutein levels were identified by high-performance 
liquid chromatography (HPLC) in the leaves of freshly harvested kale from a UK 
Lincolnshire farm along with kale acquired from a UK supermarket where the same 
farm supplies to, at different times of the year. Both varieties of kale were used to 
compare the effects of post-harvest minimal processing and sourced throughout 
different times of the year to determine the pre-harvest climatic effects on 
caroteneogensis. Kale was further investigated in relation to its L stability upon 
domestic processing procedures such as boiling, blanching, steaming, frying, 
microwaving and liquidising. In addition, L concentrations in freshly harvested and 
supermarket purchased kale were analysed upon various fridge and freezer storage 
periods. Results from the study will provide patients and clinicians with a clearer 
understanding of the effects of pre-and post-harvest conditions on the carotenoid 
content of vegetables which will enable precise suggestions for increasing retinal 
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levels of these nutrients. Dr Val Franklin, a collaborator from the University with 
expertise in HPLC was appointed to assist with this project. 
 
3.2 Methods 
 
 
Method of preparation techniques for kale samples 
 
 
The first stage of the analysis included preparation and cooking techniques which 
enabled the concentration of L to be extracted and then identified by HPLC. High- 
performance liquid chromatography is a form of liquid chromatography to separate 
compounds that are dissolved in a solution. HPLC instruments consist of a reservoir 
of mobile phase, a pump, an injector, a separation column, and a detector [262]. 
Compounds are separated by injecting a plug of the sample mixture onto the column. 
The different components in the mixture pass through the column at different rates 
due to differences in their partitioning behaviour between the mobile liquid phase and 
the stationary phase which is known as their retention time. The HPLC system then 
produces a chromatogram image on the computer which displays a series of peaks 
over different retention times for each compound. This is known as a calibration curve 
and is a general method for determining the concentration of a substance in an 
unknown sample by comparing it to a set of standard samples of known 
concentration. For example, L concentrations within samples were quantified by 
determining the peak area in the HPLC chromatogram calibrated against a known 
amount of L standard. Standards of L were processed at different concentrations first 
to produce the calibration curve which enabled the quantity within the sample to be 
determined. 
 
 
 
 
 
 
Figure 2.4: A schematic diagram representing the HPLC process. 
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A portion of freshly harvested kale leaves were delivered from a main UK industrial 
supplier (harvested and delivered within 24 hours, before its shelf life) over the 
months of March (Spring), August (Summer), October (Autumn) and January 
(Winter). Kale leaves were also purchased from a local UK supermarket, within its 
shelf life constituency on the same day of each specific month. Within 24 hours of 
delivery and purchase, the samples of freshly harvested and shop purchased kale 
were prepared for analysis in the common manner, which included hard stems and 
blemishes being removed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Freshly harvested kale delivered from the farm within 24 hours ready for 
preparation and L analysis by HPLC. 
 
One sample of each kale variety was retained raw and the rest were processed in 
various methods to determine the containing L stability via HPLC. These methods 
included steaming, boiling, blanching, microwaving, frying and liquidising. Lutein 
concentrations in kale samples were also quantified after a range of storage 
treatments, which included conventional fridge and freezer storage over various 
periods of time.   Each treatment was performed in four replicates to increase 
reliability. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Kale samples equally weighed ready for processing in their labelled 
containers. 
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Method of processing techniques for kale samples 
 
 
The first analyses were carried out in spring where L concentrations of raw kale of 
each variety along with three common domestic cooking techniques (steaming, 
boiling and frying) were determined. This pilot investigation was needed to identify 
any potential issues with the methodology. During these initial stages frying was 
performed using a conventional cooking method with a small amount of olive oil (2ml 
per 1g sample). Due to lower than expected readings and difficulty measuring L within 
the lipid structure, kale was fried without the use of oil in future analyses (summer, 
autumn, winter). Technical issues with the steaming equipment were also noted 
during the pilot investigation, thus future analyses using this process were not carried 
out. 
 
 
Additional methods for cooking and processing kale were included in the summer, 
autumn and winter months. These included microwaving kale using three techniques 
(micro 1: 1 minute with a dessert spoon of water, micro 2: 2 minutes with a dessert 
spoon of water, micro 3: 2 minutes with a tablespoon of water) and liquidising kale 
with a small amount of water (2ml per 1g sample). Blanching kale was investigated 
as an alternative method to boiling kale in the winter to establish whether or not a 
shorter duration of exposure to boiling water would be better at retaining L 
concentrations. Blanching may be described as the process whereby vegetables are 
immersed in boiling water and then removed after a brief, timed interval to halt the 
cooking process. The ratios of water to kale were 
 
 
Various fridge and freezer storage periods were also included in the post spring 
analyses to determine the storage effects on L concentrations in kale.  After all 
preparation and cooking techniques were completed, samples were ready for 
extraction and analysis by HPLC. 
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Fresh (spring, 
summer, autumn, 
winter) 
Boiling (spring, 
summer) 
Steaming (spring) Frying with oil (spring) 
Within 24 hours of 
collection, four 
replicates of each 
kale variety were 
weighed in to 1g 
samples and kept 
fresh without 
processing 
Within 24 hours of 
collection, four 
replicates of each kale 
variety were weighed 
in to 1g samples and 
placed in a container of 
10ml of boiling water 
for 3 and 5 minutes. 
Each container was 
covered to prevent 
evaporation of water 
Within 24 hours of 
collection, four 
replicates of each kale 
variety were weighed 
in to 1g samples and 
steamed using a 
conventional steamer 
for 4 minutes over 4ml 
of water 
Within 24 hours of 
collection, four 
replicates of each kale 
variety were weighed 
in to 1g samples and 
fried for 10 minutes in 
2ml of olive oil. They 
were then dabbed with 
blotting paper to 
absorb excess oil 
 
 
Microwaving 
(summer, 
autumn, winter) 
Frying no oil 
(summer, 
autumn, winter) 
Liquidising 
(summer, autumn, 
winter) 
Fridge storage 
(summer, 
autumn, winter) 
Freezer storage 
(summer, 
autumn, winter) 
Within 24 hours 
of collection, four 
replicates of each 
kale variety were 
weighed in to 1g 
samples and 
placed in a 
microwavable 
bowl for 1 minute 
and 2 minutes 
with a dessert 
spoon of water 
(micro 1 and 2) 
and for 2 minutes 
with a tablespoon 
of water (micro 
3). Each 
container was 
covered to 
prevent water 
loss due to 
evaporation 
Within 24 hours 
of collection, four 
replicates of each 
kale variety were 
weighed in to 1g 
samples and fried 
in a small pan on 
a hot plate 
without oil for 5 
and 10 minutes 
Within 24 hours of 
collection, four 
replicates of each 
kale variety were 
weighed in to 1g 
samples and 
liquidised for 1 
minute with a 2ml 
of water in a 
conventional 
smoothie maker 
Within 24 hours 
of collection, 
four replicates of 
each kale 
variety were 
retained raw 
and weighed in 
to 1g samples 
ready for fridge 
storage. 
Samples were 
placed in a bag 
and sealed then 
stored in a 
fridge at 4°C for 
four days and 
seven days. 
Within 24 hours 
of collection, 
four replicates of 
each kale 
variety were 
retained raw 
and weighed in 
to 1g samples 
ready for freezer 
storage. 
Samples were 
placed in a bag 
and sealed then 
stored in a 
freezer at -18°C 
for seven days 
and twenty-eight 
days 
 
 
 
Table 2.9: Spring, summer, autumn and winter L analyses: processing and storage 
techniques. 
 
Selection and modification of the extraction and HPLC technique 
 
 
A review of the literature was carried out on the Web of Science, PubMed and Science 
Direct databases to identify relevant studies that had investigated extraction and 
HPLC analysis of L from food sources. Search terms used were 'lutein', 'HPLC' and 
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'analysis'. We identified articles that reported on L quantification of vegetables through 
extraction and HPLC analysis techniques published in peer-reviewed journals. The 
chosen method for the extraction and HLPC technique was taken from a study by 
Chung, H Rasmussen, H and Johnson, E (2004), as it was well cited in the literature 
and fit best with the equipment we had available [96]. The only modification that was 
made to the method was using micro bore columns for the injection process, thus the 
sample weight and solvents were reduced proportionally to accommodate for the 
present HPLC system. 
 
Extraction process: 
 
 
The first stage of extraction once the kale samples had been processed in the various 
methods included incubating the samples in methanol overnight for 16 hours. 
Carotenoids are lipid soluble molecules and therefore usually extracted from a plant 
source with water-miscible organic solvents. To obtain a safe extract, elimination of 
the residual solvents can be avoided by using food grade organic solvents such as 
methanol [263]. Firstly samples were homogenised using a pestle and mortar until 
ground down. 5ml of methanol was then added to each 1g of sample in a 50ml glass 
vial. Sample containers were labelled and covered with tin foil and para fill and 
incubated overnight for 16 hours in a fridge at 4°C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Kale samples being grinded up ready for the additional of methanol 
 
(solvent 1); kale samples after the first stage of extraction ready for incubation. 
 
 
 
The second stage of extraction included the addition of the second solvent 
tetrahydrofuran (THF). The incubated samples were centrifuged at 800xg for 10min 
and then the methanol layer was removed into separate glass containers using a 
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Pasteur Pipet. 5ml of THF was added to each vial, vortexed for 30 seconds and then 
centrifuged at 800xg for 2 minutes. The THF layer was then added to each methanol 
container. This extraction process with THF was repeated four more times adding a 
THF layer to the methanol container each time. A sufficient amount of THF was added 
to make the final volume up to 25ml. 10ml of each sample of mixed solvent was dried 
under nitrogen to concentrate the sample and preserve the active ingredients. 100ul 
of the mixed solvent was re dissolved in to a dried down sample. A pipette was used 
to extract each re dissolved sample in to an amber vial. Samples were then ready to 
inject on to the HPLC column. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8: Kale samples after the second stage of extraction; one sample upon 
completion of the extraction process ready to be injected on the HPLC column. 
 
HPLC analysis: 
 
 
To adequately separate the L a HPLC system comprised of a Waters 600S controller 
(Millipore), Waters 616 pump, Waters 717 autosampler, Wavelength 44nm 
photodiode array detector, and C30 carotenoid column (3 μm, 150 × 4.6 mm, YMC) 
was used. The HPLC mobile phase was methanol: MTBE: water (95:3:2, v/v, with 
1.5% ammonium acetate in water, solvent A) and methanol: MTBE: water (8:90:2, 
v/v, with 1.0% ammonium acetate in water, solvent B). The gradient procedure, at a 
flow rate 0.4 mL/min (10 8C), was as follows: (1) start at 100% solvent A, (2) a 21‐
 
min linear gradient to 45% solvent A and 55% solvent B, (3) 1‐min hold at 45% solvent
 
A and 55% solvent B, (4) an 11‐min linear gradient to 5% solvent A and 95% solvent
 
B, (5) a 4‐min hold at 5% solvent A and 95% solvent B, (6) a 2‐min linear gradient
 
back to 100% solvent A, and (7) a 28‐min hold at 100% solvent A.. Lutein was
 
quantified by determining the peak area in the HPLC chromatogram calibrated 
 
against a known amount of standard. Peak identification in samples was based on 
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comparisons with retention time and absorption spectra of the carotenoid standard of 
 
L. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: HPLC system used in the study. 
 
 
3.3 Results (effects of minimal processing and season) 
 
The first section of results describes the variation in L content of raw kale sourced 
from both the farm and supermarket. Freshly harvested kale was sourced from a farm 
in Lincolnshire and delivered for analysis within 24 hours of harvest. The kale was 
classified as being intact whole produce that had not been minimally processed, a 
technique used for retail purposes which includes cutting, washing and modified 
atmosphere packaging. Minimally processed kale was purchased from a retailer 
which the same farm supplies to within its five-day shelf life constituency. Prior to 
delivery to its retail outlets the kale was washed, sliced and packaged in 200g units 
and sold within five days. Kale was delivered to the supermarket within 24 hours of 
harvest. Four raw sample lots for each season (spring, summer, autumn and winter) 
were collected at different times during the season and analysed individually. All 
samples were analysed immediately after collection. 
 
 
Shop 
(mg/100g) 
  Spring   Summer   Autumn   Winter    
13.41 10.64 10.54 11.74  
13.39 10.65 10.5 11.73  
13.41 10.63 10.54 11.73  
  13.40   10.63   10.54   11.73    
13.40 10.64 10.54 11.73 Mean 
0.004 0.010 0.004 0.003 SD 
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Farm 
(mg/100g) 
  Spring   Summer   Autumn   Winter    
20.30 21.62 21.52 21.98  
20.31 21.62 21.53 21.99  
20.31 21.62 21.53 21.98  
  20.30   21.62   21.53   21.98    
20.31 21.62 21.53 21.98 Mean 
0.006 0.003 0.005 0.003 SD 
 
Table 3.1: Lutein levels in mg/100g for raw kale sourced from both the supermarket 
 
and farm during various times of the year. 
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Figure 3.1: Difference in lutein levels between raw farm and shop kale upon various 
times of the year using the mean values. 
 
Table 3.1 and figure 3.1 display data on L levels in raw kale of each variety (farm and 
shop) throughout different periods of the year. Four replicates of each HPLC 
determination were performed for both kale varieties at these seasonal intervals and 
the raw data is expressed in table 3.1. Figure 3.1 displays the L concentrations of raw 
farm and shop kale expressed as mean values. 
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Statistical Analyses 
 
Data for L levels in raw freshly harvested and minimally processed kale at different 
times of the year were analysed in statistical software IBM SPSS version 20 (IBM UK 
Ltd, Portsmouth, Hampshire) to draw comparisons between results using parametric 
and non- parametric tests. Normality of data was evaluated using a Kolmogorov- 
Smirnov and Shapiro-Wilk Test. Mean values were considered significantly different 
at p < 0.05. To determine the difference between L concentrations of raw minimally 
processed and freshly harvested kale, a Mann- Whitney U test was used. It was found 
that kale purchased from the supermarket within its shelf life constituency had 
statistically significantly lower L concentrations (11.58 ± 1.12 mg/100g) compared to 
kale sourced direct from the farm within 24 hours of harvest (21.4 ± 0.65 mg/100g), Z 
= -4.826, p < 0.001. 
 
 
 
The differences between the L concentrations of raw shop and farm kale at different 
times of the year (spring, summer, autumn, winter) were detected by a two-way 
ANOVA. There was a statistically significant main effect for kale source [F(1,429)= 
27792837.4, p<0.001]  and kale season [F(1,429)= 58614.2, p<0.001] and the effect 
size was large for both factors (eta squared = 1.00). The interaction effect between 
kale source and kale season was significant (season*source: sig.=<0.001), therefore 
follow up statistical tests were used to explore this relationship further. The file was 
split by kale source to investigate the effects of season separately by a one-way 
ANOVA. A statistically significant difference was found between all four seasons for 
shop kale (p<0.0001) and for farm kale (p< 0.0001). Despite this, the actual difference 
in the mean values was very small, particularly for farm kale, as observed in the plot 
graph. For example, the mean L values for farm kale were 20.31, 21.62, 21.53, and 
21.98 mg/100g in spring, summer, autumn and winter respectively. 
 
 
3.4 Results (effects of cooking and storage) 
 
 
The second section of results describes the effects of various domestic processing 
methods (boiling, steaming, stir frying, microwaving, blanching, liquidising) and fridge 
and freezer storage on the L levels in freshly harvested and minimally processed kale. 
Freshly harvested kale was sourced from a farm in Lincolnshire and delivered for 
analysis within 24 hours of harvest. The kale was classified as being intact whole 
produce that had not been minimally processed, a technique used for retail purposes 
which includes cutting, washing and modified atmosphere packaging. Minimally 
processed kale was purchased from a retailer which the same farm supplies to within 
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its five-day shelf life constituency. Prior to delivery to its retail outlets the kale was 
washed, sliced and packaged in 200g units and sold within five days. Kale was 
delivered to the supermarket within 24 hours of harvest. Four replicates of each 
treatment were performed and results were presented as mean values. All samples 
were analysed immediately after collection. 
 
 
Sample/Treatment Spring 
(n=4) 
Summer 
(n=4) 
Autumn 
(n=4) 
Winter 
(n=4) 
Mean SD 
 L 
(mg/100g) 
L 
(mg/100g) 
L 
(mg/100g) 
L 
(mg/100g) 
L 
(mg/100g) 
 
Fresh 13.40 10.64 10.54 11.73 11.58 1.15 
Steam 9.88    9.88  
Boil 3 min 6.46 6.38 6.32  6.38 0.06 
Boil 5 min 3.79 3.86 3.79  3.81 0.03 
Blanch    9.97 9.97 0.00 
Fried (oil) 2.02    2.02  
Fried (no oil) 5 m  4.76 4.70 4.83 4.76 0.05 
Fried (no oil) 10 m  3.76 3.98 4.06 3.93 0.13 
Micro 1  7.34 7.24 7.38 7.32 0.06 
Micro 2  5.35 5.20 5.43 5.33 0.09 
Micro 3  5.20 5.13 5.31 5.21 0.08 
Liquidise  9.37 9.15 9.42 9.31 0.12 
Fridge 4 days  6.20 6.16 6.20 6.19 0.02 
Fridge 7 days  4.44 4.36 4.42 4.40 0.04 
Freezer 7 days  7.20 6.98 7.34 7.17 0.15 
Freezer 28 days  4.38 3.99 4.23 4.20 0.16 
 
Table  3.2:  Mean  L  concentrations  in  minimally  processed  kale  after  various 
processing and storage procedures throughout different periods of the year. 
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Sample/Treatment Spring 
(n=4) 
Summer 
(n=4) 
Autumn 
(n=4) 
Winter 
(n=4) 
Mean SD 
 L 
(mg/100g) 
L 
(mg/100g) 
L 
(mg/100g) 
L 
(mg/100g) 
L 
(mg/100g) 
 
Fresh 20.31 21.62 21.53 21.98 21.36 0.73 
Steam 11.50    11.50  
Boil 3 min 6.64 6.79 6.74  6.72 0.08 
Boil 5 min 3.94 3.89 3.83  3.89 0.05 
Blanch    11.69 11.69  
Fried (oil) 5 m 2.57    2.57  
Fried (no oil) 5 m  4.89 4.83 4.99 4.90 0.08 
Fried (no oil) 10 m  3.89 4.07 4.29 4.08 0.20 
Micro 1  9.63 9.52 9.73 9.63 0.11 
Micro 2  6.83 6.70 6.84 6.79 0.08 
Micro 3  6.33 6.28 6.34 6.32 0.03 
Liquidise  16.81 16.60 16.73 16.71 0.10 
Fridge 4 days  8.80 8.76 8.85 8.80 0.04 
Fridge 7 days  5.04 4.98 5.33 5.11 0.19 
Freezer 7 days  9.63 9.47 9.80 9.63 0.17 
Freezer 28 days  6.25 5.99 6.29 6.18 0.16 
 
Table 3.3: Mean L concentrations in freshly harvested kale after various processing 
and storage procedures throughout various periods of the year. 
 
 
Tables 3.2 and 3.3 display the mean L concentrations in minimally processed and 
freshly harvested kale after each processing and storage treatment. Four replicates 
of each analysis were performed and the data were presented as mean readings. 
Further mean readings were reported of the L concentrations of kale samples across 
the year. A pilot analysis was carried out in spring where raw kale of each variety 
along was investigated in relation to three common domestic cooking techniques, 
which included steaming, boiling and frying. During this pilot investigation, frying 
which was performed using a conventional cooking method with a small amount of 
olive oil (2ml per 1g sample) was found to be the most detrimental of the methods. 
However, the values obtained should be taken with caution as L is a fat-soluble 
molecule and it is likely that the low amounts reported were related to the active being 
retained in the oil. Due to lower than expected readings and difficulty measuring L 
within the lipid structure, kale was fried without the use of oil in future analyses. 
Boiling, particularly for a longer duration of five minutes, also had negative effects on 
L levels in both varieties of kale therefore blanching was used as an alternative 
method of cooking in the winter analyses. Additional methods for cooking and 
processing kale in the summer, autumn and winter periods included microwaving kale 
using three techniques (micro 1: 1 minute with a dessert spoon of water, micro 2: 2 
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minutes with a dessert spoon of water, micro 3: 2 minutes with a tablespoon of water) 
and liquidising kale with a small amount of water (2ml per 1g sample) from raw. 
Various fridge and freezer storage periods were also included in the post spring 
analyses to determine the storage effects on L concentrations in kale. 
 
 
Shop Kale Mean L 
mg/100g   
% reduction of L from raw 
Steam 9.88 14.80% 
Boil 3 min 6.38 44.91% 
Boil 5 min 3.81 67.10% 
Blanch 9.83 15.11% 
Fried (oil) 2.02 82.56% 
Fried (no oil) 5 min 4.76 58.89% 
Fried (no oil) 10 min 3.93 65.63% 
Micro 1 7.32 36.79% 
Micro 2 5.33 53.97% 
Micro 3 5.21 55.01% 
Liquidise 9.31 19.60% 
Fridge 4 days 6.19 46.55% 
Fridge 7 days 4.40 62.00% 
Freezer 7 days 7.17 38.80% 
Freezer 28 days 4.20 63.73% 
 
Table 3.4: Percentage in reduction of L concentrations from raw supermarket sourced 
kale after each processing and storage treatment. 
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Farm Kale Mean L 
mg/100g   
% reduction of L from raw 
Steam 11.50 46.16% 
Boil 3 min 6.72 68.54% 
Boil 5 min 3.89 81.79% 
Blanch 10.85 49.20% 
Fried (oil) 2.57 87.97% 
Fried (no oil) 5 min 4.90 77.06% 
Fried (no oil) 10 min 4.08 80.09% 
Micro 1 9.63 54.92% 
Micro 2 6.79 68.21% 
Micro 3 6.32 70.41% 
Liquidise 16.71 21.77% 
Fridge 4 days 8.80 58.80% 
Fridge 7 days 5.11 76.08% 
Freezer 7 days 9.63 54.92% 
Freezer 28 days 6.18 71.07% 
 
Table 3.5: Percentage in reduction of L concentrations from raw farm sourced kale 
 
after each processing and storage treatment. 
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Figure 3.2: Mean L concentrations of supermarket sourced and farm sourced kale 
upon various processing procedures. 
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Figure 3.3: Mean L concentrations of supermarket sourced and farm and sourced 
kale upon various storage procedures. 
 
Statistical Analyses 
 
 
Data for L levels after various cooking and storage procedures were analysed in 
statistical software IBM SPSS version 20 (IBM UK Ltd, Portsmouth, Hampshire) to 
draw comparisons between results using parametric and non- parametric tests. 
Normality of data was evaluated using a Kolmogorov-Smirnov and Shapiro-Wilk Test. 
Mean values were considered significantly different at p < 0.05. Statistical 
comparisons were made between lutein levels in raw and cooked samples, and 
between individual cooking and storage techniques. These differences were detected 
by independent t-tests and Mann-Whitney U tests depending on the normality of data. 
Differences were considered to be significant at p < 0.05. 
 
3.5 Discussion (effects of minimal processing and season) 
 
 
The study described here explored the L levels in raw freshly harvested kale sourced 
from the farm along with minimally processed supermarket purchased kale, at various 
times of the year. As a possible preventer of AMD, efforts to increase MP levels 
through simple dietary methods such as increasing dark green leafy vegetables in the 
diet are important. Gathering further information about the pre-and post-harvest 
effects on the L levels in kale is needed, thus setting a precedent for this study. 
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The L concentrations in mg/100g of kale as affected by source and season are shown 
on table 2.3. Lutein levels differed significantly (p<0.001) between kale which had 
been prepared for supermarket retailing and kale which was sourced directly from the 
farm, which had not been minimally processed by cutting, washing or vacuum 
packaging. Kale which was minimally processed contained 37%, 51%, 51%, and 
47%, lower levels of L respectively, in the spring, summer, autumn and winter than 
freshly harvested intact whole kale sourced direct from the farm. Possible 
explanations for these variances are discussed below. 
 
 
Fresh-cut vegetables and fruits are widespread throughout the fresh produce industry 
and refers to the process whereby raw vegetables and fruits are cut, shredded, 
peeled, abraded, or otherwise prepared to produce convenient ready-to-eat or ready- 
to-cook portions [264-266]. Additionally, this includes the final stage of packaging 
before being sold to supermarkets, restaurants, hotels and other smaller retail outlets. 
In earlier literature this process is also referred to as ‘minimal processing’ [267]. 
Consumer demand for fresh fruits and vegetables coupled with a demand for 
convenience is fuelling an interest in these minimally processed products. Since 
thermal and other drastic processing conditions are not used, minimally processed 
products are expected to retain fresh and be of superior nutritive quality. Low 
temperature and modified atmosphere packaging techniques (low O2, high CO2) are 
used which are intended to help retain freshness, extend shelf-life and limit the growth 
of micro-organisms [268]. However, studies to demonstrate the effects of minimal 
processing and modified atmosphere packaging on individual bioactive compounds, 
particularly in leafy green vegetables are still limited. 
 
In this study, the L values of minimally processed kale were found to be significantly 
lower than that of freshly harvested kale (p <0.001) classified as being whole intact 
produce. Previous data which has investigated L concentrations in raw kale has only 
considered farmed kale or minimally processed kale separately [199, 202, 269], thus 
this is the first study to examine the L differences between raw intact kale and its 
corresponding fresh-cut kale commodities, grown from the same farm. The rapid 
deterioration in L concentrations of kale sourced from the marketplace may be 
attributed to several things. Firstly, fresh-cut vegetables deteriorate faster than intact 
produce, which may be a direct result of the wounding associated with processing, 
leading to a number of physiological and biochemical changes which differ from intact 
commodities [267, 270, 271]. Nutrient losses are generally accelerated following 
tissue wounding, which may allow for substrate–enzyme interactions. In addition, 
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exposure of inner plant components, including carotenoids and phytochemicals to 
oxygen during minimal processing enhances oxidative degradation [261]. 
 
The degradation in carotenoid concentrations may be further enhanced during kale 
shelf-life in the supermarket. In this study, L levels were found to decrease by 37-51% 
respectively, from farm to shelf throughout the year. Kale which is grown in the UK 
typically has a shelf life of five days; and is stored under continuous retail lightening 
at 8°C. Previous studies have found carotenoid concentrations in minimally 
processed kale to reduce dramatically at temperatures above 4°C, with or without 
light exposure. Kobori, et al (2011) found that at 11°C under light, L decreased in 
minimally processed kale by 7.1%, and 24.1%, respectively, after 5 days and 10 days 
on the shelf [272]. 
 
In terms of the seasonal or climatic effects on the carotenoid concentrations in kale, 
although statistically significant, this study found only limited changes in L 
concentrations in both kale varieties throughout various periods of the year. Minimally 
processed kale sourced from the shelf had higher variations in L concentrations 
through various seasons, where by L levels were significantly higher in the spring 
than any other time of year (M=13.40mg SD 0.004 p<0.001). In freshly harvested kale 
however, spring L levels were slightly lower than other seasons meaning the retention 
of L in minimally processed kale in spring may be related to post-harvest rather than 
pre-harvest climatic effects. 
 
Two processes occur in photosynthetic tissues such as dark green leafy vegetables, 
which have opposing effects on carotenoid levels. These are known as 
caroteneogenesis and photo degradation. Exposure to sunlight and high temperature 
enhances the biosynthesis of carotenoids (caroteneogenesis), but also promotes 
photo degradation, which potentially lowers carotenoid concentrations. There is 
evidence to suggest that vegetables including kale produced in greenhouses, or in 
plots covered with plastic roofing, show higher carotenoid concentrations in the 
summer as opposed to the winter, as the plants are protected from excessive sunlight 
during the summer, thus favouring caroteneogenesis instead of photo degradation 
[199, 258, 273]. In the present work, kale which hadn’t been subject to post-harvest 
cutting or packaging had highest L levels in winter, indicating that the effect of sunlight 
and high temperature on photo degradation prevailed in the spring, summer and 
autumn. The kale used in this study was farmed in open fields for the majority of its 
harvest life which gives added clarification to these findings. Two previous studies 
have also found carotenoid concentrations to be higher in the winter than the summer 
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for leafy green vegetables harvested in open fields, suggesting that sunlight and high 
temperature may promote photo-degradation when vegetables are not protected by 
roofing  [202], [274]. 
 
3.6 Summary (effects of minimal processing and season) 
 
 
This study adds to the small amount of information that is currently available 
concerning the retention of antioxidant constituents such as L in raw kale during 
handling and retail storage at different times of the year. These findings, as well as 
previous literature on other varieties of fruits and vegetables, indicate that fresh-cut 
produce has different properties to its corresponding intact vegetables, in that it has 
an increased perishability of nutrients. This means that the knowledge accumulated 
over many decades regarding the physiology and handling of commercial vegetables 
may have to be re-examined and new understanding and information developed for 
each fresh-cut produce item is needed. Further information and research is required 
on the chemical and biochemical alterations that occur in post-harvest minimally 
processed foods sold in supermarkets and on the improved maintenance of their 
nutritional quality, particularly for food sources that have not previously been 
addressed such as kale. In terms of climatic effects of caroteneogenesis, this study 
is in agreement with previous findings which suggest that carotenoid concentrations 
are higher in the winter than the summer for leafy green vegetables harvested in open 
fields, as sunlight and high temperatures may promote photo-degradation when 
vegetables are not protected by roofing or packaging. 
 
3.7 Discussion (effects of cooking and storage) 
 
 
The study described here explored the L levels in minimally processed retail prepared 
kale, and kale freshly harvested from the farm, following various domestic processing 
and storage procedures. Unlike fruits, most vegetables are commonly consumed after 
being submitted to a cooking process. Cooking methods are used to improve 
vegetables’ palatability by softening the tissues, and inactivating anti-nutritional 
compounds, toxic substances and microorganisms. However, when comparing their 
biological actions and antioxidant activities in vitro and in humans, there is no 
consensus regarding the best way to consume them [204]. As a possible preventer 
of AMD, efforts to increase MP levels through simple dietary methods such as 
increasing dark green leafy vegetables are recommended. Therefore, gathering 
further information about the post-harvest effects on the L levels in kale is important, 
thus setting a precedent for this study. 
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Kale L levels within this study were dramatically affected by cooking and storage, with 
the notion that the longer the kale was cooked or stored the more L was lost. There 
were less apparent changes in L concentrations upon processing procedures which 
used shorter durations, lower temperatures and smaller concentrations of water such 
as blanching, liquidising and steaming. Possible explanations for these variances are 
discussed below. 
 
 
Effect of cooking methods on the L concentrations in kale varieties 
 
 
Steaming, boiling and stir-frying with oil: 
 
 
 
Steaming, boiling and stir-frying are common domestic cooking methods in the UK, 
therefore these were the first processing techniques to be analysed in the initial pilot 
investigation in spring. As shown in tables 3.7 and 3.8, boiling for 3 and 5 min and stir 
frying with a small amount of olive oil resulted in significant losses of L in both varieties 
of kale. In both the shop and farm kale, the fried sample with oil showed the highest 
degradation of total L relative to the raw samples (83% shop, 88% farm, p < 0.05). 
Similarly, a recent study investigating certain phenolic compounds in kale after 
boiling, steaming and stir-frying, found that stir-fried kale (4 min with soybean oil) had 
the greatest decrease in L levels compared to all other cooking methods (4.66 ± 1.81 
μg/g) [204]. Boiling for a longer duration of 5 min was more detrimental than boiling 
for 3 min in both kale types (p < 0.05) although both techniques resulted in substantial 
losses in L (boiling 3 min: 45% shop, 67% farm) (boiling 5 min: 69% shop, 89% farm). 
In both shop and farm kale, steaming showed the lowest degradation of total L relative 
to the raw samples amongst all processing techniques (14.8% shop, 46.6% farm) so 
would be the optimal cooking technique for retaining L levels in kale. In the study 
previously mentioned steaming kale was found to be more detrimental for L levels 
than boiling kale. Raw kale contained 56.18 ± 2.9 μg/g of L, after boiling and steaming 
this decreased to 6.9 ± 0.54 μg/g and 5.81 ± 1.14 μg/g respectively [204]. Other 
studies investigating steaming, boiling and stir-frying effects on L concentrations in 
kale are limited; therefore, further studies may be needed to support these findings. 
 
 
Although freshly harvested raw kale was superior in L concentrations than minimally 
processed raw kale within its shelf life constituency, upon processing, L levels 
declined further in kale sourced from the farm. The reasons for this are likely to be 
related  to  the  effects  of  minimal  processing.  Fat-soluble  nutrients  such  as  the 
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carotenoids (including L) are sensitive to heat, light, oxygen, and pH. Minimal 
processing, such as cutting, or slicing is useful from a convenience standpoint, 
however it causes injury to the plant tissues which initiates enzymatic changes, such 
as ethylene production, respiration, accumulation of secondary metabolites and water 
loss from tissues [275]. This increases susceptibility to microbial spoilage, which not 
only compromises food safety, but alters chemical make-up and promotes loss of 
nutrients [276]. Therefore, to preserve moisture and humidity as well as protect fresh- 
cut products, packaging is used. Packaging may help to preserve some nutrients in 
fresh-cut products, particularly if done at the right time and under appropriate 
conditions, mainly because it delays ripening and deterioration. Other techniques 
such as modification of pH, irradiation, or chemical preservation (dips in ascorbic acid 
and/or citric acid), a technique used in the kale sourced, may further prevent 
deterioration of minimally processed vegetables [197, 277]. It seems freshly 
harvested intact kale commodities may initially benefit from an enhanced nutrient 
value in their raw state, but exposure to heat and oxygen without the added protection 
of packaging and chemical preservation from acid washing may further increase their 
carotenoid degradation upon processing. 
 
Frying without oil, microwaving, blanching and liquidising 
 
 
 
After the pilot investigation in spring, kale was stir-fried for both 5 and 10 minutes 
without the use of oil. Previous studies investigating the use of stir-frying vegetables 
have found that frying treatments cause loss of (all-E)-isomers of carotenoids [204, 
278], which could be explained by the lipophilic nature of carotenoids with the 
consequent leaching of these molecules into the oil. This may explain why L levels 
were lower in the pilot investigation where oil was used. Recent human intervention 
studies have shown that this leaching of carotenoids into oil may potentially improve 
their bioavailability, since the bioavailability of lutein has found to be higher when 
administered in oil [279-281]. Dietary fat increases carotenoid bioavailability by 
providing a depot for the release of hydrophobic compounds from the food matrix, 
stimulating the secretion of bile salts and pancreatic lipases for micelle formation, and 
inducing chylomicron synthesis [282]. A study which explored L bioavailability in kale 
found that approximately 5-10g fat in a meal was required for efficient absorption of 
carotenoids in to the blood, although more fat was required when the diet contained 
L esters instead of free L [283]. In the current study, dry fried kale samples without 
the use of oil still showed a high degradation of total L relative to the raw samples 
(59%-66% shop, 77-80% farm), with frying for a longer duration of 10 min being more 
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detrimental. Frying with the addition of oil in the pilot investigation resulted in 
significantly lower levels of total L than frying without oil (Mann-Whitney U test p 
=0.001), giving further evidence to support the lipophilic nature of these molecules. 
 
 
 
Microwaved kale for the longest duration with the highest amount of water showed L 
degradation of 55% and 70% in shop and farm kale respectively, relative to the raw 
sample, suggesting that shorter processing times and the use of minimal water during 
microwaving kale would be preferred. To the best of my knowledge, this is the first 
study which has investigated various microwaving techniques on the L concentrations 
in kale. A small number of studies have investigated the effects of microwaving on 
other predominant carotenoid containing vegetables. The levels of carotenoids in raw 
and cooked (microwaved, boiled, steamed, stewed) green vegetables and tomatoes 
were extensively studied by Khachick et al, (1992). It was shown that while the 
epoxycarotenoids were somewhat sensitive to heat treatment, L and hydrocarbon 
carotenoids such as neurosporene, a- and P-carotene, lycopene, (-carotene, 
phytofluene, and phytoene) survived the heat treatments [284]. The effects of 
induction boiling, conventional boiling and microwave steaming on the sensory 
qualities and carotenoid retention of broccoli, carrots, green beans and sweet 
potatoes were investigated by Nunn et al [285]. The L/Z content of microwave- 
steamed broccoli was significantly higher (p < 0.05) than that prepared by either of 
the two boiling methods. The current study is in agreement with these findings, in that 
the concentration of L in microwaved kale using minimal water for 1 min (Micro 1) was 
significantly higher in both kale varieties than that prepared by boiling (p <0.001) or 
frying (p <0.001) for the shortest durations. 
 
 
Blanched kale exhibited similar effects on L levels than steaming kale, showing a fair 
conservation of total L with a reduction of 15% and 50% for shop and farm kale 
respectively. Although intact whole kale sourced fresh from the farm showed a higher 
degradation than its minimally processed commodity, 100 g of blanched kale of this 
variety would still provide 10.85 mg of L. Similarly 100 g of shop purchased kale would 
provide a sufficient quantity of 9.83 mg. 10 mg of L per day has been associated with 
a delay in the progression of AMD [10] and the most beneficial effects on MP levels 
in the eye [98, 99]. The concentration of L in blanched kale of both varieties was not 
significantly different than that prepared by steaming (Mann Whitney U test p = 0.92), 
thus both methods may be considered as optimal cooking techniques for retaining L 
levels in kale. 
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Previous data in regard to blanching effects on kale are limited. One study which 
investigated total carotenoid losses in kale after blanching found that blanching kale 
leaves for 2.5 min did not significantly alter the level of total carotenoids and beta- 
carotene from raw [286].  Furthermore, a study which investigated the effect of 
blanching on Ethiopian and Indian green vegetables found that, blanching increased, 
in general, neoxanthin, L and beta-carotene contents to a slight degree, explaining 
their results with better extraction and quantification of these compounds from the 
denatured plant tissue [287]. Even if heat may result in some loss of carotenoids, the 
inactivation of oxidative enzymes by blanching may prevent higher losses of 
carotenoids during holding before thermal processing, slow processing and storage 
[288]. Akapap, et al. reported that blanching of fresh fluted pumpkin leaf, okra, African 
spinach, and water leaf at 98 °C for 3 min caused total losses of carotenoids which 
ranged from 29.5% in okra to 34.9% in both fluted pumpkin leaf and African spinach. 
It was further reported that blanching the vegetables before storage at -10 °C slightly 
improved the retention of nutrients, again because blanching possibility inactivated 
the enzymes [289]. 
 
Of all the processing methods, liquidising kale from raw showed the best conservation 
of total L in both kale varieties with a reduction of only 20% and 22% in shop and farm 
kale respectively. Although L losses were similar in the two kale varieties, the 
concentration of L in farm sourced kale after liquidising (M=9.31 mg/100g, SD= 0.12) 
was significantly higher than that of shop sourced kale (M=16.71mg/100g, SD= 0.10) 
(independent t test p = <0.001). Thus, it was evident that freshly harvested intact 
whole kale was less susceptible to damage by a processing method which did not 
require heat and therefore should be recognised as a superior source of L to minimally 
processed kale prepared for retailing, if this is the desired method of consumption. 
 
 
Effect of storage methods on the lutein concentrations in kale varieties 
 
 
As reported in the previous chapter, vegetables such as kale are often the most 
health-promoting when harvested and consumed at their peak maturity, before the 
addition of post-harvest handling and processing. In westernised countries like the 
UK, nowadays home-growing vegetables is outdated, and sourcing mass produced 
minimally processed products available freely in supermarkets is a more convenient, 
conventional consumer habit.  Fruits and vegetables grown in the UK may spend up 
to 2 days in transit following harvest before arriving at a retail outlet. At the retail store, 
fruits and vegetables may spend a further 1–5 days on shelf display prior to being 
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purchased by the consumer, who then may store them for up to 7 days prior to 
consumption. This means that fresh fruits and vegetables may not be consumed for 
a significant length of time following harvest, during which time nutrient degradation 
may occur. 
 
 
Due to continued respiration and enzymatic activity, fruits and vegetables suffer 
changes in nutritional value and sensory quality including loss of texture, appearance 
and flavour during storage [275], especially if factors such as temperature, 
atmosphere and relative humidity are not well regulated [277]. In the current study, it 
was found that fridge storage for the longest duration of 7 days showed a significantly 
higher (p=<0.001) L degradation (47% shop and 58% farm) than fridge storage for 4 
days (62% shop, 76% farm), relative to the raw samples. The trend that the 
degradation of L levels increases further upon longer storage times is documented in 
other studies. Bunea, et al. reported that in spinach, the carotenoids such as L and 
beta-carotene were all affected by prolonged storage time and temperature. The 
content of carotenoids was best preserved after storage for one day at 4°C [259]. A 
study which investigated the effects of storage for four days at 7-9°C on the 
carotenoid contents of kale found that all four carotenoids decreased significantly; L 
(27%), violaxanthin (20%) neoxanthin (31%) and beta-carotene (14%). The authors 
noted that the retention of the carotenoids could have been improved, by using 
modified atmosphere packaging and a lower storage temperature [199].  Although 
storage temperatures were lower in the current study, the losses observed may have 
occurred due to longer storage durations and the use un-optimised packaging, as 
minimally processed kale was removed from its original packaging and both kale 
varieties were placed in simple sealable bags. Freezer storage also had detrimental 
effects on L concentrations in kale; however, L preservation was slightly better than 
that of fridge storage.  Kale stored in the freezer for a longer duration of 28 days 
showed a high L degradation of 64% and 71% in shop and farm kale respectively, 
relative to the fresh samples, compared with 39% and 55% in freezer storage for 
seven days. 
 
 
3.8 Summary (effects of cooking and storage) 
 
 
Processing and storage of foods have become integral parts of the modern-day food 
chain. More emphasis should be given to increase consumer knowledge on the 
depletion of important nutrients in vegetables due to the post-harvest processing and 
storage  techniques  required  for  retail  manufacturing  or  domestic  processing. 
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Domestic cooking, storage and preparation have substantial negative effects on the 
content and bio-availability of carotenoids in foods. If domestic processing is to occur, 
reducing processing/storage time and using cooking methods which require lower 
processing temperatures and minimal amounts of water, improves L retention 
significantly, regardless of kale source. 
 
Furthermore, it may be beneficial to suggest the method of steaming kale rather than 
boiling or stir-frying, and to advise more thoroughly on alternative methods to 
conventionally cooking kale, such as liquidising and blanching, or better still 
consuming kale raw. Although the use of oil may improve L bioavailability in the 
addition of frying, alternative cooking techniques which involve the addition of fat 
should be encouraged. Previous data suggests that blanching in particular may 
prevent subsequent nutrient losses if performed before storage due to the inactivation 
of certain enzymes. Blanched and pureed vegetables may result in increased 
extractability of carotenoids in vegetables compared to the raw homogenized form; 
however, there is paucity of information in this area. Loss of nutrients during fresh 
storage may be more substantial than consumers realize, so consumers should be 
educated about this. Fruits and vegetables should be consumed soon after harvest, 
or postharvest handling conditions must be controlled such that nutrient degradation 
does not occur. For example, shorter storage durations, exclusion of oxygen through 
modified atmosphere packaging, protection from light and low temperature 
diminishes carotenoid decomposition during storage. 
 
In conclusion, L levels in kale which is both freshly cut and pre-prepared for retailing 
are negatively affected by processing and storage conditions. The evidence suggests 
that regardless of the method chosen, retention of L decreases with longer processing 
or storage time and higher processing temperatures. The results of the study 
described here can be used to enrich the current advice about kale consumption in 
those who suffer with AMD, and provided evidence to support the design and 
production of a novel intervention to improve diet in this population. 
 
Limitations 
 
 
These studies contain several limitations. Firstly, the processing and storage 
treatments used were not consistent throughout the seasons; for example, in the pilot 
analysis in spring alternative cooking methods were examined compared with 
analyses in following seasons. This procedure was adopted to address any 
methodological issues early on and to test various processing treatments in order to 
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alter and identify the optimum requirements for retention of L in kale. However, 
repeating the same analyses throughout every season would have provided more 
data for statistical comparisons. Secondly, temperature during frying was not 
measured and controlled which would have increased the reliability and repeatability 
of results. The kale types used in the studies were curly kale, though other varieties 
of kale are popular in the UK such as Cavalo Nero. It would have been useful to draw 
comparisons of L concentrations between varied kale types to provide further data on 
the optimum sources of L amongst dark green leafy vegetables grown and sourced 
in the UK. Overall, further research is needed to support the carotenoid composition 
of UK kale; comparisons with previous studies are difficult as variations are most likely 
due to differences in cultivars and environmental factors. Although the present data 
may provide new information to enrich the current advice about dietary L sources, 
there are many uncontrollable inter-individual variations that regulate the digestion, 
absorption, transport and eventual retinal uptake and maintenance of these nutrients 
[93, 104, 279, 290, 291]. It is  therefore important for studies to not only assess the 
total L or carotenoid content of plants but also their stability along the food chain [292]. 
 
 
Chapter four will describe a qualitative study conducted to establish food choices and 
preferences in AMD patients, the physical and psychological factors which may 
influence eating habits and thus the potential barriers to dietary change. The 
acceptability of ready meals specifically designed to support the nutritional needs of 
AMD patients as a novel intervention for improving diet was also discussed with 
subjects to help inform the design of a questionnaire to use in a larger cohort of 
patients. 
75  
Chapter 4: Use of a focus group to identify eating habits in AMD patients 
 
 
4.1: Background and rationale 
 
 
Lutein and Z consumption can improve MP levels in the ocular media [293], which 
may be of benefit in the primary prevention of onset or progression of AMD. As L and 
Z are not formed within the body and can only be obtained from our diet their dietary 
intake is important in AMD patients [294], [81]. However, subjects who suffer with 
AMD are presented with a wealth of nutritional information available from a variety of 
sources such as magazines, newspapers and the internet. Conflicting information, a 
lack of evidential research and aggressive marketing campaigns have led to 
confusion among patients and practitioners in what supplements to take, and  what 
foods should be consumed in order to maximise absorption of these useful nutrients 
[209]. 
 
Many patients turn to organisations for clarity of information such as the MS – the 
only UK charity that is devoted to helping those with diseases of the macula. The MS 
has 16,000 members, a busy helpline and counselling service and 235 local support 
groups nationally [210]. They produce training programmes and information for 
patients and health professionals. They also sponsor research into treatments, quality 
of life issues, a cure and campaigns for access to treatments and services [295]. 
Members of the MS may be considered an ‘informed’ population as the society 
provides patients with various educational tools to assist with increasing knowledge 
on nutrition and AMD. These consist of nutrition leaflets, articles in their monthly 
patient magazine ‘Side View’ and yearly health professional magazine ‘Digest’ all of 
which are updated to keep abreast of current research. Members and non-members 
also have access to a patient portal on the main website which includes detailed 
information on all areas of nutrition including diet and supplementation advice [296]. 
 
Despite this wealth of nutritional information presented by the MS, dietary analysis 
research within this population informs us that patients are not consuming enough 
nutrients that are recommended for their condition. A previous study conducted by 
our research group at Aston University and a follow up study addressed in chapter 
two have found that average L/Z intakes in this population were much lower than the 
recommended dosage for patients who suffer with AMD [211]. Participants also 
consumed daily calories intakes significantly below the government DRV’s. Other 
important nutrients consumed below the DRV’s included carbohydrates, fibre, and 
vitamin D and potassium. 
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Although these cohorts were groups of highly motivated individuals who had taken 
the initiative to contact the MS, the evidence does not suggest that the information 
that participants had received from the MS or other sources modified their behaviour 
[211]. There may be various reasons for this such as a dislike for the nutrient-rich 
foods, lack of knowledge on how to cook or prepare them, misjudgement on the 
amounts required per day, lack of control (family or caregivers cook food), and 
difficulty in acquiring or preparing foods. Although the association between education 
barriers in the visually impaired and diet-related health outcomes has not been 
studied in depth, some studies have considered the above factors [210, 251]. 
 
A study which assessed the perceived health and vision states and awareness of 
lifestyle factors of AMD patients looked further in to the barriers to why AMD patients 
who seek the services of the MS are under consuming nutrients, by determining their 
awareness of the relationship between nutrition and AMD. It documented that over 
half (56%) of AMD subjects were able to acquire food themselves, and used a 
supermarket as a primary source for acquiring food sources. However, the remaining 
44% of patients were unable to shop for themselves. When considering patient’s food 
choices, the largest influencer appeared to be preference (44%), with the next largest 
(33%) being foods that the subjects believe would affect their health. The ability to 
prepare the foods was a factor for 6% of subjects, and 3% said that the ability to 
acquire the food was the predominant influencer [297]. Further research from 
Douglas, et al’s survey into independent living for the RNIB [251] showed that 
‘preparing a meal’ was one of the most commonly identified challenging task by 
visually impaired people (33% respectively). Further information about how they 
acquired their food revealed that 56% of the participants were able to go food 
shopping; 28% relied on a family member, 3% had a friend and 2% had a caregiver 
who went food shopping for them.  A further 12% of subjects had another method of 
acquiring food such as the internet, meals on wheels, etc. 
 
Changing eating habits may be difficult in these older populated groups and requires 
novel intervention methods. Effective health education for promoting nutrition literacy 
among elderly people may only be the first step when encouraging dietary change. 
Current research suggests that there are numerous factors which may play a part in 
influencing AMD patient’s dietary habits [210]. It is therefore essential to design 
effective measures for improving the diet of individuals with, or at risk of, AMD, which 
consider underlying barriers to dietary change. 
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The aim of this study was to design and conduct a focus group to discover what foods 
patients like to eat and in more detail, what factors may influence their food choice 
and preferences and the potential barriers to dietary change. The idea of ready meals 
as a potential intervention for improving diet in AMD patients was also discussed. The 
focus group method was selected for this study because it fostered open interaction 
and discussion among group members which generated rich data related to the 
individual needs of older adults living with visual impairment. 
 
Ethics 
 
This study was approved by the Aston University Ethics Committee (Ethics number 
 
843). Verbal informed consent was obtained from all subjects and formally recorded. 
Verbal informed consent was obtained from all subjects and formally recorded. 
 
4.2: Method 
 
 
Step by step scheme of work 
 
 
1.  Recruitment of AMD patients for focus group via a Macular Society local peer 
support group meeting 
2.  Carry out focus group with AMD patients 
 
3.  Design questionnaire for larger cohort based on findings from the focus group 
 
4.  Carry out questionnaire in larger cohort 
 
5.  Design ready meals for AMD patients based on the findings from the focus 
group and questionnaires. 
 
 
Subjects of focus group 
 
 
Patients of the MS who are members of a local peer support group were invited to 
take part in a focus group to discuss their individual food choice and preferences and 
possible physical and psychological barriers to dietary change. Six AMD patients 
were invited to join the focus group. Inclusion criteria were subjects with either form 
of AMD who were over 50 years of age. 
 
Method 
 
 
One focus group was conducted involving six AMD patients. The session was held at 
a local peer support group for MS members, where participants were recruited from 
the peer support group beforehand. The peer support group involves forty-five MS 
members. Subjects who agreed to take part in the focus group were asked to stay 
after their peer support group meeting to be involved in the 90-minute session. The 
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focus group was conducted by a facilitator and assisted by a moderator who took 
detailed notes throughout the discussion. The focus group was also transcribed by 
the moderator where possible. Before the discussion session began, the facilitator 
and moderator introduced themselves to the participants and started the ice-breaking 
session in which each of the participants were asked to briefly introduce themselves 
to the group. The session then proceeded with an introduction to the study where the 
aims and objectives were explained and the confidentiality of the outcome from the 
focus group. After the introduction, the discussion session was initiated by asking 
semi-structured and open-ended questions to subjects. The semi-structured question 
design was centred on the following topics: the way that participants choose and 
prepare their daily foods, the factors influencing their food choices and eating habits 
and possible barriers to not making appropriate dietary changes. This included 
questions such as: 
 
Which foods do you like to eat/ what is your favourite food? 
Why do you like the food? 
What foods do you not like to eat? 
Why do you not like the food? 
Do you eat more hot or cold foods? 
 
 
What meals would you normally prepare? 
 
 
Do you often make meals with dark green leafy vegetables such as kale? 
How do you usually like to cook these foods? 
If not, why do you not include these foods in your meals? 
How do you feel about ready meals? 
How do you feel about cooking home-made meals? 
Where do you normally shop? 
How much do you like to pay for an average dinner (ready meal/home cooked)? 
How much would you spend on an average ready meal? 
The sample consisted of one male and five females who were Caucasian and aged 
above 50 years. All participants presented with some form of AMD. The themes that 
79  
emerged from the data focused on the food/meal likes and dislikes of patients, patient 
cooking habits, patient’s opinion on ready meals, and perceived barriers of dietary 
change. 
 
Analysis of focus group 
 
 
Data from the focus group was analysed using a Micro-interlocutor Analysis, which is 
a relatively new method of analysis for focus group research, taken from an article by 
Onwuegbuzie, et al (2009) [298]. Micro-interlocutor analysis goes beyond analysing 
only the verbal communication of focus group participants and therefore increases 
the rigor of focus group analyses in qualitative research. It may be described as a 
process where meticulous information about which participant responds to each 
question, the order in which each participant responds, response characteristics and 
the nonverbal communication used is collected, analysed, and interpreted. A template 
which allowed for the transcribing of this information was used to analyse and 
interpret data (appendix 2). Themes that emerged from the focus group discussion 
were identified and are highlighted below. 
 
4.3 Results 
 
 
Food/meal likes and dislikes of patients 
 
 
All participants agreed that fish was the preferred choice of food to base around a 
meal, with fish pie or fish accompanied by sides being mentioned as participants’ 
favourite food/meal. One subject revealed that this was primarily white fish. Other 
favourite foods or meals consisted of lasagne (participant 1), chicken risotto, soup 
(participant 2), stir fry (participant 3), soup (participant 4), chilli con carne, quiche, 
curry (participant 5) chicken risotto (participant 6). Some of the reasons behind 
subjects’ food preferences included taste, texture and digestibility. Food/meal dislikes 
included tuna, pilchards (participant 1), and spicy food (participant 2-4). Two 
participants indicated that they did not dislike any particular foods. Spicy food was 
specified as causing issues with digestibility, and oily fish was considered to be 
unsavoury. 
 
Patient cooking/eating habits 
 
 
All six participants enjoyed both hot and cold meals. Cold meals mentioned by all 
participants as being particularly favourable included quiche, salads and cold fish. 
Only two out of six subjects home cooked their meals on most days of the week. One 
subject lived with a relative who regularly cooked for them. The remaining three 
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subjects cooked two times a week, and on the other days of the week ate ready meals 
 
– this included supermarket purchased meals and home delivered meals such as 
Wiltshire Farm Foods (www.wiltshirefarmfoods.com). All three of these patients lived 
alone and mentioned this as being one of the main reasons for not cooking as often. 
 
The three participants who were most likely to home cook meals frequently included 
dark green leafy vegetables such as kale in their dishes. Kale was predominantly 
used as a side dish in a meal. Two of these subjects stated that they mostly enjoyed 
stir frying kale with other vegetables. The three subjects who cooked less home-made 
meals rarely added kale to their meals, despite them being aware it contained 
nutrients important for their condition. This was mainly due to a lack of accessibility, 
issues with food preparation and a dislike for food wastage. All participants were 
unsure of ideal methods in which to prepare, store and cook kale for the retention of 
important nutrients, but were particularly interested in knowing so. Two subjects 
identified this lack of information to be an additional factor for not including kale in the 
diet. 
 
Participant’s opinion on ready meals 
 
 
Two out of six subjects did not consume ready meals due to a perceived unpleasant 
taste, a concern with the addition of additives and preservatives and high fat and 
sugar contents. They also mentioned that they enjoy the concept of acquiring food 
and cooking. These participants disclosed that if they were to consider ready meals 
in the future they would have to be unrepresentative of the usual supermarket 
convenience food that they deem as ‘unhealthy’. Other subjects enjoyed the idea of 
ready meals because of the convenience and simplicity that they offer. One point that 
was frequently mentioned by this group was the dislike for fresh foods going to waste 
when they are only acquiring and cooking food for themselves. Subjects further 
highlighted that acquiring, preparing and cooking foods were particularly difficult for 
them without the added support of another person. When buying vegetables, these 
subjects tend to choose frozen alternatives. All participants would not let price 
influence their choice over a ready meal, with nutritional impact and taste being the 
two key drivers for choice. All subjects agreed that if they were to be influenced by 
price then between £2 and £4 or even above £4 would be reasonable. 
 
Perceived barriers of dietary modification 
 
 
Food wastage and storage concerns. ‘Kale comes in a large 200g bag with much 
 
of it going to waste as I am only cooking for myself. This puts me off buying it despite 
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knowing it is good for my eyes’, stated one participant. Other patients agreed with this 
statement and said they would prefer to have access to more local independent 
suppliers of kale where they could choose their own amounts of produce. For 
example, one participant commented that ‘kale I buy from the supermarket tends to 
go off very quickly when it is not used, I would like to be able to buy kale from local 
producers where it is fresh and not pre-cut and packaged’. Another participant added 
‘I would like to know if I could freeze the excess kale and then re-use it or would this 
have an effect on its nutrients’. Most patients agreed with this query, two patients 
stated that they prefer to purchase frozen vegetables as they last longer. 
 
Acquiring, preparing and cooking foods. Only two out of six patients experienced 
cooking their own meals on regular days of the week. One patient revealed ‘I live with 
my son who cooks and prepares food for me; otherwise I would struggle to be 
independent’. The remaining patients agreed with this statement, claiming that health, 
mobility and visual impairment prevent them for acquiring, preparing and cooking 
foods as much as they would like to. ‘When you are on your own you do not want to 
prepare, and cook for one person, it is too much effort and food goes to waste so I 
prefer to eat cold meals or heat up ready meals in the microwave’ said one elderly 
man. Patients who lived on their own were in agreement with this statement, 
preferring to opt for foods requiring limited preparation or cooking.  ‘I use Wiltshire 
Farm Foods to deliver my ready meals for the same reasons, however I have not 
come across any ready meals they do which contain kale, that would be good’ another 
woman stated. Patients that incorporated kale in to their meals had various opinions 
and ideas on cooking methods. Two patients stated ‘stir fried kale is the tastiest and 
you can add all sorts of other vegetables, oils or sauces’ another remarked ‘is this a 
good way to cook kale?’ One patient had opposing opinions stating ‘I prefer to steam 
my vegetables I have heard this method is best for retaining nutrition and keeping 
flavour and texture’. 
 
4.4: Discussion 
 
 
Research has shown that AMD patients are not taking on board the recommendation 
dietary advice for their condition [211]. The reasons for this are likely to be multi- 
factorial. In a previous study within a similar cohort of patients, participants were 
asked through the use of a survey what influenced or dictated their choice of food. 
The largest influencer appeared to be preference (44%), with the next largest (33%) 
being foods that the subject’s believe would affect their health. The ability to prepare 
the foods was a factor for 6% of subjects, and 3% said that the ability to acquire the 
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food was the predominant influencer [200]. Results from the focus group present 
similar findings, a person’s food choices and preferences are very much individually 
varied. Within this small cohort of AMD patient’s individual constraints to not 
consuming a diet recommended to support the nutritional needs of their condition 
were difficulty with acquiring, preparing and cooking foods, a dislike towards food 
wastage and a lack of information regarding optimal cooking and storage methods for 
vegetables such as kale. These barriers were further emphasised in those who lived 
alone and lacked the support of family members or carers. Strategies to ensure that 
nutritional information and interventions consider these multi-factorial barriers within 
this vulnerable population may be needed. 
 
Only two out of six patients experienced cooking their own meals on regular days, 
acquiring and preparing food was noted as being an enjoyable factor in this. One 
patient was solely dependent on a relative to do this for them and the remaining 
subjects (half the cohort) opted for convenience food such as ready meals or meals 
that required minimum preparation. Difficultly acquiring preparing and cooking foods 
when living alone led to more interest in these food choices. Living alone can have a 
tremendous impact on quality of life - The RNIB’s 2003 commissioned survey of 588 
BT customers found that 63% of blind and partially sighted people live alone, which 
is a much higher figure than the elderly population without sight impairment [15]. 
Participants were aware that dark green leafy vegetables contained important 
nutrients to support eye health, however only half of the group incorporated kale in to 
their meals on a regular basis. Food wastage was a concern with all patients who 
were in agreement that the proportions of pre-packaged kale available in most 
supermarkets were too large. There was significant confusion amongst subjects on 
the best ways to cook and store kale and all patients anticipated further information 
within this area. Frozen foods such as vegetables were particularly appealing to those 
who were living in a single occupancy household and seeking convenience from their 
meals. 
 
Ready meals were a primary attribution to the diet of half of the patients within this 
group. Participants who live alone and find it difficult to acquire, cook and prepare 
foods benefit from the simplicity and convenience that these meals offer. However, 
two out of six subjects had an aversion towards ready meals due to the ‘unhealthy’ 
connotation that surrounds them. Subjects were concerned with the notion that ready 
meals contain additives and preservatives and likely high sugar and fat contents. 
Subjects were also keen to gain added information about how they should cook, 
prepare or store foods recommended for their condition, such as kale. Further 
83  
information in this area may give patients more practical advice for encouraging 
dietary change. 
 
Limitations 
 
 
One criticism of qualitative focus group analysis is that findings are usually not 
generalisable beyond the local research participants as it typically involves 
examination of data extracted from small, non-random samples [299, 300]. The 
rationale for the small focus group size within this study stems from the goal that focus 
groups should include enough participants to yield diversity in data provided, yet they 
should not include too many participants because large groups can create an 
environment where subjects do not feel comfortable sharing their thoughts, opinions, 
beliefs, and experiences [301]. Krueger (1994) has endorsed the use of very small 
focus groups, what he terms “mini-focus groups” where participants have specialised 
knowledge and/or experiences to discuss in the group [302]. 
 
A distinct limitation to the current study may be the use of only one focus group to 
collect data. The number of times a focus group meets can vary from a single meeting 
to multiple meetings however, using multiple focus groups allows the assessment of 
the extent to which saturation has been reached [303], [304]. Data saturation may 
result when information occurs so repeatedly that the researcher can anticipate it and 
whereby the collection of more data appears to have no additional interpretive worth; 
or theoretical saturation when the researcher can assume that the emergent theory 
is adequately developed to fit any future data collected [305]. The subjects used in 
the current study are, of course, not a truly accurate representation of all patients 
seeking services from the MS; however a more diverse group with a range of cultures 
and socioeconomic levels would likely raise a range of viewpoints. This research also 
solely focuses on AMD patients who are members of the UK charity the Macular 
Society. It would also be important to find out the opinions of those with AMD who 
have not sought support from non-professional organisations. 
 
4.5: Summary 
 
 
Ageing is characterized by a decrease in activity [306], a decline in lean body mass 
[307], and loss of appetite [308] which may lead to poor dietary impacts in older adults. 
This study indicates, however, that barriers to eating sufficient energy requirements 
and following a healthy diet may include both the consequences of normal ageing for 
the control of appetite, and changes in psychosocial circumstances which may 
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exacerbate diminished appetite such as fewer social eating occasions, living alone, 
and poor cooking skills. These barriers may be heightened in subjects who suffer with 
sight loss who have additional physical barriers involving food preparation and eating. 
It is evident that subjects recognise the importance of following a diet which contains 
important nutrients to help slow the progression of AMD, yet altering dietary habits is 
proven difficult when there are underlying individual barriers to change. Ready meals 
which are nutritionally tailored to support the needs of these individuals may be a 
promising intervention for improving the diet of AMD patients in the future. The results 
of this study will inform the design of a questionnaire to use in a larger cohort of 
subjects from the Macular Society to further determine AMD patient’s interest in the 
design and production of such meals. 
 
Chapter seven will describe the results of a survey which was designed to establish 
AMD patient’s opinions and current usage of ready meals, their food likes and dislikes 
and their future interest in ready meals nutritionally tailored to support the needs of 
AMD. The survey generated rich data which aided with the design and production of 
these meals. 
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Chapter 5: Use of a survey to establish AMD patient’s usage and opinions on 
ready meals 
 
5.1: Background and rationale 
 
 
It is evident that convenience plays a prominent role in the food choices of today’s 
consumers. Demographic changes have produced an increasing demand for food 
products which are regarded by many consumers as convenient and affordable [309]. 
Rapidly growing Westernised populations typically consume fewer home cooked 
meals and more pre-prepared food products, such as ready meals and fast food. The 
convenience food sector is expanding rapidly; currently the US and the UK are the 
largest ready meal markets in the world, respectively valued at £7.2 billion [310] and 
£2 billion [311]. In Western Europe, the size of the market is estimated at £3.9 billion 
[312]. The majority of this is due to the UK market, which is expected to grow by 20% 
by 2017 [313]. Convenience food now constitutes more than a third of the British food 
market with approximately 8.8 kg of chilled and frozen ready-made meals consumed 
per capita per year [314]. This makes UK citizens the largest consumer of ready- 
made meals in Europe and the second largest worldwide (after the US); they are also 
the largest consumers of chilled ready-made meals in the world [313]. 
 
This growth in demand for ‘convenience’ foods that requires little preparation can be 
attributed to the population rise, increase in life expectancy, increase in single 
occupant households, lack of cooking skills and the changing needs of modern 
households including the shifting routines and rhythms associated with increased 
female labour-force participation [315], [316]. These foods represent a quick and easy 
alternative to home-prepared meals, as they are sold in a part or completely cooked 
form and are ready to eat within minutes, requiring no further ingredients or 
preparation other than heating [317]. Before reaching the consumer, ready-made 
meals already undergo some form of processing to ensure food safety or hygiene or 
to enhance palatability, texture or flavour. Processing may involve the addition of 
other foods or ingredients, such as preservatives, as well as heating, cooling or 
pressure-cooking. The distinction from raw or unprocessed foods or meals prepared 
at home is that the consumer cannot control the nutritional quality of the basic 
ingredients; therefore convenience foods are associated with palatable but less 
healthy food options. This has given rise to serious concerns about public health, as 
it has been argued that the consumption of convenience foods such as ready meals 
are linked with the consumption of more energy, saturated fat, salt and fewer fruits 
and vegetables [318], [319]. 
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In practice, however, the ‘convenience’ food sector is extremely diverse with a wide 
array of foods in frozen, chilled and other formats. More than 90% of ready-meals 
sold in the UK are supermarket own-brand products [320]. Most supermarkets ‘brand’ 
their own-brand products into premium or luxury, ‘healthier’, economy or value, and 
standard ranges [321]. Fresh and frozen varieties of many ready meals are available 
across these ranges. As well as supermarket sold ready meals, there are also many 
food production companies which offer home delivered ready meal services. 
Examples include Wiltshire Farm Foods, [322], Oakhouse Foods [323] and Lodge 
Farm Kitchens [324]. These home delivered ready meal companies range from large 
franchises to small family run businesses, so ready meals are expected to range in 
quality, nutritional value and price. 
 
As ready meals are often criticised for being ‘unhealthy’, the UK government’s 
Change4Life initiative [325] advises against frequent consumption of ready meals, as 
these food products, and diets high in these, tend to be more energy dense and higher 
in fat, saturated fat, salt and sugar, and lower in fibre than is optimal for health [326], 
[327], [328]. However, few studies have comprehensively examined the nutritional 
content of ready meals sold in the UK market. Studies that have are focused solely 
on ready meals purchased from supermarkets and are therefore not representative 
of the entire market. A study which investigated the nutritional quality of one hundred 
own brand ready meals sold by three leading UK supermarket chains found them to 
be high in protein, fat, saturated fat, and sodium, yet low in carbohydrates, and within 
the recommended range for sugar according to the World Health Organisation 
nutritional guidelines for the avoidance of diet related diseases [329]. Similarly, a 
recent study which investigated the nutrient and cost profile of 166 ready-meals from 
forty-one UK stores found that overall; ready-meals were high in saturated fat and 
salt, and low in sugar. One-fifth of meals were low in fat, saturated fat, salt and sugar, 
including two-thirds of the ‘healthier’ option ready meals [330]. Interestingly, a study 
which compared the nutritional properties and cost of the ten most frequently 
purchased ready meals in a sample of Scottish households to equivalent meals 
cooked from fresh ingredients found that in the ten most frequently purchased meals 
(pizza, chicken curry, lasagne, macaroni cheese, cottage/shepherd’s pie, Chinese 
chicken dishes, fish pie, spaghetti bolognaise, pasta and chicken bake and jacket 
potatoes) there were no significant differences between the ready meals and home 
cooked recipes for energy, macronutrients, fibre or sodium [331]. 
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There has been a strong need to assess salt in ready meals, hence the development 
of these ‘healthier’ alternatives. The combination of food reformulation with improved 
food labelling and initiatives to raise consumer awareness on unhealthy foods has 
already led to successful national-wide salt reduction programmes, e.g. in Finland 
and the UK [332], [333]. Although there are commercially available ‘healthier’ 
alternatives in the ready meal industry, problems associated with nutritional 
imbalance of these meals is still apparent. Since the importance of convenient ready 
meals is likely to persist, different ways of addressing the problem of nutritionally 
unbalanced meals should be encouraged. Creating and offering consumers more 
ready meals with appropriate energy content, balanced macronutrient distribution and 
optimisation of nutritional value (such as the addition of vegetables), may have a 
better impact on consumer health. 
 
The relationship, existing between adequate health and fresh fruit and vegetable 
consumption has been clearly documented, where regular consumption is associated 
with the prevention of chronic diseases such as heart disease, cancer, and diabetes 
[334-336]. The UK Department of Health have established a “five a day” programme 
to improve access to, and increase consumption of, fruit and vegetables [337]. In 
terms of AMD, there is evidence to suggest that increasing intake of certain nutrients 
found in vegetables may be helpful in delaying the onset or progression of macular 
degeneration [8, 10]. In the AREDS 2 trial 10mg of L per day was associated with the 
most beneficial results in AMD patients [10, 98]. Other studies have suggested that 
doses of 10mg/day of L or higher are associated with the most positive effects on MP 
levels [98, 99]. In dietary terms this would equate to a 50-100 g serving of uncooked 
kale per day (chapter four), depending on kale source. Despite this, AMD patients 
who seek the services of the Macular Society are not taking on board the dietary 
advice and recommendations related to AMD, which may in fact require novel 
interventions [210, 211]. Results from the focus group suggest that educational tools 
to improve patient’s knowledge on aspects of diet and AMD have so far been 
unsuccessful; therefore, a more practical approach may be necessary. 
 
It is clear that convenience has a significant impact on the food choices of today’s 
consumers which may be particularly apparent in those suffering with sight conditions 
that tend to have difficulty with acquiring and preparing foods. This suggests that food 
products which offer more convenience may be deemed more preferable to these 
consumers. Therefore, adding convenience traits to certain products considered 
88  
healthy and/or beneficial, such as fresh fruits and vegetables, could increase the 
consumption of these specific food items. 
 
The aim of this research was to investigate the current usage and opinions of ready 
meals in AMD patients and the potential interest in ready meals nutritionally tailored 
to support the needs of their condition. Creating ready meals which contain important 
food sources for AMD, which do not possess the ‘unhealthy’ traits of conventional 
supermarket ready meals and are nutritionally balanced, may lead to an increased 
consumption of these foods, and consequently, better ocular health for AMD patients. 
 
Ethics 
 
This study was approved by the Aston University Ethics Committee (ethics number 
 
843). Verbal informed consent was obtained from all subjects and formally recorded. 
 
 
 
5.2 Method 
 
A literature search was unable to provide a similar survey to use as a template. 
Therefore, a cross sectional survey was designed with both open and closed ended 
questions which were created with the help of the outcomes of the focus group. The 
survey was then piloted over the telephone on six AMD patients from the MS sight 
impairment register who volunteered to take part. These volunteers were asked to 
then validate the questionnaire at three weeks later. Each volunteer had an informal 
discussion with a moderator – the survey questions were asked again to check if the 
answers matched, and then the volunteers were asked to comment on how easy the 
questions were to understand and opinions on the topics covered. The telephone 
pilots were recorded and analysed to further refine the survey. The survey was then 
administered to the cohort. 
 
The cohort consisted of patients on the MS sight impairment register, members of a 
local MS peer support group and MS members who participated in the previous 
dietary analysis study (chapter 2).  The initial questions covered demographic topics 
such as age, gender and type of AMD. The following questions focused on the current 
usage and opinions of ready meals, the foods they like to eat (in ready meals or 
normal meals) and the potential interest in ready meals that were nutritionally tailored 
to support the needs of their condition (questionnaire attached in appendix). 
 
Inclusion criteria 
 
 
The inclusion criteria included those aged over fifty-five who had been diagnosed with 
a form of AMD; the exclusion criteria were the inability to hear and reply to questions 
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in English over the telephone. There was no need to define and categorise the 
amount of visual loss the participant had, as the objective was to assess typical 
patients seeking the MS services. 
 
Recruitment of subjects (MS sight impairment register) 
 
 
People who were registered on the MS impairment list who suffered with some form 
of AMD were invited by letter to complete the survey. The letter explained the study 
procedure and protocol including the inclusion and exclusion criteria for those wishing 
to be involved (attached in appendix). The letter included a telephone number and 
email address that they could use to contact the investigator if they wished to 
participate in the study. They were advised that the investigator would call them back 
at a convenient time for them to conduct the short questionnaire. Before the telephone 
survey began participants were made aware that the results of the questionnaire were 
not to be used other than to aid the design of ready meals nutritionally tailored to 
support the needs of AMD patients. 
 
Recruitment of subjects (MS local peer support group) 
 
 
Members of the MS who are members of a local peer support group were invited to 
take part in the survey via email by their group leader. The peer support group 
involves forty-five MS members. Like the letter, the email explained the study 
procedure and protocol including the inclusion and exclusion criteria if they were 
interested in participating. Patients were advised that if they wanted to take part in 
the survey then they could contact the researcher by telephone or email to confirm 
their interest. They were advised that the researcher would call them back at a 
convenient time for them to conduct the short questionnaire. Alternatively, subjects 
were given the option to fill out the questionnaire themselves at the next group 
meeting. 
 
Recruitment of subjects (MS patients who were previously involved in the dietary 
assessment study) 
 
Members of the MS who were involved in the previous dietary analysis study were 
invited to take part in the survey over the telephone. Subjects were advised of the 
study procedure and protocol including the inclusion criteria before they gave their 
verbal consent. If subjects were happy to participate and met the inclusion criteria, 
then the questionnaire was conducted. Before the telephone survey began 
participants were made aware that the results of the questionnaire were not to be 
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used other than to aid the design of ready meals nutritionally tailored to support the 
needs of AMD patients. 
 
5.3 Results 
 
Table 3.6 displays the demographics of the included subjects. In total, there were fifty 
AMD participants aged 56-83 (mean 72 ± sd 6 years). Of the cohort, 36% were male 
and 64% were female. Dry AMD was more predominant within the cohort with 64% 
of subjects diagnosed with this form, compared with 36% of subjects diagnosed with 
wet AMD. 
 
 
Characteristic Characteristic Percentage of AMD patients 
Gender Male 36% 
 Female 64% 
AMD type Wet 36% 
 Dry 64% 
 
 
Table 3.6 Participant characteristics. 
 
 
 
 
Ready meal consumption 
 
 
 
 
13 
 
Included in diet 
 
Not included in diet 
 
37 
 
 
 
 
 
 
Figure 3.4: Ready meal consumption in participants. 
 
 
 
Subjects current ready meal usage 
 
 
The first and most important question on the survey was whether or not subjects 
consumed ready meals currently. Thirteen out of a total of a total of fifty subjects did 
not include ready meals in their diet and thirty-seven subjects did (figure 3.4). 
Subjects who did not include ready meals in their diet were referred to later questions 
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in the survey which were designed to find out if they would consider including ready 
meals in their diet which contained kale and which were nutritionally tailored to 
support the needs of their condition. Of the thirteen subjects who did not consume 
ready meals, eleven would consider ready meals which contained kale. One subject 
who opposed this idea mentioned that they take the medication ‘warfarin’ on a regular 
basis so avoid large amounts of green leafy vegetables due to the high content of 
vitamin K. Twelve of these subjects would however consider ready meals in their 
future diet which were nutritionally tailored to support the needs of their condition. 
 
The main reasons for not consuming ready meals amongst subjects were having a 
spouse or relative who regularly cooks for them, a dislike towards their taste and a 
disapproval of the ‘unhealthy’ conception which is associated with processed foods. 
One subject revealed that they suffer with various allergies so avoid including pre- 
prepared foods in their diet. Convenience was the key driver for inclusion in the diet, 
as the majority of those who included them listed in the open ended comment box. 
Other reasons cited for inclusion in the diet included living alone, difficulty cooking, 
dislike towards cooking and the general enjoyment of the taste of ready meals. 
 
 
Frequency in ready meal consumption 
 
 
 
5 
1 
7 
Once a month 
Once a fortnight 
 
1-2 times per week 
4 
10 
2-3 times per week
 
3-4 times per week 
10 Everyday 
 
 
 
 
Figure 3.5: Frequency in consumption of ready meals for subjects who included them 
in their diet. 
 
In regard to the frequency in consumption of ready meals, seven subjects consumed 
them once a month; four subjects consumed them once a fortnight, ten subjects 
consumed them 1-2 times per week, ten subjects consumed them 2-3 times per week, 
five subjects consumed them 3-4 times per week and one subject consumed them 
every day. 
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Cost and source of ready meals in subjects 
 
 
Twenty-seven out of the thirty-seven subjects who consumed ready meals would be 
happy to pay over £4 for them. A total of eight subjects would prefer to pay between 
£2 and £4 and one subject would prefer to pay under £2. All subjects used a 
supermarket as the main source for acquiring their ready meals; however, five of 
these subjects also used an online distributor to purchase meals over the phone or 
via the corresponding website such as Oakhouse Foods (www.oakhousefoods.co.uk) 
and Wiltshire Farm Foods (wiltshirefarmfoods.com). 
 
Consideration of ready meals which contained kale and which were nutritionally 
tailored to support the needs of AMD 
 
All subjects who took part in the survey, including those who currently do not consume 
ready meals, were asked if they would consider ready meals which contained kale 
and ready meals that was tailored to support the needs of people with AMD. Out of a 
possible fifty subjects, forty-seven would consider consuming ready meals which 
contained kale. As previously mentioned one of the subjects in disagreement with 
consuming kale who did not include ready meals in their current diet avoided dark 
green leafy vegetables due to the high content of vitamin K which can have adverse 
interactions with the medication Warfarin. Despite this, forty-eight subjects would 
consider ready meals which were nutritionally tailored to support the needs of their 
condition. 
 
Food likes and dislikes 
 
 
Fish, chicken, beef, lamb and pork were popular with all subjects in the cohort. Nine 
subjects mentioned that they avoid frequent consumption of red meat so prefer fish 
and chicken alternatives on a daily basis. There were no subjects who only consumed 
vegetarian food options however most subjects did enjoy them. Some subjects 
mentioned that they like a variety of fish and meat in their diet. Only fifteen out of the 
total number of participants liked foods which you can eat without utensils for example 
pasties and pies. Some of the feedback received during the survey about these food 
items were that patients deem them as ‘unhealthy’. The majority of subjects did 
however enjoy eating one pot meals such as soups and casseroles (48 out of 50 
subjects ticked this box). Extra feedback drawn out from the survey revealed that 
vegetable soups in particular were favourable with subjects. Some subjects cited that 
they enjoy casserole dishes but do not cook them often due to long cooing durations 
and the nature of the dish being large in size when home prepared, which inevitably 
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leads to food wastage in those who live alone. Popular examples of what foods 
subjects like to eat in ready meals or normal meals included soup, casseroles, fish 
pie, pasta dishes, cottage pie, curry, and lasagne. The majority of those who gave 
pasta as an example of a favourite or popular dish in their diet indicated that they 
prefer a creamy sauce base to accompany it. 
 
Foods or ingredients subjects find difficulty with due to sight impairment 
 
 
The final question on the ready meal survey was designed to encourage patients to 
give examples of any foods or ingredients that they may find difficulties with in their 
diet due to being visually impaired. Thirty out of a total of fifty subjects did not have 
any difficulties or aversions to certain foods. Of the remaining subjects, six indicated 
that they did not like meat or fish with bones due to finding it problematic when 
recognising them with impaired vision. Two subjects highlighted an important issue in 
regard to meals being too mixed together, for instance in vegetarian meals or stir- 
fries where there is an array of ingredients which are finely chopped together. This 
makes it difficult for those with sight impairment to differentiate between the various 
items in the meal and therefore be aware of what they are consuming. Other subjects 
had individual aversions to certain food items such as liver and offal, starchy and 
spicy foods. 
 
5.4 Discussion 
 
 
Within this cohort of fifty AMD subjects who are members of the MS, a total of thirty- 
seven included ready meals in their diet. The majority of these subjects (70%) 
consumed these meals at least once per week however 19% of subjects consumed 
them infrequently (once a month). Although recent population-representative data in 
the UK on the frequency of consumption of ready meals is not available, in 2006 it 
was estimated that around 40% of UK households ate such meals at least once per 
week. Convenience was a major influence behind subject’s desire to include ready 
meals in their weekly diet, this was further emphasised in those who lived alone and 
lacked the support of family members or carers. Twenty-six out of a possible thirty- 
seven subjects lived alone and enjoyed the ease and simplicity that ready-made 
meals have to offer. In the focus group discussion with MS members in the previous 
chapter, four out of six members reported living alone to be a key barrier to achieving 
a healthy diet. This is similar to the finding of the RNIB’s 2003 commissioned survey 
of 588 BT customers [15] who ordered their bills in large print or braille, to examine 
their living arrangements and quality of life. It documented that 63% of blind and 
partially sighted people live alone – a higher figure than the ‘normal’ sighted elderly 
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population (32%). In further discussions subjects gave details about the difficulty and 
inconvenience of preparing and cooking home cooked meals for one, and their 
concerns with food wastage when regularly purchasing fresh fruit and vegetables. In 
light of these findings, it may be proposed that frozen ready meals which require no 
addition of added ingredients, which are easy to prepare and available in portion sizes 
adequate for a single consumer, would be a suitable alternative to a home cooked 
meal in those living with sight impairment. 
 
Despite the majority of subjects enjoying the concept of ready meals in their current 
diet, there were a small number of subjects who opposed this idea. Popular reasons 
for this included a concern with the negative connotations which surround such meals, 
a dislike towards their taste or having a spouse or relative that regularly cooks for 
them. These findings are not surprising given the fact that ready meals are pre- 
prepared and the consumer cannot control the nutritional quality of the basic 
ingredients or the amount of added salt, saturated fats or additives and preservatives 
used. Inevitably, this leads to a belief that such foods contain unfavourable amounts 
of these nutrients. A survey which collected nutritional data on 166 supermarket own- 
brand chilled and frozen ready-meals available in branches of ten national 
supermarket chains in one city in northern England, found that the nutritional content 
of ready meals varied substantially according to meal range and type [338]. Overall, 
meals were categorised as high in saturated fat and salt, and low in sugar according 
to current UK guidance for front-of-pack nutritional labelling [339]. This may indicate 
that maximum nutritional benefit is more likely to be derived from home cooking of 
nutritionally balanced recipes primarily using raw ingredients, rather than relying on 
manufactured ready meals which are created on a larger scale [340]. Other previous 
work which has attempted to compare the absolute nutritional content of ready-meals 
with nutritional standards for meals found that ready-meals often contain substantially 
fewer calories than is recommended for a meal [341], [342]. Ready-meals are 
perhaps more sensibly considered ‘ready-main-courses’ than complete meals, which 
may explain why the total energy content is less than might be expected. This is an 
important concept for this research as within previous dietary analysis data (chapter 
2 and [211]) it has been revealed that AMD patients who seek the services of the MS 
are consuming calorie intakes which are significantly below the government DRV’s. 
As such, meals ought to be designed that are not calorie dense, yet still of high 
nutritional quality and which incorporate a tasty, home-cooking style method using 
freshly sourced ingredients. This may increase the desire for these products in this 
population and also help consumers to achieve a more balanced diet. 
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In total forty-eight subjects, would be interested in the idea of consuming ready meals 
that were nutritionally tailored to support the needs of AMD by including ingredients 
which are high in L and Z. When asked how much participants would be willing to pay 
for a ready meal, over half responded that they would pay more than £4 per meal, 
with the remaining participants willing to pay less than this amount. This is a promising 
finding, despite a total number of thirteen subjects who did not consume ready meals 
currently. It seems patients are keen to improve their diet, and ready meals which 
contain adequate levels of L and Z through the supply of dark green leafy vegetables 
may be a feasible way to do so. Popular examples of favourite meals included fish 
pie, creamy pasta dishes, cottage pie, curry, and lasagne. Soups and casseroles 
were also extremely popular dishes within this cohort, with many subjects revealing 
that they do not cook them due to being large dishes which require lots of time and 
preparation. This may be related to the large number of subjects who live alone, as 
those that live alone are much more likely to find their visual impairment a hindrance 
than those that live with other people. Perissinotto et al’s study into the functional 
decline of the elderly (2012) found that loneliness was strongly associated with 
functional decline; those who reported being lonely were more likely to have a decline 
in activities of daily living, develop difficulties with ‘upper body tasks’, experience a 
decline in mobility, and have difficulty in climbing stairs [343]. 
 
Certain concerns for those who are severely sight impaired must be taken in to 
consideration when creating ready meals for this population. For example, a small 
number of subjects had issues recognizing bones in foods, or differentiating between 
various ingredients in a meal when they are too finely chopped or mixed together. 
 
Limitations 
 
 
Although the depth of detail provided from both open and closed ended surveys 
provides strength to the methodology and suggests reliability of results, there are 
obvious limitations in this study. Due to time constraints this was a small study, with 
a relatively small sample of AMD subjects who were all members of the MS. Patients 
who have sought the help of the MS could be considered an ‘informed’ population as 
they have information available to them in the form of monthly magazines, written 
material, a helpline and the Society’s website. Since the AMD cohort all had a form 
of AMD, and were motivated to contact the MS for assistance, it may be presumed 
that they were engaged and proactively interested in preventing the disease from 
progressing. Therefore the results may not be generalisable to other populations, 
such as those with AMD who may be managing alone, without the society’s support. 
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Another limitation to the study was the lack of control or comparator group. Comparing 
data to a cohort of age matched subjects without the condition would have provided 
more reliable data on the barriers and facilitators of achieving a healthy diet within 
visually impaired populations. Results indicated that 73% of those who consumed 
ready meals would be happy to pay over £4 for them, however due to the selection 
bias within the study; it is unknown whether these findings would be different in a 
larger, more diverse cohort of subjects. 
 
5.5 Summary 
 
 
Ready meals are popular with subjects who suffer with sight impairment, who benefit 
from the ease and convenience that these meals offer.   However, the general 
perception of these meals is that they are ‘unhealthy’ and of lower standard to home 
cooked meals which contain fresh produce and no addition of manufactured 
ingredients such as additives and preservatives. AMD patients are keen to improve 
their diet and ready meals which are nutritionally tailored to support the needs of their 
condition by containing vegetables which provide high levels of L/Z may be a popular 
tool to doing so. To increase overall interest in these ready meals it is required that 
meals are produced with an improved nutritional profile compared with conventional 
supermarket sold ready meals, which can be low in calories and high in other macro- 
nutrients. 
 
What this study found 
 
 
 A large proportion of AMD patients currently eat ready meals due to the 
convenience they offer 
 These benefits were further heightened in those who lived alone and struggled 
with the concept of cooking with sight impairment 
 Those who did not consume ready meals are concerned with the ‘unhealthy’ 
connotation that surrounds them, however many of these subjects also had a 
spouse or family member who cooks for them 
 Despite this, nearly all AMD subjects of this cohort would consume ready 
meals that contained kale and/or that were nutritionally tailored to support the 
needs of their condition 
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Ready meals to create based on these findings 
 
 
 Recipes  must  have  an  improved  nutritional  profile  which  differs  from 
conventional supermarket sold ready meals 
 The majority of patients are happy to pay over £4 for a ready meal and usually 
source them from the local supermarket 
 Recipes must include ingredients which contain adequate sources of L and Z 
 
such as kale, an ingredient subjects are happy to have included in their meals 
 
 Consideration  should  be  given  to  recipes  that  contain  no  additives  or 
preservatives, are not low in calories and are not classified as high in fat, salt, 
or sugar 
 Fish, meat and vegetarian dishes were all popular with subjects – some 
subjects did not like to eat red meat too often 
 Popular examples of such meals included soups, casseroles, fish pie, cottage 
pie, lasagne, curry and creamy pasta dishes 
 A small portion of subjects had certain concerns with their meals due to 
impaired vision such as meat or fish containing bones, or meals that had finely 
chopped ingredients which are very mixed together. 
 
In this chapter we found that the usage of ready meals in AMD patients is generally 
high due to the convenience and simplicity that these meals offer. Patients expressed 
a keen interest in the production of ready meals which are nutritionally tailored to 
support the needs of their condition. Chapter six will describe the design of such 
meals, and their evaluation and impact in a sample of AMD patients. 
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Chapter 6: Production and evaluation of ready meals for AMD patients 
 
 
6.1 Background and rationale 
 
 
Collaboration with the food production company ‘Lodge Farm Kitchen’ 
(http://www.lodgefarmkitchen.com/) was formed to enable the production of ready 
meals which were nutritionally tailored to support the needs of those suffering with 
AMD. Lodge Farm Kitchen were chosen as the ready meal manufacturer as they are 
a small family run business who specialise in creating fresh, hand-prepared high 
quality food. Located in a valley in rural Herefordshire, UK, the company grow many 
of their own vegetables and herbs, or source them from local farmers to ensure 
nutritious fresh produce without the addition of additives and preservatives. According 
to their website they claim ‘our mission at Lodge Farm Kitchen is to provide customers 
with convenient, tasty, nutritious frozen meals made from fresh ingredients sourced 
locally whenever we can – all hand prepared with pride, passion & integrity’. 
 
Once cooked by the team at Lodge Farm Kitchen the meals are blast frozen on the 
same day to retain their nutrition and flavour. Flash or blast freezing refers to the 
process in various industries whereby objects are frozen in a few hours by subjecting 
them to cryogenic temperatures [344].  In the food industry this is used to prevent 
perishing of food items [345]. Lodge Farm Kitchen are identified by their home cooked 
meals which contain only ingredients used in conventional cooking and no addition of 
additives, preservatives or other chemical enhancers used for taste and preservation. 
The meals are convenient because they have a twelve-month shelf life from the date 
cooked and can be heated and served from frozen in a matter of minutes. Lodge 
Farm Kitchen supply wholesale ready meals to shops, delicatessen and 
supermarkets, or personal ready meals delivered to individuals. The current product 
range includes meat dishes such as casseroles, curries and pastas, fish dishes such 
as fish pie and fish soup and vegetarian meals such as soups, lasagnes and curries. 
 
6.2 Production of ready meals 
 
 
Based on the results of the survey, the ready meals which were created for AMD 
patients included various soup options such as a curried potato and kale soup, pea 
and ham soup, and a leek, potato and kale soup. It is likely that soup was a 
predominant choice of meal for AMD subjects as it easy to eat, easily digested and 
does not contain a mixture of textures and food items that may be unrecognisable to 
those with impaired vision. Other meals which were created to support the nutritional 
needs of AMD patients based on the findings from the ready meal survey included a 
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fish pie with spinach, cottage pie with kale, Normandy pork casserole, chicken ham 
and leek casserole and a creamy kale and smoky bacon pasta. All meals contained 
adequate amounts of additional food items high in L and Z such as eggs, kale, spinach 
and other vegetables. Kale was added to the meals at the very end of their preparation 
to ensure only minimal cooking occurred and to retain as much of its nutrient value 
as possible. Within ready meal dishes this method of cooking kale would have been 
similar to blanching, as found in the previous analytical studies (chapters 4 and 5) 
retention of L was maximum with shorter cooking times, lower temperatures and 
minimal amounts of water. A small amount of fat in the form of butter or olive oil was 
also added to the meal recipes to improve the bioavailability of L. 
 
The meals were created by the Lodge Farm Kitchen team after several meetings 
where results of the qualitative (focus group and questionnaire chapters six and 
seven) and quantitative (kale L analyses chapters four and five) were discussed. It 
was decided that at least 5 mg of lutein per meal would be sufficient to support the 
recommended daily amount of 10 mg per day to improve MP levels and visual 
function in AMD patients  [98, 99, 130-133], and delay the progression of AMD [10] 
as found in one large scale epidemiological study. Results from the laboratory study 
investigating L concentrations in kale upon various pre-and post-harvest factors 
(chapters four and five) assisted with determining the amount of kale needed to 
ensure adequate concentrations of L per meal, as this was the first study to 
investigate the L concentrations from raw kale grown and sold in the UK (table 3.7). 
 
Based on the HPLC laboratory findings 100g of raw minimally processed retailed kale 
contained on average 12 mg of L, whereas freshly harvested kale contained on 
average 21 mg of L. Therefore it was proposed that one third of these portions (33.3 
g of kale) would provide at least 5 mg of L per meal. For spinach, average L 
concentrations per 100 g of fresh weight were extracted from previous data. A study 
which investigated the L content of vegetables and vegetable products, fruits as well 
as eggs available on the Polish market using HPLC analysis, found that raw spinach 
contained a mean L content of 8.95 mg/100 g [346]. Moreover, a recent study which 
analysed the L content of a batch of fresh baby leaf spinach (Spinacia oleracea) 
purchased from a local retailer in Migros, Switzerland found that the whole leaves 
contained an average of 11.08 mg/100 g [347]. For the purpose of the ready meal 
design, we attained from this data that on average 100 g of fresh raw spinach would 
contain around 10 mg of L. This would mean that 20 g of raw spinach would contain 
an average L concentration of 2 mg. 
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Eggs are also considered a good source of L and Z, and may have enhanced 
bioavailability of these carotenoids in this form because of the co-ingestion with fat in 
which they contain [96]. The chicken egg yolk, a matrix composed of digestible lipids, 
i.e., cholesterol, triglycerides, and phospholipids, contains L and Z along with other 
fat-soluble micronutrients such as vitamin A, vitamin D, and vitamin E. A randomised 
controlled trial found that in older adults over 60 years of age, five weeks of consuming 
one egg per day significantly increased serum L (26% increase) and Z (38% increase) 
concentrations without elevating serum lipids and lipoprotein cholesterol 
concentrations [348]. Two other reports examined the same human subjects (mean 
age 62 y, range: 46–78 y) and showed a 28–50% increase in plasma L and a 114– 
142% increase in plasma Z concentrations [349] following a diet supplemented with 
 
1.3 eggs/day for 4.5 weeks. However, this increase was associated with an 8–11% 
 
increase in plasma LDL cholesterol (LDL-C) concentrations [350]. 
 
 
In terms of MP levels, a study assigned twenty-four females, between 24 and 59 
years, one of two egg treatments for 12 weeks. Individuals consumed six eggs per 
week, containing either 331 mg (EGG 1) or 964 mg (EGG 2) of L and Z per yolk. 
MPOD increased in both the EGG 1 (P = 0.001) and EGG 2 (P = 0.049) groups [102]. 
However, concentrations of L and Z in egg yolk are reported to be low in comparison 
to dark green leafy vegetables. For instance, a study which investigated the L content 
of vegetables and vegetable products, fruits as well as eggs available on the Polish 
market using HPLC analysis found that the L content of egg yolk ranged from 0.71 to 
2.82 mg/100 g and varied depending on the method of chicken farming. The mean L 
content of egg yolk from battery hens was 1.07 mg/100 g whereas the mean L content 
for hens bred on a rural farm were almost 50% higher at 2.08 mg/100 g [346]. The 
results of this study are consistent with those of other authors (Leth et al., 2000 [351]; 
Ollilainen et al., 1989 [352]; O’Neill et al., 2001 [353]). A study carried out in Denmark 
showed that egg yolks from the “organic farms” had more than a twofold higher 
amount of L compared to yolks from battery hens and threefold higher in relation to 
yolks from free – living hens 1320, 527 and 384 g/100 g, respectively) [351]. Although 
the concentrations of L and Z in one egg yolk may be modest relative to other sources, 
such as kale and spinach, their bioavailability to the serum and retina appears to be 
high [102]. Therefore, both eggs and spinach, sourced from local organic farms were 
used as additional ingredients in the ready meals to further increase L and Z 
concentrations and their bioavailability from these food sources. 
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 Amount Shop 
Kale 
Farm 
Kale 
Spinach 
Average Lutein 100g 
10g 
30g 
5g 
12mg 
1.2mg 
3.6mg 
0.6mg 
21mg 
2.1mg 
6.3mg 
1.05mg 
10mg 
1mg 
3mg 
0.5mg 
 
 
 
Table 3.7: Lutein quantifications for farm and shop kale based on the HPLC study; 
 
lutein quantifications for spinach based on previous data. 
 
 
 
 
 
8.3 Nutritional analyses of ready meals using Al la Calc 
 
 
Curried Soup 
   Normandy Pork 
Casserole 
 
 
Name 
per 300g 
serving 
 
unit 
  
Name 
per 350g 
serving 
 
unit 
Energy 755 kJ  Energy 1696 kJ 
Energy 381 kcal  Energy 404 kcal 
Fat 5.3 g  Fat 15.6 g 
of which of which 
saturates 2.9 g  saturates 5.5 g 
Carbohydrate 35.5 g  Carbohydrate 24.1 g 
of which sugars 12.2 g  of which sugars 8.5 g 
Fibre 8.1 g  Fibre 4.1 g 
Protein 6.1 g  Protein 40 g 
Salt 1 g  Salt 1.8 g 
Sodium 384.34 mg  Sodium 700.96 mg 
Zinc 1.2 mg  Zinc 6.3 mg 
Selenium 3.2 μg  Selenium 55.7 μg 
Beta Carotene 2324 μg  Beta Carotene 3526.4 μg 
Vitamin D MCG Trace μg  Vitamin D MCG Trace μg 
Vitamin D IU Trace IU  Vitamin D IU Trace IU 
Vitamin E 1.2 mg  Vitamin E 1.8 mg 
Vitamin B6 0.4 mg  Vitamin B6 1.1 mg 
Vitamin B12 Trace μg  Vitamin B12 1.6 μg 
Folate 84.9 μg  Folate 153.9 μg 
Vitamin C 53 mg  Vitamin C 64.2 mg 
L/Z 3.4 mg  L/Z 6.6 mg 
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Kale & Smoky 
Bacon Pasta 
   Pea and Ham 
Soup 
 
 
Name 
per 350g 
serving 
 
unit 
  
Name 
per 300g 
serving 
 
unit 
Energy 1903 kJ  Energy 874 kJ 
Energy 451 kcal  Energy 308 kcal 
Fat 16 g  Fat 5.6 g 
of which of which 
saturates 7.7 g  saturates 2.6 g 
Carbohydrate 
of which 
sugars 
56.9 
 
9.7 
g 
 
g 
 Carbohydrate 
of which 
sugars 
28.7 
 
8.7 
g 
 
g 
Fibre 4.1 g  Fibre 9 g 
Protein 21.9 g  Protein 13.9 g 
Salt 1.3 g  Salt 1.6 g 
Sodium 501.25 mg  Sodium 639.66 mg 
Zinc 2.2 mg  Zinc 2.3 mg 
Selenium 11.8 μg  Selenium 5.5 μg 
Beta Carotene 
Vitamin D 
MCG 
2629 
 
0.4 
μg 
 
μg 
 Beta Carotene 
Vitamin D 
MCG 
2575.3 
 
0 
μg 
 
μg 
Vitamin D IU 16.5 IU  Vitamin D IU 0 IU 
Vitamin E 1.4 mg  Vitamin E 0.9 mg 
Vitamin B6 0.3 mg  Vitamin B6 0.5 mg 
Vitamin B12 1.6 μg  Vitamin B12 0.3 μg 
Folate 101.4 μg  Folate 149 μg 
Vitamin C 42.9 mg  Vitamin C 82.9 mg 
L/Z 4.3 mg  L/Z 6.4 mg 
 
Cottage Pie 
   Chicken Ham & 
Leek Casserole 
  
 
Name 
per 350g 
serving 
 
unit 
  
Name 
per 434g 
serving 
 
unit 
Energy 1142 kJ  Energy 2339 kJ 
Energy 370 kcal  Energy 554 kcal 
Fat 4.1 g  Fat 15.6 g 
of which of which 
saturates 1.8 g  saturates 5.4 g 
Carbohydrate 38.1 g  Carbohydrate 23.1 g 
of which sugars 7.8 g  of which sugars 3.8 g 
Fibre 6.2 g  Fibre 3.5 g 
Protein 22.5 g  Protein 85.4 g 
Salt 1.5 g  Salt 1.8 g 
Sodium 607.4 mg  Sodium 1508.15 mg 
Zinc 4.1 mg  Zinc 3.6 mg 
Selenium 5.8 μg  Selenium 40.7 μg 
Beta Carotene 4237.7 μg  Beta Carotene 3665.7 μg 
Vitamin D MCG 0.4 μg  Vitamin D MCG 0.5 μg 
Vitamin D IU 14.9 IU  Vitamin D IU 19.2 IU 
Vitamin E 2.2 mg  Vitamin E 1.4 mg 
Vitamin B6 0.8 mg  Vitamin B6 1.7 mg 
Vitamin B12 1.5 μg  Vitamin B12 0.5 μg 
Folate 110 μg  Folate 108.4 μg 
Vitamin C 98.4 mg  Vitamin C 50 mg 
L/Z 3.1 mg  L/Z 3.5 mg 
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Fish Pie with 
Spinach 
   Leek Potato & 
Kale Soup 
 
 
Name 
per 350g 
serving 
 
unit 
  
Name 
per 300g 
serving 
 
unit 
Energy 1928 kJ  Energy 1126 kJ 
Energy 458 kcal  Energy 368 kcal 
Fat 16.5 g  Fat 12.7 g 
of which of which 
saturates 5.8 g  saturates 5.5 g 
Carbohydrate 36.1 g  Carbohydrate 26.6 g 
of which sugars 4.5 g  of which sugars 9.4 g 
Fibre 3.6 g  Fibre 3.2 g 
Protein 42.1 g  Protein 15.8 g 
Salt 1.5 g  Salt 1.7 g 
Sodium 576.91 mg  Sodium 685.16 mg 
Zinc 2 mg  Zinc 1.6 mg 
Selenium 55.9 μg  Selenium 16.1 μg 
Beta Carotene 1725.8 μg  Beta Carotene 2442.2 μg 
Vitamin D MCG 3.7 μg  Vitamin D MCG 1.9 μg 
Vitamin D IU 147.4 IU  Vitamin D IU 76.8 IU 
Vitamin E 3.3 mg  Vitamin E 2 mg 
Vitamin B6 0.7 mg  Vitamin B6 0.5 mg 
Vitamin B12 5.2 μg  Vitamin B12 2.8 μg 
Folate 127 μg  Folate 130.5 μg 
Vitamin C 32.5 mg  Vitamin C 52.8 mg 
L/Z 3.3 mg  L/Z 3.8 mg 
 
Table 3.8: Nutritional analysis of each ready meal recipe using Al La Calc (Red Hot 
Rails LLP, Doncaster, UK) dietary analysis software. Only key macro-nutrients and 
nutrients important for AMD are included. Full Al La Calc results of these nutritional 
analyses can be found in the appendices. 
 
 
The ready meal recipes were nutritionally analysed using A La Calc, for numerous 
nutrients, calorie values and other constituents using the USDA (United States 
Department of Agriculture) SR25 food database (http://ndb.nal.usda.gov/). This 
provided further data on the L/Z quantifications per meal and on the quantities of total 
calories, total fat, of which saturates, carbohydrates, fibre, protein, salt, and 
information on important vitamins and minerals for the eyes such as zinc, beta- 
carotene, vitamin C, vitamin E, vitamin D, vitamin B6, vitamin B12, and folate.  Al La 
Calc recognised 100 g of spinach to contain 12 mg of L/Z, slightly higher than some 
previous studies have reported. For kale, A La Calc recognised 100 g of fresh raw 
kale to contain 8.9 mg of L/Z, slightly lower than our HPLC lutein study determined. 
This information was taken in to consideration when interpreting the nutritional 
analysis data on L/Z from Al La Calc; for instance meals which contained kale were 
recognised as containing slightly more L/Z than the software suggested. For these 
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purposes, information on L levels in kale as determined by the previous HPLC study 
(chapter four) was used as a reference for estimating the L levels in the meals, as 
this was the same kale sourced in the ready meals. 
 
 
Ready 
  meal   
Kale 
(g)   
Spinach 
(g)   
Egg 
(g)   
L shop 
(mg)   
L farm 
(mg)   
L spinach 
(mg)   
L/egg 
(mg)   
Total L (mg) 
CS 35 0 0 4.2 7.35 0 0 4.2-7.35 
NPC 0 50 0 0 0 5 0 5 
KSBP 30 15 0 3.6 6.3 1.5 0 5.1-7.8 
PHS 20 15 0 2.4 4.2 1.5 0 3.9-5.7 
CP 35 0 0 4.2 7.35 0 0 4.2-7.35 
CHLC 35 0 0 4.2 7.35 0 0 4.2-7.35 
FP 10 20 60 1.2 2.1 3 2 6.2-7.1 
LPKS 30 0 60 3.6 6.3 0 2 5.6-8.3 
 
 
 
Table 3.9: Lutein amounts for each ready meal dependent on their ingredients and 
kale source. (CS- Curried Soup, NPC- Normandy Pork Casserole, KSBP- Kale and 
Smoky Bacon Pasta, PHS- Pea and Ham Soup, CP- Cottage Pie, CHLC- Chicken, 
Ham and Leek Casserole, FP- Fish Pie, LPKS- Leek, Potato and Kale Soup). 
 
 
Table 3.9 displays the content of kale, spinach and eggs in each ready meal and the 
subsequent L concentrations from each food source.  Total L concentrations of each 
meal varied depending on whether or not the kale was sourced directly from the farm 
or within its shelf life constituency purchased from a supermarket. All ready meal 
recipes contained kale, spinach or eggs, or a combination of these food sources. The 
amount of kale present in the meals varied and was dependent on the addition of 
spinach and eggs. For instance, lower amounts of kale were found in the meals which 
contained additional measures of these alternate food items. The resultant L amounts 
in each meal were lower than the anticipated 5 mg per meal if the kale was sourced 
from a local supermarket (3.6-6.2 mg per meal) therefore it was decided that all meals 
would contain kale that was sourced within 24 hours of harvest from a local farm, as 
this would increase the final L amounts to at least 7 mg per meal. 
 
 
Nutritional profiles of the ready meals were compared with the UK government DRV’s 
for males and females of those aged over 50 years [354], displayed in the following 
table. 
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 Unit DRV F >50 DRV M >50 
 
Energy 
 
Kcal 
 
1840-2079 
 
2294-2581 
Fat g 70 95 
of which saturates g 20 30 
Carbohydrate g 230 300 
of which sugars g 90 120 
Fibre g 24 24 
Protein g 53 53 
Salt g 6 6 
Zinc mg 7 9.5 
Selenium µg 60 75 
Beta Carotene µg - - 
Vitamin D IU 400 400 
Vitamin E mg 10 10 
Vitamin B6 mg 1.2 1.4 
Vitamin B12 µg 1.5 1.5 
Folate µg 200 200 
Vitamin C mg 40 40 
 
Table 4.1: UK female and male DRV’s for important macro-nutrients and vitamins 
and minerals associated with AMD research. There are currently no DRV’s for beta- 
carotene. 
 
Overall ready meals were categorised as being low in saturated fat and salt, and low 
in sugar according to current UK guidance, front-of-pack traffic light nutritional 
labelling [355]. This is unlike previous work, where it has found that ready-meals in 
the UK tended to be high in saturated fat and salt [340]. All ready meals aside from 
the kale and smoky bacon pasta (curried soup, Normandy pork casserole, pea and 
ham soup cottage pie, chicken, ham and leek casserole, fish pie and leek, potato and 
kale soup) contained below 6 g of saturated fat per whole portion size of 300-350 g. 
This was substantially below the maximum recommended daily allowance of 20 g per 
day. The kale and smoky bacon pasta contained approximately 6.7 g of saturated fat 
per whole meal size of 350 g. The slightly higher levels of saturated fat in this recipe 
may be attributed to the creamy nature of the dish, something subjects expressed 
their liking towards in the ready meal survey (chapter seven). Evidence indicates that 
saturated fat intake should be no more than 7% of total daily energy intake [356], this 
is based primarily on the prediction of a progressive reduction in cardiovascular 
disease risk associated with greater reductions in LDL cholesterol [357].  As 1 g of 
saturated fat equates to 9 kcal, 7% of the average recommended 2000 kcal would be 
15.5 g of saturated fat per day for females and 19.4 g of saturated fat per day for 
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males requiring 2500 kcal per day. Given these findings, it seems reasonable to 
suggest that all meals contained appropriate low amounts of saturated fat. 
 
All eight meals included fewer than 2 g of salt per portion, which represents only 33% 
of the recommended daily allowance of salt. There is an overwhelming body of 
evidence to suggest that dietary salt is the major cause of hypertension and that a 
reduction in salt intake lowers blood pressure, thereby, reducing blood pressure- 
related diseases, [358] [359-361]. For instance, several lines of evidence including 
population, and prospective cohort studies, as well as outcome trials, demonstrate 
that a reduction in salt intake is related to a lower risk of cardiovascular disease [362- 
368]. It was therefore of increased importance that all meals had a low salt profile. In 
terms of calorie amounts, each meal contained between 300 and 600 kcal per whole 
portion size, which are adequate values for one meal if consumers abide by the 
general notion of three meals per day, plus snacks. All soups (curried soup, pea and 
ham soup, leek potato and kale soup) were lower than other dishes in calories, 
containing around 300 kcal per 300 g, as to be expected from a liquidised food source 
such as soup which is typically accompanied by a carbohydrate food item as a side 
dish. The chicken, ham and leek casserole was the highest in calories, containing 
554 kcal per 350 g, which may be attributed to the two meats and small amount of 
chicken fat in which it contained. Despite this, it encompassed only 5.5 g of saturated 
fat per whole meal size of 350 g. This was substantially below the recommended 
maximum limit of 20 g per day and therefore was considered balanced in its nutritional 
profile. 
 
Zinc levels were particularly high in the Normandy pork casserole (6.3 mg) and the 
cottage pie (4.1 mg), providing over half of the DRV for both males and females. In 
the previous diet analysis study within a sample of AMD patients (chapter two) male 
and female zinc consumption was similar to the DRV. Zinc has been investigated with 
regard to its potential preventative role in AMD. The AREDS group found a suggestive 
reduction in the risk of progression of AMD in participants supplementing with 25 mg 
zinc daily [10]. A small number of cohort studies assessing dietary intakes of zinc in 
elderly subjects have also found an inverse relationship between high zinc intake and 
the incidence of early AMD [150, 175]. All meals were additionally high in vitamin C 
due to their increased quantities of vegetables. As well as typically being high in the 
carotenoids L and Z, research has shown that dark green vegetables such as collard 
greens (kale) and spinach also contain high concentrations of vitamin C [257, 369]. 
Seven out of eight meals contained concentrations of vitamin C which were above 
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the DRV of 40 mg per day. This was a positive attribute to the meals given the 
protective antioxidant properties of vitamin C in the human retina [370]. 
 
It is important to note that micronutrients do not feature in the FSA traffic light labelling 
of food products and the DRV standards used are based on average intakes over 
time rather than on individual meals. Therefore it is not necessarily the case that one 
main course should meet these standards. However, in the absence of international 
criteria for the nutritional content of individual meals, these standards are the best 
currently available and have been used previously for assessment of individual 
products [371], [372]. 
 
Overall, it was found that the ready-meals created for AMD patients were a healthier 
alternative to conventional supermarket meals which are available within the ready- 
meal sector. In particular, it was found that meals were rated as low in fat, saturated 
fat and salt, and were therefore much more likely to achieve ‘low’ ratings of all four 
front-of-pack nutrients. As well as this balanced supply of key macro-nutrients, most 
importantly the ready meals contained substantial amounts of L and Z, as well as 
antioxidant micro-nutrients such as zinc and vitamin C, which may be of benefit in the 
primary prevention of the onset or progression of AMD. 
 
Kale cup weights 
 
 
According to the USDA National Nutrient Database for Standard Reference Release 
 
26, the weight for one cup of raw, chopped kale is 67 grams - among the highest for 
raw leafy vegetables. For spinach, the USDA reports that one cup of raw baby leaf 
spinach is 30 grams [373]. Therefore, if we assume that there are 10 – 20 mg of L in 
100g raw kale (chapter four: dependant on source) and that a cup of kale weighs 67 
g, then one cup of raw kale should be enough to provide around 10 mg of L per day. 
Moreover, if we assume that one cup of spinach weighs 30 g and that there is 10 mg 
of L in 100 g of raw spinach then this should equate to 3 mg of L. However, during 
creation of the ready meal recipes contradictions in these findings were apparent. To 
ensure at least 30 g of kale per meal, kale and spinach were initially weighed in a 
standardised measuring cup before being added to a recipe. The findings revealed 
that one cup of raw, chopped kale with hard stems removed, weighed approximately 
20 g. Interestingly, these findings correspond with a recent study to suggest that the 
USDA recommendations are in fact not a true representation of kale cup sizes [374]. 
Based on the USDA data, one current dietary suggestion for AMD patients is to 
consume at least one cup of kale per day to provide enough L to support the 
prevention of onset or progression of AMD.  However if 20 g of kale is a true 
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representation of cup size, then our HPLC data indicates that this would only provide 
 
3 mg of L, which may be insufficient for AMD patients. If patients were to try and 
increase their dietary L intakes without the use of supplements, they would need to 
consume just over three cups of shop purchased kale per day to ensure a sufficient 
supply of L. Patient nutritional information resources such as those given out by the 
MS may therefore need to be updated in connection with these findings. Further 
research in regard to the quantification of L within other raw leafy green vegetables 
sourced from the UK and verification of their cup weights may also be needed to 
warrant realistic dietary recommendations for AMD patients. 
 
6.4 Delivery and evaluation of ready meals 
 
 
Once hand prepared by the team at Lodge Farm Kitchen, the ready meals were blast 
frozen and then delivered to the corresponding research institute on the same day. 
Once received by the researcher they were instantly transported for a taste testing 
session with AMD subjects at a local MS peer support group. The MS peer support 
group, located in Barnt Green, Birmingham, UK, included some of the same MS 
members used in the focus group study. Forty-Five MS members were present at the 
group during the taste testing session. All participants suffered with some form of 
AMD. A brief introduction was given to the group before the ready meals were served, 
to explain the research behind the ready meals, their nutritional quality, the company 
Lodge Farm Kitchen and the aims and objectives of the study. Participants were made 
aware that they would be required to give basic feedback on the meals during the 
session and were therefore encouraged to try as many of the dishes as possible to 
support the research. 
 
 
Three to four meals of each recipe were cooked following the relevant instructions 
and smaller samples of each dish were served to the group. Meals were cooked from 
frozen using an oven and microwave. A list of ingredients and cooking instructions for 
the meals was also given to each table of participants. Once participants had finished 
tasting the meal samples, an organoleptic test sheet was given to each participant for 
verbal completion with the help of a scribe. The test required participants to give a 
mark out of five for appearance, smell, texture, and taste, as displayed in the below 
figure. Only subjects who felt comfortable with their visual acuity were required to 
score for appearance. At the end of the taste testing session a brief talk was given to 
the participants. During the talk subject’s overall opinion of the meals was discussed, 
where subjects were encouraged to speak out if they had something they would like 
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to say about the meals. Samples of each ready meal in its original packaging and full 
size were also given out to subjects to gain feedback on portion sizes and packaging. 
Participants were asked whether or not each dish would be an adequate portion for 
one meal and whether or not the packaging, cooking instructions and ingredient lists 
were easy to comprehend. Points raised by the group were transcribed. 
 
 
 
 
 
 
 
 
 
 
Organoleptic Test 1-5 (5 very good, 4 good, 3 average, 2 poor, 1 very poor) 
Product Visual Smell Texture Taste Comment 
 
Chicken, ham & leek casserole 
     
 
Curried potato apple & kale 
     
 
Fish pie with spinach 
     
 
Kale & smokey bacon pasta 
     
 
Leek potato & kale soup 
     
 
Normandy pork casserole 
     
 
Pea and ham soup 
     
 
Cottage Pie 
     
 
 
 
Figure 3.6: Organoleptic test sheet used to gain patient feedback on the ready meals. 
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Taste testing results 
 
 
 
 Chicken 
Casserole 
Curried 
Kale Soup 
Fish 
Pie 
Kale 
Pasta 
Leek & 
Kale Soup 
Pork 
Casserole 
Pea 
Soup 
Number of 
Tasters 
  
9 
 
7 
 
8 
 
8 
 
7 
 
7 
 
7 
Total 
Score 
 
Visual 
 
29 
 
27 
 
31 
 
28 
 
30 
 
29 
 
21 
 Smell 40 32 33 27 32 30 23 
 Texture 43 31 36 25 32 27 27 
 Taste 43 32 36 27 32 27 30 
  Chicken Curried Fish Kale Leek & Pork Pea 
  Casserole Kale Soup Pie Pasta Kale Soup Casserole Soup 
Average 
Score 
 
Visual 
 
3 
 
4 
 
4 
 
4 
 
4 
 
4 
 
3 
 Smell 4 5 4 3 5 4 3 
 Texture 5 4 5 3 5 4 4 
  Taste  5  5  5  3  5  4  4   
 
Table 4.2: Results of the taste testing session with ready meals including total and 
 
mean organoleptic scores per meal. 
 
 
 
 
 
Mean organoleptic scores 
 
6 
 
5 
 
4 
Visual 
3 Smell 
2 Texture 
 
1 Taste 
 
0 
Chicken 
 
Curried 
 
Fish Pie Kale 
 
Leek & 
 
Pork 
 
Pea Soup  Cottage 
Casserole Kale Soup Pasta Kale Soup Casserole Pie 
 
 
Figure 3.7: Mean organoleptic test scores for smell, taste and texture of each ready 
meal. 
 
 
Table 4.2 displays the results of the organoleptic test used to test the ready meals 
created for AMD patients. The test was used in a group of forty-five AMD patients 
from a local MS peer support group. The number of tasters for each meal is displayed 
at the top of the table in red. Total and mean scores for appearance, smell, texture 
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and taste are displayed for each meal. Figure 3.7 displays the mean results of the 
organoleptic test for visual appearance, smell, texture and taste. Results showed that 
the chicken casserole, curried soup, fish pie, leek soup and cottage pie all had the 
highest mean score of 5 for taste, which represented the patient opinion of ‘very 
good’. The pork casserole and pea soup had a mean score of 4 for taste which 
represented ‘good’ and finally the kale and smoky bacon pasta had a mean score of 
3 which represented an ‘average’ mark. The kale and smoky bacon pasta also had 
the lowest scores for smell and texture out of all ready meals available. Many patients 
made comments during the test to suggest that the pasta was slightly dry in taste and 
texture which may justify these findings. The kale pasta was the only ready meal 
which was cooked in the microwave as opposed to the oven, which may have 
contributed to the dry texture. All meals may be oven or microwaved cooked from 
frozen, however as we were preparing samples on a large scale both cooking 
techniques were utilised to save time and space. 
 
 
Aside from the kale and smoky bacon pasta, meals scored a 4 or above for texture 
and taste which signified patient’s overall satisfaction with the meals. Comments from 
patients about the ready meals in general were excellent, with many subjects giving 
highly positive feedback in regard to taste and freshness. For smell, most ready meals 
had an average score of 4 or above, aside from the kale pasta and the pea and ham 
soup. Both the pea and ham soup and kale and smoky bacon pasta scored an 
average of 3 for smell. Some patients stated that the slightly unpleasing smell did not 
affect the taste of the meals. 
 
 
For appearance, meals scored a 4 for ‘good’ aside from the kale and smoky bacon 
pasta and the pea and ham soup. Only subjects who felt their vision was good enough 
to judge a meal by its appearance gave a score for visual attributions. In regard to the 
kale and smoky bacon pasta, some subjects gave comments that it appeared dry and 
crispy in texture. Subjects also mentioned that the pea and ham soup appeared very 
thick and gloopy. The dry appearance of the pasta again may be attributable to the 
cooking method used. 
 
Feedback for group questions after taste testing session: 
 
 
Upon completion of the taste testing session, participants were asked to partake in a 
group discussion in order to gain some oral feedback on the ready meals. Questions 
relating to taste and enjoyment were propositioned to the group to gather a more 
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rounded view. Feedback on portion sizes and whether or not the packaging, cooking 
instructions and ingredient lists were easy to read and understand was also invited 
from the group. Comments from participants about the ready meals in general were 
excellent, with many subjects giving favourable responses. Subjects were in 
agreement that the meals did not taste like standard supermarket purchased ready 
meals and were more comparable in taste and flavour to home cooked meals. 
Participants were enthused by the notion that meals contained no additives or 
preservatives, were cooked using locally sourced fresh ingredients and methods 
which ensured optimisation of their nutritional value. 
 
 
Portion sizes of the meals were approximately 300g for the soup dishes and 350g for 
all other meals. Whole meal samples in their original packaging were passed around 
the group so subjects could get a better idea of portion size. All subjects were in 
agreement that the portion sizes of the dishes were substantial for one whole meal. 
Cooking instructions and ingredient lists for each meal were handed out with the 
corresponding dish; a large clear bold text font in black was used on a yellow 
background which enabled subjects to interpret the details with ease. This colour 
contrast between text and background is used within all MS resources as a typical 
black to white contrast may cause glare in those with visual impairments. 
 
 
Limitations 
 
 
 
One limitation to this study may be the possibility of response bias resulting from the 
experimental design. A brief introduction was given to the group before the ready 
meal analysis, which explained the research behind the ready meals, their nutritional 
quality, the company Lodge Farm Kitchen and the aims and objectives of the study. 
Such circumstances may have led to a nonrandom deviation of the answers from their 
true value, as subjects may have believed to have understood the experiment and its 
expected findings, so adapted their responses to suit. This may have prompted them 
into giving answers skewed towards the researchers own opinions, prejudices and 
values [375, 376]. This type of bias should have be factored into the experiment and 
the amount of information given to the subjects restricted, which would have 
prevented them from understanding the full extent of the research. 
 
 
There are several limitations to using food composition databases (such as Al la Calc) 
to accurately predict nutrient values in food sources. One of these may be the 
variability in the composition of foods, as being biological materials foods exhibit 
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natural variations in the amounts of nutrients contained [377]. A database is unlikely 
to predict within narrow limits the composition of a particular sample of food, because 
the limits will vary according to the source of food item and to the nutrient [378]. Al La 
Calc quantified the levels of L and Z together, which made it difficult to use the HPLC 
determination of L levels within kale (chapter 4) as a comparison for the ready meal 
nutrient composition tables produced by Al La Calc. As the kale used in the ready 
meals was sourced from the same farm investigated in the analytical study, estimates 
for the L concentrations of these meals were derived from the calculations of this 
study and not Al la Calc. 
 
However, proposed L concentrations of these recipes should still be taken with 
caution as this natural variability in the composition of foods is increased by different 
methods of plant storage, processing and treatment. Processed foods such as ready 
meals, despite being subject to quality control during production, may vary, in part 
because of variations in the composition of ingredients but also because of changes 
in formulation and production [276]. Kale was added to meals at the end of their 
preparation to ensure only minimal cooking occurred and to retain as much of the 
nutrient value as possible, as this was similar to the blanching method used the 
previous analytical study where the retention of L was highest with shorter cooking 
times, lower temperatures and minimal amounts of water. In this previous study 
however, kale was analysed for L concentrations individually and not within the ready 
meal source. Furthermore, the extent to which leaching occurred was not analysed 
within the previous report. Determining the L content of the water after the cooking 
process would have given further reliable information about the proposed L content 
of these meals. 
 
6.5 Summary 
 
 
 
A taste testing session was conducted with a group of forty-five AMD patients from a 
local Macular Society peer support group. All ready meals designed with the help of 
Lodge Farm Kitchen were included in the evaluation session and subjects were 
required to give scores out of five for appearance, taste, texture and smell using an 
organoleptic test method. Oral feedback was gained from the subjects during a group 
session after the testing to distinguish overall opinions of the meals and the suitability 
of portion sizes.  The ease at which subjects could comprehend the corresponding 
ingredient lists and cooking instructions for meals was also discussed. Out of the total 
number of eight ready meals, seven scored four (good) or above for taste, with the 
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exception being the kale and smoky bacon pasta which scored a three (average). All 
meals also scored a three or above for other factors such as appearance, smell and 
texture and overall comments from study group members in regard to the meals were 
excellent. To improve the taste and texture for the lowest scoring meal of the kale and 
smoky bacon pasta it may be necessary to recommend oven cooking as opposed to 
microwave cooking in order to prevent meal dryness.  Feedback from the group 
discussion informed us that portion sizes were suitable for subjects and ingredient 
lists and cooking instructions were easily read and understood. Subjects were further 
enthused by the facts that meals contained no additives or preservatives, were 
cooked using locally sourced fresh ingredients and methods which ensured 
optimisation of their nutritional value. This evaluation study gives insight in to the use 
of ready meals as a novel intervention to improve diet in those suffering with AMD. 
The highly positive feedback gained from subjects during the session will be valuable 
when exploring how to further develop these prototype meals and the next steps in 
manufacturing them on a larger scale. 
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Chapter 7: Discussion 
 
Current knowledge suggests that nutrition through dietary modification or supplement 
use may prevent the onset or progression of AMD [8, 10].  The investigations 
described over the course of the previous chapters aimed to contribute new 
information to the literature on nutrition and AMD, with the use of various qualitative 
and quantitative studies which focus on optimising dietary modification for this 
condition. There are various limitations to the studies constructed within this thesis 
which need to be considered when interpreting the overall quality, validity and 
generalisability of results reported. However, the problems and limitations 
encountered provide valuable feedback to inform further development of research 
methods in these populations and larger scale studies of such interventions. 
 
 
The peer-reviewed literature in chapter one provided a detailed review on the pre-and 
post-harvest effects of the carotenoid concentrations in leafy green vegetables. 
These findings are important because they demonstrate that there is a paucity of 
evidence that has investigated the pre and post-harvest processing and storage 
effects of kale grown and retailed in the UK, thus setting a precedent for the study in 
chapter three. Currently AMD patients are advised to include more dark green 
vegetables such as kale in to the diet to increase their intake of L and Z, which are 
implicated in the maintenance of retinal health and possible prevention of the onset 
or progression AMD [379, 380]. Therefore, information regarding their stability during 
domestic cooking and storage is crucial. 
 
Notable and statistically significant findings were obtained in chapter three; L levels 
in minimally processed kale prepared for retail were significantly lower than that of in- 
tact whole kale sourced freshly harvested from the farm (p<0.001). Domestic cooking 
and storage were also found to have significant negative effects on the content of L 
in these kale sources. Reducing processing/storage time and using cooking methods 
which require lower temperatures and minimal amounts of water such as steaming, 
blanching and liquidising, improved L retention significantly. These outcomes have 
been reported in studies which have investigated the cooking and storage stability of 
other predominant carotenoid containing foods, thus vegetables such as kale should 
be consumed soon after harvest, or postharvest handling conditions must be 
controlled such that nutrient degradation does not occur [199, 277]. Further research 
is required to support the chemical and biochemical alterations that occur in post- 
harvest  minimally  processed  foods  sold  in  supermarkets  and  on  the  improved 
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maintenance of their nutritional quality, particularly for food sources that have not 
been rigorously investigated such as UK kale. 
 
The UK charity the MS advocates the use of vegetables high in L and Z within their 
patients resources. However the dietary analysis data in chapter two indicated that 
patients who seek their services are under consuming nutrients regarded as important 
for their condition, such as L and Z [211]. The qualitative research in chapter four was 
designed to follow up this work and gain and understanding of the dietary behaviour 
of AMD patients and the possible barriers to dietary change. A focus group method 
was selected as this approach fosters open interaction and discussion among group 
members, which generated rich data related to the individual needs of older adults 
living with visual impairment. Data revealed that patients recognised the importance 
of following a diet which contains important nutrients to help slow the progression of 
AMD, yet altering dietary habits is proven difficult when there are underlying individual 
barriers to change. Chapter five expanded on this evidence by establishing, in more 
detail, the food choices and preferences of AMD patients by use of an open ended 
survey within a larger cohort. It was concluded that ready meals which are nutritionally 
tailored to support the needs of these individuals, may be a promising intervention for 
improving diet in these individuals. 
 
The external validity of the results presented in the observational studies within this 
report may be questioned due to the presence of small sample sizes. One criticism 
of qualitative data analysis is that because it typically involves examination of data 
extracted from small, non-random samples, findings are usually not generalisable 
beyond the local research participants [375, 376]. However, what is a limitation for 
one purpose is a strength for another purpose. Specifically, the examination of 
relatively small samples allows qualitative researchers to collect maximally rich data 
via the methods configured within these reports (e.g. focus groups, observations, 
nonverbal communication and open ended surveys) [299]. This, in turn, makes it more 
likely that as a result of the qualitative data analysis, verstehen will be achieved. 
 
The subject samples used in the above studies, of course, are not a truly accurate 
representation of all patients seeking services from the MS. More time and access to 
information from more patients would have provided a more rounded and reliable 
view. Furthermore, the overall health of subjects was not investigated within these 
cohorts, suggesting that results relating to issues with visual impairment may have 
been the cause of other contributing factors. As dietary habits are multi-factorial [381], 
future research taking in to consideration other  cofounding variables should be 
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encouraged. This research solely focuses on AMD patients who are members of the 
UK charity the MS. Since the AMD cohorts all had a form of AMD and were motivated 
to contact or engage with the MS for support, it may be presumed that they were 
interested in preventing the disease from progressing. Thus, future research should 
aim to find out the opinions of those with AMD who have not sought support from 
professional  or  non-professional  organisations  and  therefore  not  considered  an 
‘informed’ population. 
 
 
This PhD thesis contributes new evidence to the research base within nutrition and 
AMD. The results were in aligning with previous studies that, in spite of advice being 
given to patients by the MS, they primarily eat food they enjoy and are used to [211]. 
Changing eating habits therefore requires novel intervention methods [210]. This 
project outlines the design of an effective and innovate measure for improving diet in 
patients with, or at risk of, AMD. The ready meals were designed based on the food 
likes and dislikes of AMD patients (chapter five) and on the optimum conditions for 
acquirement and handling of kale (chapter four). Upon the success of a taste testing 
session within an AMD cohort (chapter six), the MS agreed to endorse the ready 
meals and assist with the marketing and promotion of them through their member 
resources.  The ‘macular meals’ are now available for members of the public to 
purchase through the Lodge Farm Kitchen website either online or via the telephone. 
As a result, there has been a large interest in the ready meals amongst AMD patients 
and other members of the public. 
 
 
Results from the laboratory investigation within this report intend to enrich the current 
dietary advice and information given to AMD patients. Indeed, 40–80% of medical 
information provided by healthcare practitioners is forgotten immediately [382] and 
the greater the amount of information presented, the lower the proportion correctly 
recalled [383]. However, Ley's model on effective communication in medical practice 
stresses the importance of memory next to factors such as the understanding of 
information and satisfaction with the treatment [382]. Thus, providing further 
understanding on the pre and post-harvest effects of L levels in kale will enable 
precise suggestions for increasing retinal levels of these nutrients, which in turn, may 
result in improved dietary habits. Though it is important to consider that modifying a 
diet to include high amounts of L and Z may not have as much effect as one would 
hope. The reasoning behind this uncertainty stems from the knowledge that there are 
many uncontrollable inter-individual variations that regulate the digestion, absorption, 
transport and eventual retinal uptake and maintenance of L and Z [279], which haven’t 
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been explored here. Nevertheless, results of this report will hopefully support the 
continued investigation of L and Z within AMD therapy. 
 
 
In summary, this PhD project has enabled research to be taken from the laboratory, 
conducting HPLC analysis to determine the lutein concentrations of kale upon various 
pre-and post-harvest factors, to the patient, by producing evidence-based ready 
meals to improve diet in people with macular degeneration. The evidence embedded 
gives insight in to the use of ready meals as a novel intervention to improve diet in 
those suffering with AMD and provides the foundations for the manufacturing of these 
meals on a larger scale. 
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Appendix  2:  Focus  group  data  analysis  sheet:  Matrix  for  assessing  level  of 
 
consensus in the focus group. 
 
 
Focus Group 
Question 
 
Member 1 
 
Member 2 
 
Member 3 
 
Member 4 
 
Member 5 
 
Member 6 
 
 
1 
      
 
 
2 
      
 
 
3 
      
 
 
4 
      
 
 
… 
      
 
 
The following notations were entered in the cells: 
 
A = Indicated agreement (i.e., verbal or nonverbal) 
D = Indicated dissent (i.e., verbal or nonverbal) 
SE = Provided significant statement or example suggesting agreement 
SD = Provided significant statement or example suggesting dissent 
NR = Did not indicate agreement or dissent (i.e., nonresponse). 
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Appendix 3: Ready meal questionnaire for AMD patients. 
 
 
1)   What is your gender? 
 
 
2)   How old are you? 
 
 
3)   Do you suffer with dry AMD or wet AMD?   Dry Wet 
 
 
4)   Do you eat ready meals? 
 
Yes No 
 
If answer Yes go to Q3 if answer No go to Q2 
 
5)   Can you tell me the main reasons why you do not eat ready meals? 
 
…………………………………………………………………………………………………… Go to Q8 
 
6)   Why do you eat ready meals? 
 
 
…………………………………………………………………………………………………………………………… 
7)   How often do you eat ready meals? 
 
 
Once a month Once a fortnight  1-2 times a week 2-3 times a 
week 3-4 times a week Everyday 
 
 
8)   How much would you willing to pay for a ready meal? 
 
< £2 £2-4 > £4 
 
9)   Can you tell me which of the following outlets you access ready meals from? 
 
Telephone Supermarket Website Shopping channel 
 
10) Would you consider eating a ready meal which contained kale? 
 
 
Yes No 
 
 
11) Would you consider eating a ready meal that was tailored to suit the nutritional 
needs of people with AMD? 
 
 
Yes No 
 
 
12)  What kinds of foods do you like to eat? (In ready meals or normal meals) 
 
 
………………………………………………………………………………………………………………………… 
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13) Which of the following types of food would you like to eat? 
 
 
Fish Chicken Beef Lamb Pork 
 
 
Vegetarian meals Food that I can eat without utensils (e.g. a pasty) 
One-pot meals such as soup or casserole 
14) If you are visually impaired can you tell me about any foods that are particularly 
difficult for you to eat? 
 
 
…………………………………………………………………………………………………………………………… 
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Appendix 4: Letter inviting subjects of the Macular Societies sight impairment 
register to partake in the ready meal survey. 
9th December 2015 
Dear Macular Society member 
The Macular Society is working with Aston University to 
develop ready meals suited towards people who are 
visually impaired. We are looking for Macular Society 
members to complete a simple questionnaire about the 
foods that they like to eat. To take part you must be over 
55 years old and be diagnosed with AMD. You must also 
be able to hear and reply to questions in English over the 
telephone. 
If you are willing to take part, please contact Rachel 
Walsh: 
By phone: 0121 4511154 07572037342 
By email: walshr1@aston.ac.uk 
Rachel will call you back at a convenient time to 
complete the questionnaire over the phone. 
Thank you in advance. 
164 
Appendix 5: Ingredient lists for each ready meal created. 
Product 
Ingredients Weight Gram per portion 
Curried potato and kale soup Onion 300g 36 
Potato 48 
Apple 28.5 
Kale 35 
Leek 24 
Parsnip 12 
Vegetable boullion 2 
Curry powder 0.01 
Apple cider vinegar 1.2 
Water 180 
Salt 0.02 
Pepper 0.001 
Apple juice 30 
Honey 2 
Coconut powder 10 
Crème fraiche half fat 25 
Normandy pork casserole Bramley apple 350g 35.38 
Olive oil 0.1 
Butter 0.1 
Onion 34.6 
Shoulder of pork 184.6 
Water 115.3 
Marigold vegetable boullion 3.84 
Apsall dry cider 38.46 
Leeks 26.15 
Red pepper 27.69 
New potatoes 38.46 
Spinach 50 
Crème fraiche half fat 8 
Cornflour 3.84 
Kale and smoky bacon pasta Pasta 350g 53.33 
Olive oil 0.05 
Smokey bacon lardons 26.66 
Cream cheese low fat 40 
Spinach 15 
Butter 5 
Milk semi skimmed 133.33 
Flour 13.33 
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Kale 30 
Seaweed 0.333 
Pea and ham soup Peas 300g 120 
Ham 26 
Onion 20.2 
Potato 37 
Kale 20 
Spinach 15 
Water (from cooked ham) 128 
Chicken boullion 2.4 
Salt 0.02 
Pepper 0.01 
Butter 4.4 
Cottage pie Minced beef 350g 74.4 
Onion 26.66 
Tinned tomato 66.66 
Tomato puree 3.33 
Red pepper 20 
Beef boullion 3.33 
Celery 14 
Kale 35 
Water 33.33 
Carrot 18.66 
Cornflour 1.66 
Potato 133 
Salt 0.02 
Pepper 0.001 
Chicken ham and leek casserole Water 350g 210 
Chicken boullion 6 
Chicken breast 120 
Butter/chicken fat 4.5 
Carrots 15.5 
Kale 35 
Leeks 30 
Plain flour 8 
Cooked ham 45 
New potatoes 50 
Fish pie with spinach Haddock 350g 34.28 
Salmon 34.28 
Smoked haddock 34.28 
Eggs 60 
Flour 8.49 
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Butter 14.28 
Milk 67 
Spinach 20 
Kale 10 
Potatoes 150 
Pepper 0.03 
Salt 0.3 
Leek potato and kale soup Leek 300g 65.62 
Potato 45 
Kale 30 
Water 62.5 
Vegetable boullion 4.375 
Salt 0.01 
Pepper 0.001 
Butter 6.87 
Milk 150 
Eggs 60 
Nutmeg 
Arrowroot 2.08 
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Appendix 6: Full nutrient analyses of ready meals from Al La Calc. 
Curried Soup 
Name 
per 
100g unit 
per 300g 
serving unit 
Energy 177 kJ 755 kJ 
Energy 42 kcal 381 kcal 
Fat 1.2 g 5.3 g 
of which saturates 0.7 g 2.9 g 
Carbohydrate 8.3 g 35.5 g of 
which sugars 2.9 g 12.2 g 
Fibre 1.9 g 8.1 g 
Protein 1.4 g 6.1 g 
Salt 0.2 g 1 g 
Sodium 89.85 mg 384.34 mg 
Calories from Fat 11 kcal 47 kcal 
Fatty Acids 
Monounsaturated 0.3 g 1.1 g 
Fatty Acids 
Polyunsaturated 0.1 g 0.4 g 
Trans Fatty Acids trace g 0.1 g 
Starch 0.1 g 0.3 g 
Water 87.6 g 374.5 g 
Nitrogen trace g 0.2 g 
Cholesterol 0 mg 0 mg 
Potassium 165.8 mg 709.2 mg 
Calcium 29.9 mg 127.8 mg 
Magnesium 22.1 mg 94.5 mg 
Phosphorus 40.7 mg 174 mg 
Iron 0.7 mg 2.9 mg 
Copper 0.2 mg 1.1 mg 
Zinc 0.3 mg 1.2 mg 
Chloride 4.5 mg 19.4 mg 
Manganese 0.2 mg 0.9 mg 
Selenium 0.7 μg 3.2 μg 
Iodine 0.5 μg 2.3 μg 
Retinol 14 μg 60 μg 
Carotene 1.8 μg 7.8 μg 
Alpha Carotene 4.4 μg 18.9 μg 
Beta Carotene 543.3 μg 2324 μg 
Vitamin D MCG trace μg trace μg 
Vitamin D IU trace IU trace IU 
Vitamin E 0.3 mg 1.2 mg 
Thiamin trace mg 0.2 mg 
Riboflavin trace mg 0.2 mg 
Niacin 0.4 mg 1.6 mg 
Tryptophan/60 trace mg 0.1 mg 
Vitamin B6 0.1 mg 0.4 mg 
Vitamin B12 trace μg trace μg 
Folate 19.8 μg 84.9 μg 
Pantothenic Acid 0.1 mg 0.5 mg 
Biotin 0.1 μg 0.4 μg 
Vitamin C 12.4 mg 53 mg 
Ash 0.5 g 2.1 g 
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Folic Acid 0 μg 0 μg 
Food Folate 18.8 μg 80.3 μg 
Dietary Folate Equivalents 18.8 μg 80.3 μg 
Choline 2.7 μg 11.6 μg 
Vitamin A IU 961.8 IU 4113.7 IU 
Vitamin A RAE 60.1 μg 257 μg 
Beta Cryptoxanthin 7.5 μg 32.1 μg 
Lycopene 0 μg 0 μg 
Lutein Zeaxanthin 781.6 mg 3.343 mg 
Vitamin K 61.3 μg 262.1 μg 
Normandy Pork Casserole 
Name 
per 
100g unit 
per 350g 
serving unit 
Energy 376 kJ 1696 kJ 
Energy 90 kcal 404 kcal 
Fat 3.5 g 15.6 g 
of which saturates 1.2 g 5.5 g 
Carbohydrate 5.4 g 24.1 g of 
which sugars 1.9 g 8.5 g 
Fibre 0.9 g 4.1 g 
Protein 8.9 g 40 g 
Salt 0.4 g 1.8 g 
Sodium 155.64 mg 700.96 mg 
Calories from Fat 31 kcal 141 kcal 
Fatty Acids 
Monounsaturated 1.4 g 6.3 g 
Fatty Acids 
Polyunsaturated 0.4 g 1.7 g 
Trans Fatty Acids trace g trace g 
Starch 2 g 8.8 g 
Water 80.5 g 362.7 g 
Nitrogen trace g 0.2 g 
Cholesterol 27.5 mg 123.9 mg 
Potassium 282 mg 1270.2 mg 
Calcium 26 mg 117.1 mg 
Magnesium 22.7 mg 102.3 mg 
Phosphorus 100.4 mg 452.1 mg 
Iron 1.1 mg 4.8 mg 
Copper 0.1 mg 0.4 mg 
Zinc 1.4 mg 6.3 mg 
Chloride 11.1 mg 50 mg 
Manganese 0.2 mg 0.7 mg 
Selenium 12.4 μg 55.7 μg 
Iodine 0.5 μg 2.1 μg 
Retinol 6.3 μg 28.4 μg 
Carotene 0.4 μg 1.7 μg 
Alpha Carotene 1.2 μg 5.5 μg 
Beta Carotene 783 μg 3526.4 μg 
Vitamin D MCG trace μg trace μg 
Vitamin D IU trace IU trace IU 
Vitamin E 0.4 mg 1.8 mg 
Thiamin 0.4 mg 1.8 mg 
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Riboflavin 0.2 mg 0.7 mg 
Niacin 2 mg 9.2 mg 
Tryptophan/60 trace mg 0.2 mg 
Vitamin B6 0.3 mg 1.1 mg 
Vitamin B12 0.3 μg 1.6 μg 
Folate 34.2 μg 153.9 μg 
Pantothenic Acid 0.4 mg 1.9 mg 
Biotin 0.2 μg 0.9 μg 
Vitamin C 14.3 mg 64.2 mg 
Ash 0.7 g 3.3 g 
Folic Acid 0 μg 0 μg 
Food Folate 31.6 μg 142.3 μg 
Dietary Folate Equivalents 31.6 μg 142.3 μg 
Choline 3.5 μg 15.8 μg 
Vitamin A IU 1351.5 IU 6086.7 IU 
Vitamin A RAE 72.9 μg 328.4 μg 
Beta Cryptoxanthin 30.1 μg 135.7 μg 
Lycopene 0 μg 0 μg 
Lutein Zeaxanthin 1468 mg 6.6114 mg 
Vitamin K 56.7 μg 255.3 μg 
Kale & Smoky Bacon Pasta 
Name 
per 
100g unit 
per 350g 
serving unit 
Energy 613 kJ 1903 kJ 
Energy 145 kcal 451 kcal 
Fat 5.2 g 16 g 
of which saturates  2.5 g  7.7  g 
Carbohydrate      18.3 g  56.9  g 
of which sugars      3.1 g  9.7  g 
Fibre      1.3 g  4.1  g 
Protein     7 g   21.9  g 
Salt      0.4    g   1.3   g 
Sodium 161.53 mg 501.25 mg 
Calories from Fat 46 kcal 144 kcal 
Fatty Acids 
Monounsaturated 1.6 g 4.9 g 
Fatty Acids 
Polyunsaturated 0.5 g 1.7 g 
Trans Fatty Acids trace g 0.1 g 
Starch 13.5 g 41.9 g 
Water 67.1 g 208.2 g 
Nitrogen 0.9 g 2.9 g 
Cholesterol 18.3 mg 56.9 mg 
Potassium 236.4 mg 733.7 mg 
Calcium 96.3 mg 298.9 mg 
Magnesium 22.7 mg 70.5 mg 
Phosphorus 117.6 mg 364.8 mg 
Iron 0.8 mg 2.3 mg 
Copper 0.3 mg 1.1 mg 
Zinc 0.7 mg 2.2 mg 
Chloride 199.5 mg 619.1 mg 
Manganese 0.3 mg 0.8 mg 
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Selenium 3.8 μg 11.8 μg 
Iodine 12.1 μg 37.7 μg 
Retinol 32.2 μg 100 μg 
Carotene 17.3 μg 53.8 μg 
Alpha Carotene 5.2 μg 16.2 μg 
Beta Carotene 847.2 μg 2629 μg 
Vitamin D MCG 0.1 μg 0.4 μg 
Vitamin D IU 5.3 IU 16.5 IU 
Vitamin E 0.5 mg 1.4 mg 
Thiamin 0.1 mg 0.4 mg 
Riboflavin 0.2 mg 0.5 mg 
Niacin 2.3 mg 7.1 mg 
Tryptophan/60 1.1 mg 3.4 mg 
Vitamin B6 0.1 mg 0.3 mg 
Vitamin B12 0.5 μg 1.6 μg 
Folate 32.7 μg 101.4 μg 
Pantothenic Acid 0.6 mg 1.9 mg 
Biotin 1.8 μg 5.7 μg 
Vitamin C 13.8 mg 42.9 mg 
Ash 0.5 g 1.6 g 
Folic Acid 0 μg 0 μg 
Food Folate 25.2 μg 78.1 μg 
Dietary Folate Equivalents 25.2 μg 78.1 μg 
Choline 2.5 μg 7.7 μg 
Vitamin A IU 1539.7 IU 4777.7 IU 
Vitamin A RAE 106.2 μg 329.7 μg 
Beta Cryptoxanthin 7.8 μg 24.3 μg 
Lycopene 0 μg 0 μg 
Lutein Zeaxanthin 1382.2 mg 4.2891 mg 
Vitamin K 91.7 μg 284.5 μg 
Pea and Ham Soup 
Name 
per 
100g unit 
per 300g 
serving unit 
Energy 234 kJ 874 kJ 
Energy 56 kcal 308 kcal 
Fat 1.5 g 5.6 g 
of which saturates 0.7 g 2.6 g 
Carbohydrate 7.7 g 28.7 g of 
which sugars 2.3 g 8.7 g 
Fibre 2.4 g 9 g 
Protein 3.7 g 13.9 g 
Salt 0.4 g 1.6 g 
Sodium 171.48 mg 639.66 mg 
Calories from Fat 13 kcal 49 kcal 
Fatty Acids 
Monounsaturated 0.4 g 1.5 g 
Fatty Acids 
Polyunsaturated     0.2 g  0.6  g 
Trans Fatty Acids     trace g   trace  g 
Starch    1.7 g  6.3  g 
Water      85.4 g   318.7  g 
Nitrogen    0.3   g   0.9  g 
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Cholesterol 6.6 mg 24.5 mg 
Potassium 205.7 mg 767.3 mg 
Calcium 24.6 mg 91.7 mg 
Magnesium 20.9 mg 78.1 mg 
Phosphorus 71.9 mg 268.1 mg 
Iron 0.8 mg 2.9 mg 
Copper 0.2 mg 0.6 mg 
Zinc 0.6 mg 2.3 mg 
Chloride 79.8 mg 297.5 mg 
Manganese 0.2 mg 0.8 mg 
Selenium 1.5 μg 5.5 μg 
Iodine 0.5 μg 1.7 μg 
Retinol 7.9 μg 29.5 μg 
Carotene trace μg trace μg 
Alpha Carotene 9.7 μg 36 μg 
Beta Carotene 690.4 μg 2575.3 μg 
Vitamin D MCG 0 μg 0 μg 
Vitamin D IU 0 IU 0 IU 
Vitamin E 0.2 mg 0.9 mg 
Thiamin 0.2 mg 0.6 mg 
Riboflavin 0.1 mg 0.3 mg 
Niacin 1.5 mg 5.6 mg 
Tryptophan/60 0.3 mg 1 mg 
Vitamin B6 0.1 mg 0.5 mg 
Vitamin B12 0.1 μg 0.3 μg 
Folate 39.9 μg 149 μg 
Pantothenic Acid 0.2 mg 0.6 mg 
Biotin 0.2 μg 0.9 μg 
Vitamin C 22.2 mg 82.9 mg 
Ash 0.5 g 1.8 g 
Folic Acid 0 μg 0 μg 
Food Folate 37.3 μg 139.3 μg 
Dietary Folate Equivalents 37.3 μg 139.3 μg 
Choline 10.5 μg 39.2 μg 
Vitamin A IU 1188.4 IU 4432.9 IU 
Vitamin A RAE 66 μg 246.1 μg 
Beta Cryptoxanthin 4.3 μg 16.2 μg 
Lycopene trace μg trace μg 
Lutein Zeaxanthin 1727.1 mg 6.4425 mg 
Vitamin K 65.4 μg 243.9 μg 
 
 
Cottage Pie 
 
 
Name 
per 
100g unit 
per 350g 
serving unit 
Energy 288 kJ 1142 kJ 
Energy 68 kcal 370 kcal 
Fat 1 g 4.1 g 
of which saturates                0.4         g                 1.8                      g 
Carbohydrate                         9.6         g                 38.1                    g 
of which sugars                      2            g                 7.8                      g 
Fibre                                       1.6         g                 6.2                      g 
Protein                                   5.7         g                 22.5                    g 
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Salt 0.4 g 1.5 g 
Sodium 153.1 mg 607.4 mg 
Calories from Fat 9 kcal 37 kcal 
Fatty Acids 
Monounsaturated 
 
0.4 
 
g 
 
1.7 
 
g 
Fatty Acids 
Polyunsaturated 
 
0.1 
 
g 
 
0.4 
 
g 
Trans Fatty Acids trace g 0.2 g 
Starch 6.1 g 24.1 g 
Water 81.8 g 324.7 g 
Nitrogen 0.8 g 3.3 g 
Cholesterol 6.9 mg 27.5 mg 
Potassium 341.4 mg 1354.6 mg 
Calcium 24.9 mg 99 mg 
Magnesium 19.4 mg 77.1 mg 
Phosphorus 64.8 mg 257.3 mg 
Iron 0.7 mg 2.8 mg 
Copper 0.2 mg 0.8 mg 
Zinc 1 mg 4.1 mg 
Chloride 238.4 mg 945.6 mg 
Manganese 0.1 mg 0.6 mg 
Selenium 1.5 μg 5.8 μg 
Iodine 2.9 μg 11.5 μg 
Retinol trace μg trace μg 
Carotene 69.8 μg 277.1 μg 
Alpha Carotene 169.3 μg 671.7 μg 
Beta Carotene 1068.2 μg 4237.7 μg 
Vitamin D MCG 0.1 μg 0.4 μg 
Vitamin D IU 3.8 IU 14.9 IU 
Vitamin E 0.6 mg 2.2 mg 
Thiamin 0.1 mg 0.5 mg 
Riboflavin 0.1 mg 0.2 mg 
Niacin 2.6 mg 10.3 mg 
Tryptophan/60 0.9 mg 3.6 mg 
Vitamin B6 0.2 mg 0.8 mg 
Vitamin B12 0.4 μg 1.5 μg 
Folate 27.7 μg 110 μg 
Pantothenic Acid 0.3 mg 1.3 mg 
Biotin 0.6 μg 2.3 μg 
Vitamin C 24.8 mg 98.4 mg 
Ash 0.3 g 1.2 g 
Folic Acid 0 μg 0 μg 
Food Folate 18.2 μg 72.2 μg 
Dietary Folate Equivalents 18.2 μg 72.2 μg 
Choline 1.4 μg 5.5 μg 
Vitamin A IU 1879.9 IU 7458.1 IU 
Vitamin A RAE 103.8 μg 411.7 μg 
Beta Cryptoxanthin 31.8 μg 126.4 μg 
Lycopene 292.9 μg 1162 μg 
Lutein Zeaxanthin 785.1 mg 3.1147 mg 
Vitamin K 65.4 μg 259.6 μg 
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Chicken Ham & Leek Casserole 
 
 
Name 
per 
100g unit 
per 350g 
serving unit 
Energy 539 kJ 2339 kJ 
Energy 128 kcal 554 kcal 
Fat 3.6 g 15.6 g 
of which saturates                1.2         g        5.4                      g 
Carbohydrate                         5.3         g        23.1                    g 
of which sugars                      0.9         g        3.8                      g 
Fibre                                       0.8         g        3.5                      g 
Protein                                   19.7       g        85.4                    g 
Salt                                         0.9         g        3.8                      g 
Sodium 347.5 mg 1508.15 mg 
Calories from Fat 32 kcal 139 kcal 
Fatty Acids 
Monounsaturated 1.3 g 5.8 g 
Fatty Acids 
Polyunsaturated 0.5 g 2.3 g 
Trans Fatty Acids trace g 0.2 g 
Starch 2.9 g 12.6 g 
Water 70.3 g 305 g 
Nitrogen 3.1 g 13.3 g 
Cholesterol 59.1 mg 256.6 mg 
Potassium 346.4 mg 1503.5 mg 
Calcium 26.6 mg 115.4 mg 
Magnesium 28.2 mg 122.5 mg 
Phosphorus 199.2 mg 864.3 mg 
Iron 0.7 mg 3.1 mg 
Copper 0.2 mg 0.8 mg 
Zinc 0.8 mg 3.6 mg 
Chloride 152.8 mg 663.3 mg 
Manganese 0.1 mg 0.5 mg 
Selenium 9.4 μg 40.7 μg 
Iodine 4.7 μg 20.3 μg 
Retinol 7 μg 30.2 μg 
Carotene trace μg trace μg 
Alpha Carotene 128.5 μg 557.8 μg 
Beta Carotene 844.6 μg 3665.7 μg 
Vitamin D MCG 0.1 μg 0.5 μg 
Vitamin D IU 4.4 IU 19.2 IU 
Vitamin E 0.3 mg 1.4 mg 
Thiamin 0.2 mg 0.8 mg 
Riboflavin 0.1 mg 0.5 mg 
Niacin 11.4 mg 49.5 mg 
Tryptophan/60 3.7 mg 15.9 mg 
Vitamin B6 0.4 mg 1.7 mg 
Vitamin B12 0.1 μg 0.5 μg 
Folate 25 μg 108.4 μg 
Pantothenic Acid 1 mg 4.5 mg 
Biotin 1.5 μg 6.4 μg 
Vitamin C 11.5 mg 50 mg 
Ash 0.3 g 1.2 g 
Folic Acid 0 μg 0 μg 
Food Folate 16.5 μg 71.6 μg 
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Dietary Folate Equivalents 16.5 μg 71.6 μg 
Choline 1.2 μg 5.3 μg 
Vitamin A IU 1543.4 IU 6698.5 IU 
Vitamin A RAE 83 μg 360.1 μg 
Beta Cryptoxanthin 6.5 μg 28.4 μg 
Lycopene trace μg 0.2 μg 
Lutein Zeaxanthin 801.6 mg 3.479 mg 
Vitamin K 60.6 μg 263.2 μg 
Fish Pie with Spinach 
Name 
per 
100g unit 
per 350g 
serving unit 
Energy 425 kJ 1928 kJ 
Energy 101 kcal 458 kcal 
Fat 3.6 g 16.5 g 
of which saturates  1.3 g  5.8  g 
Carbohydrate      8 g  36.1  g 
of which sugars     1  g  4.5  g 
Fibre      0.8 g   3.6  g 
Protein    9.3 g  42.1  g 
Salt      0.3    g   1.5   g 
Sodium 127.17 mg 576.91 mg 
Calories from Fat 32 kcal 147 kcal 
Fatty Acids 
Monounsaturated 1.2 g 5.6 g 
Fatty Acids 
Polyunsaturated 0.6 g 2.7 g 
Trans Fatty Acids trace g 0.1 g 
Starch 6.4 g 29 g 
Water 77.5 g 351.8 g 
Nitrogen 1.1 g 5.2 g 
Cholesterol 63.6 mg 288.4 mg 
Potassium 310 mg 1406.3 mg 
Calcium 41.5 mg 188.1 mg 
Magnesium 24 mg 108.7 mg 
Phosphorus 116.2 mg 527.1 mg 
Iron 0.7 mg 3 mg 
Copper 0.1 mg 0.4 mg 
Zinc 0.4 mg 2 mg 
Chloride 121 mg 548.8 mg 
Manganese 0.1 mg 0.6 mg 
Selenium 12.3 μg 55.9 μg 
Iodine 54.9 μg 249.1 μg 
Retinol 28.8 μg 130.5 μg 
Carotene 1.4 μg 6.5 μg 
Alpha Carotene 1.2 μg 5.4 μg 
Beta Carotene 380.4 μg 1725.8 μg 
Vitamin D MCG 0.8 μg 3.7 μg 
Vitamin D IU 32.5 IU 147.4 IU 
Vitamin E 0.7 mg 3.3 mg 
Thiamin 0.1 mg 0.7 mg 
Riboflavin 0.1 mg 0.6 mg 
Niacin 3.1 mg 14.1 mg 
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Tryptophan/60 1.4 mg 6.5 mg 
Vitamin B6 0.2 mg 0.7 mg 
Vitamin B12 1.1 μg 5.2 μg 
Folate 28 μg 127 μg 
Pantothenic Acid 0.6 mg 2.6 mg 
Biotin 3.3 μg 15.2 μg 
Vitamin C 7.2 mg 32.5 mg 
Ash 0.2 g 1.1 g 
Folic Acid 0 μg 0 μg 
Food Folate 12.8 μg 58.2 μg 
Dietary Folate Equivalents 12.8 μg 58.2 μg 
Choline 8.1 μg 36.5 μg 
Vitamin A IU 732.9 IU 3324.9 IU 
Vitamin A RAE 60.8 μg 275.7 μg 
Beta Cryptoxanthin 1.8 μg 8.1 μg 
Lycopene trace μg trace μg 
Lutein Zeaxanthin 730 mg 3.3118 mg 
Vitamin K 36.9 μg 167.6 μg 
Leek Potato & Kale Soup 
Name 
per 
100g unit 
per 300g 
serving unit 
Energy 279 kJ 1126 kJ 
Energy 66 kcal 368 kcal 
Fat 3.2 g 12.7 g 
of which saturates 1.4 g 5.5 g 
Carbohydrate 6.6 g 26.6 g of 
which sugars 2.3 g 9.4 g 
Fibre 0.8 g 3.2 g 
Protein 3.9 g 15.8 g 
Salt 0.4 g 1.7 g 
Sodium 169.93 mg 685.16 mg 
Calories from Fat 28 kcal 113 kcal 
Fatty Acids 
Monounsaturated 0.9 g 3.8 g 
Fatty Acids 
Polyunsaturated 0.3 g 1.2 g 
Trans Fatty Acids trace g 0.1 g 
Starch 1.9 g 7.7 g 
Water 84.7 g 341.6 g 
Nitrogen 0.5 g 2.1 g 
Cholesterol 56.7 mg 228.4 mg 
Potassium 195.1 mg 786.7 mg 
Calcium 68.2 mg 275.2 mg 
Magnesium 16.5 mg 66.5 mg 
Phosphorus 75.4 mg 303.9 mg 
Iron 0.8 mg 3.2 mg 
Copper 0.1 mg 0.6 mg 
Zinc 0.4 mg 1.6 mg 
Chloride 65.6 mg 264.4 mg 
Manganese 0.2 mg 0.6 mg 
Selenium 4 μg 16.1 μg 
Iodine 17.2 μg 69.5 μg 
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Retinol 33.2 μg 133.9 μg 
Carotene 2.9 μg 11.7 μg 
Alpha Carotene 4 μg 16.2 μg 
Beta Carotene 605.7 μg 2442.2 μg 
Vitamin D MCG 0.5 μg 1.9 μg 
Vitamin D IU 19 IU 76.8 IU 
Vitamin E 0.5 mg 2 mg 
Thiamin 0.1 mg 0.3 mg 
Riboflavin 0.2 mg 0.7 mg 
Niacin 1 mg 3.9 mg 
Tryptophan/60 0.7 mg 3 mg 
Vitamin B6 0.1 mg 0.5 mg 
Vitamin B12 0.7 μg 2.8 μg 
Folate 32.4 μg 130.5 μg 
Pantothenic Acid 0.5 mg 2 mg 
Biotin 3.9 μg 15.7 μg 
Vitamin C 13.1 mg 52.8 mg 
Ash 0.3 g 1.3 g 
Folic Acid 0 μg 0 μg 
Food Folate 21 μg 84.7 μg 
Dietary Folate Equivalents 21 μg 84.7 μg 
Choline 1.8 μg 7.4 μg 
Vitamin A IU 1129.6 IU 4554.5 IU 
Vitamin A RAE 84.4 μg 340.3 μg 
Beta Cryptoxanthin 6 μg 24.3 μg 
Lycopene trace μg trace μg 
Lutein Zeaxanthin 933.2 mg 3.7626 mg 
Vitamin K 60.3 μg 243.1 μg 
